<SEC-DOCUMENT>0001628280-23-038312.txt : 20231109
<SEC-HEADER>0001628280-23-038312.hdr.sgml : 20231109
<ACCEPTANCE-DATETIME>20231109165722
ACCESSION NUMBER:		0001628280-23-038312
CONFORMED SUBMISSION TYPE:	8-K
PUBLIC DOCUMENT COUNT:		20
CONFORMED PERIOD OF REPORT:	20231109
ITEM INFORMATION:		Entry into a Material Definitive Agreement
ITEM INFORMATION:		Creation of a Direct Financial Obligation or an Obligation under an Off-Balance Sheet Arrangement of a Registrant
ITEM INFORMATION:		Other Events
ITEM INFORMATION:		Financial Statements and Exhibits
FILED AS OF DATE:		20231109
DATE AS OF CHANGE:		20231109

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			HUMANA INC
		CENTRAL INDEX KEY:			0000049071
		STANDARD INDUSTRIAL CLASSIFICATION:	HOSPITAL & MEDICAL SERVICE PLANS [6324]
		IRS NUMBER:				610647538
		STATE OF INCORPORATION:			DE
		FISCAL YEAR END:			1231

	FILING VALUES:
		FORM TYPE:		8-K
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	001-05975
		FILM NUMBER:		231393500

	BUSINESS ADDRESS:	
		STREET 1:		500 W MAIN ST
		CITY:			LOUISVILLE
		STATE:			KY
		ZIP:			40202
		BUSINESS PHONE:		5025801000

	MAIL ADDRESS:	
		STREET 1:		500 W. MAIN ST
		CITY:			LOUISVILLE
		STATE:			KY
		ZIP:			40202

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	EXTENDICARE INC
		DATE OF NAME CHANGE:	19740404

	FORMER COMPANY:	
		FORMER CONFORMED NAME:	HERITAGE HOUSE OF AMERICA INC
		DATE OF NAME CHANGE:	19671129
</SEC-HEADER>
<DOCUMENT>
<TYPE>8-K
<SEQUENCE>1
<FILENAME>hum-20231109.htm
<DESCRIPTION>8-K
<TEXT>
<XBRL>
<?xml version="1.0" ?><!--XBRL Document Created with the Workiva Platform--><!--Copyright 2023 Workiva--><!--r:5e4f0834-9750-4616-a45d-5233f2e47910,g:0ce8afb9-70ce-4fd1-b2fd-315c99189c78,d:7e0b12811e154c7bb17547217f3eb709--><html xmlns:ixt-sec="http://www.sec.gov/inlineXBRL/transformation/2015-08-31" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:dei="http://xbrl.sec.gov/dei/2023" xmlns:xbrli="http://www.xbrl.org/2003/instance" xmlns:ix="http://www.xbrl.org/2013/inlineXBRL" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns="http://www.w3.org/1999/xhtml" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:ixt="http://www.xbrl.org/inlineXBRL/transformation/2020-02-12" xml:lang="en-US"><head><meta http-equiv="Content-Type" content="text/html"/>


<title>hum-20231109</title></head><body><div style="display:none"><ix:header><ix:hidden><ix:nonNumeric contextRef="c-1" name="dei:EntityCentralIndexKey" id="f-21">0000049071</ix:nonNumeric><ix:nonNumeric contextRef="c-1" name="dei:AmendmentFlag" id="f-22">false</ix:nonNumeric></ix:hidden><ix:references xml:lang="en-US"><link:schemaRef xlink:type="simple" xlink:href="hum-20231109.xsd"></link:schemaRef></ix:references><ix:resources><xbrli:context id="c-1"><xbrli:entity><xbrli:identifier scheme="http://www.sec.gov/CIK">0000049071</xbrli:identifier></xbrli:entity><xbrli:period><xbrli:startDate>2023-11-09</xbrli:startDate><xbrli:endDate>2023-11-09</xbrli:endDate></xbrli:period></xbrli:context></ix:resources></ix:header></div><div id="i7e0b12811e154c7bb17547217f3eb709_1"></div><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-top:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-top:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">UNITED STATES</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">SECURITIES AND EXCHANGE COMMISSION</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">WASHINGTON, DC&#160;20549</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:18pt;font-weight:700;line-height:120%">FORM <ix:nonNumeric contextRef="c-1" name="dei:DocumentType" id="f-1">8-K</ix:nonNumeric> </span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">CURRENT REPORT</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Pursuant to Section 13 or 15(d) of The</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Securities Exchange Act of 1934</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Date of Report (Date of earliest event reported):&#160;<ix:nonNumeric contextRef="c-1" name="dei:DocumentPeriodEndDate" format="ixt:date-monthname-day-year-en" id="f-2">November 9, 2023</ix:nonNumeric> (November 9, 2023)</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:24pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityRegistrantName" id="f-3">Humana Inc.</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:115%">(Exact name of registrant as specified in its charter)</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityIncorporationStateCountryCode" format="ixt-sec:stateprovnameen" id="f-4">Delaware</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityFileNumber" id="f-5">001-05975</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:EntityTaxIdentificationNumber" id="f-6">61-0647538</ix:nonNumeric></span></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(State or other jurisdiction <br/>of incorporation)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(Commission <br/>File Number)</span></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:100%">(IRS Employer <br/>Identification No.)</span></td></tr></table></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:700;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityAddressAddressLine1" id="f-7">500 W. Main Street,</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressCityOrTown" id="f-8">Louisville</ix:nonNumeric>, <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressStateOrProvince" format="ixt-sec:stateprovnameen" id="f-9">Kentucky</ix:nonNumeric> <ix:nonNumeric contextRef="c-1" name="dei:EntityAddressPostalZipCode" id="f-10">40202</ix:nonNumeric> </span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Address of principal executive offices, and Zip Code)</span></div><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">(<ix:nonNumeric contextRef="c-1" name="dei:CityAreaCode" id="f-11">502</ix:nonNumeric>) <ix:nonNumeric contextRef="c-1" name="dei:LocalPhoneNumber" id="f-12">580-1000</ix:nonNumeric> </span></div><div style="margin-bottom:6pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">Registrant&#8217;s telephone number, including area code</span></div><div style="margin-bottom:12pt;text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:8pt;font-weight:700;line-height:120%">(Former name or former address, if changed since last report)</span></div><div style="margin-top:1pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-style:italic;font-weight:400;line-height:120%">see</span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%"> General Instruction A.2. below):</span></div><div style="margin-bottom:1pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"></td><td style="width:3.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.400%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:WrittenCommunications" format="ixt:fixed-false" id="f-13">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Written communications pursuant to Rule 425 under the Securities Act (17&#160;CFR&#160;230.425)</span></td></tr></table></div><div style="margin-bottom:1pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"></td><td style="width:3.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.400%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SolicitingMaterial" format="ixt:fixed-false" id="f-14">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)</span></td></tr></table></div><div style="margin-bottom:1pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"></td><td style="width:3.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.400%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementTenderOffer" format="ixt:fixed-false" id="f-15">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17&#160;CFR&#160;240.14d-2(b))</span></td></tr></table></div><div style="margin-bottom:1pt;padding-left:18pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:96.153%"><tr><td style="width:1.0%"></td><td style="width:3.400%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:94.400%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:PreCommencementIssuerTenderOffer" format="ixt:fixed-false" id="f-16">&#9744;</ix:nonNumeric></span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17&#160;CFR&#160;240.13e-4(c))</span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Securities registered pursuant to Section 12(b) of the Act:</span></div><div style="margin-bottom:6pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:99.839%"><tr><td style="width:1.0%"></td><td style="width:34.694%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.310%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:34.696%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Title of each class</span></td><td colspan="3" style="border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Trading Symbol(s)</span></td><td colspan="3" style="border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%;text-decoration:underline">Name of each exchange on which registered</span></td></tr><tr><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:Security12bTitle" id="f-17">Common Stock</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:TradingSymbol" id="f-18">HUM</ix:nonNumeric></span></td><td colspan="3" style="border-bottom:1pt solid #000000;border-left:1pt solid #000000;border-right:1pt solid #000000;border-top:1pt solid #000000;padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:100%"><ix:nonNumeric contextRef="c-1" name="dei:SecurityExchangeName" format="ixt-sec:exchnameen" id="f-19">New York Stock Exchange</ix:nonNumeric></span></td></tr></table></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (&#167;230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (&#167;240.12b-2 of this chapter).</span></div><div><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Emerging growth company&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%"><ix:nonNumeric contextRef="c-1" name="dei:EntityEmergingGrowthCompany" format="ixt:fixed-false" id="f-20">&#9744;</ix:nonNumeric></span></div><div style="margin-bottom:12pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section&#160;13(a) of the Exchange Act.&#160;&#160;</span><span style="color:#000000;font-family:'Arial Unicode MS',sans-serif;font-size:10pt;font-weight:400;line-height:120%">&#9744;</span></div><div style="margin-bottom:1pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><span><br/></span></div></div></div><div id="i7e0b12811e154c7bb17547217f3eb709_147"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div><span><br/></span></div></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 1.01. Entry into a Material Definitive Agreement.</span></div><div style="margin-bottom:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">On November 9, 2023, Humana Inc. (the &#8220;Company&#8221;) completed a public offering of $500 million aggregate principal amount of its 5.750% Senior Notes due 2028 (the &#8220;2028 Senior Notes&#8221;) and $850 million aggregate principal amount of its 5.950% Senior Notes due 2034 (the &#8220;2034 Senior Notes&#8221; and, together with the 2028 Senior Notes, the &#8220;Senior Notes&#8221;). The Senior Notes were issued under an indenture dated as of August 5, 2003, by and between the Company and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.) (as successor to The Bank of New York), as trustee (the &#8220;Trustee&#8221;) (the &#8220;Original Indenture&#8221;), as supplemented by a twenty-sixth supplemental indenture, dated as of November 9, 2023, by and between the Company and the Trustee relating to the 2028 Senior Notes (the &#8220;Twenty-Sixth Supplemental Indenture&#8221; and, together with the Original Indenture, the &#8220;Twenty-Sixth Indenture&#8221;) and a twenty-seventh supplemental indenture, dated as of November 9, 2023, by and between the Company and the Trustee relating to the 2034 Senior Notes (the &#8220;Twenty-Seventh Supplemental Indenture&#8221; and, together with the Original Indenture, the &#8220;Twenty-Seventh Indenture,&#8221; and the Twenty-Sixth Indenture and Twenty-Seventh Indenture are referred to herein as the &#8220;Indentures&#8221;). </span></div><div style="margin-bottom:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The sale of the Senior Notes has been registered with the Securities and Exchange Commission (the &#8220;Commission&#8221;) in a registration statement on Form S-3, File No. 333-254041 (the &#8220;Registration Statement&#8221;). The terms of the Senior Notes are described in the Company&#8217;s Prospectus dated March 9, 2021, as supplemented by a final Prospectus Supplement dated November 2, 2023 as filed with the Commission on November 3, 2023, pursuant to Rule 424(b)(5) under the Securities Act of 1933, as amended.</span></div><div style="margin-bottom:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the terms of each of the Indentures, the Senior Notes are unsecured senior obligations of the Company and rank equally with all of the Company&#8217;s other unsecured, unsubordinated indebtedness. The 2028 Senior Notes bear interest at an annual rate of 5.750% and the 2034 Senior Notes bear interest at an annual rate of 5.950%. Interest on the 2028 Senior Notes is payable by the Company on June 1 and December 1 of each year, beginning on June 1, 2024. Interest on the 2034 Senior Notes is payable by the Company on March 15 and September 15 of each year, beginning on March 15, 2024. The 2028 Senior Notes mature on December 1, 2028 and the 2034 Senior Notes mature on March 15, 2034. </span></div><div style="margin-bottom:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">A copy of the Original Indenture is filed as Exhibit 4.1 to this Current Report on Form 8-K and is incorporated by reference herein. A copy of the Twenty-Sixth Supplemental Indenture is filed as Exhibit 4.2 to this Current Report on Form 8-K and is incorporated by reference herein. The form of 2028 Senior Notes is filed as Exhibit 4.3 to this Current Report on Form 8-K and is incorporated by reference herein. A copy of the Twenty-Seventh Supplemental Indenture is filed as Exhibit 4.4 to this Current Report on Form 8-K and is incorporated by reference herein. The form of 2034 Senior Notes is filed as Exhibit 4.5 to this Current Report on Form 8-K and is incorporated by reference herein. The descriptions of the material terms of the Original Indenture, the Twenty-Sixth Supplemental Indenture, the 2028 Senior Notes, the Twenty-Seventh Supplemental Indenture and the 2034 Senior Notes are qualified in their entirety by reference to such exhibits. In addition, the legal opinion of Fried, Frank, Harris, Shriver &amp; Jacobson LLP related to the Senior Notes is filed as Exhibit 5.1 to this Current Report on Form 8-K and is incorporated herein by reference.</span></div><div style="margin-bottom:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Trustee has also been appointed registrar and paying agent with regard to the Senior Notes and serves the same roles with respect to certain other series of the Company&#8217;s outstanding senior notes. An affiliate of the Trustee is also a lender under the Company&#8217;s revolving credit facility and 364-day credit facility.<br/></span></div><div id="i7e0b12811e154c7bb17547217f3eb709_169"></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 2.03 Creation of a Direct Financial Obligation or an Obligation Under an Off-Balance Sheet Arrangement of a Registrant.</span></div><div style="margin-bottom:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The disclosure above under Item 1.01 of this Current Report on Form 8-K is also responsive to Item 2.03 of this Current Report on Form 8-K and is incorporated by reference into this Item 2.03.<br/></span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i7e0b12811e154c7bb17547217f3eb709_189"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 8.01. Other Events.</span></div><div style="margin-bottom:10pt;text-indent:36pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Company issued a press release announcing the closing of the offering of the Senior Notes, which is attached as Exhibit 99.1 to this Current Report on Form 8-K and is hereby incorporated by reference herein.<br/></span></div><div id="i7e0b12811e154c7bb17547217f3eb709_208"></div><div style="-sec-extract:summary;margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Item 9.01. Financial Statements and Exhibits.</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">(d) Exhibits:</span></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:8.194%"></td><td style="width:0.1%"></td><td style="width:0.1%"></td><td style="width:0.441%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.965%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Exhibit No.</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:bottom"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Description</span></td></tr><tr><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="https://www.sec.gov/Archives/edgar/data/49071/000119312503073141/dex41.htm">Indenture, dated as of August 5, 2003, by and between the Company and The Bank of New York, as trustee (incorporated herein by reference to Exhibit 4.1 to Humana Inc.&#8217;s Quarterly Report on Form 10-Q for the quarter ended September 30, 2003).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">4.2</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit42-closing8xk.htm">Twenty-Sixth Supplemental Indenture, dated November 9, 2023, between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">4.3</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit43-closing8xk.htm">Form of 5.750% Senior Notes due 2028</a></span><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">.</span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">4.4</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit44-closing8xk.htm">Twenty-Seventh Supplemental Indenture, dated November 9, 2023, between the Company and The Bank of New York Mellon Trust Company, N.A., as trustee.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-align:center"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:132%">4.5</span></div></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit45-closing8xk.htm">Form of 5.950% Senior Notes due 2034.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">5.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit51-closing8xk.htm">Opinion of Fried, Frank, Harris, Shriver &amp; Jacobson LLP.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">23.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit51-closing8xk.htm">Consent of Fried, Frank, Harris, Shriver &amp; Jacobson LLP (</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit51-closing8xk.htm">included in</a><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit51-closing8xk.htm"> Exhibit 5.1).</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">99.1</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><span style="color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline"><a style="-sec-extract:exhibit;color:#0000ff;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%;text-decoration:underline" href="exhibit991-closing8xk.htm">Press Release relating to the closing of the offering of Senior Notes, dated November 9, 2023, issued by the Company.</a></span></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:center;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">104</span></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">Cover Page Interactive Data File (embedded within the Inline XBRL document).</span></td></tr></table></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div><div id="i7e0b12811e154c7bb17547217f3eb709_227"></div><hr style="page-break-after:always"/><div style="min-height:72pt;width:100%"><div style="text-align:right"><span><br/></span></div></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">SIGNATURES</span></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Pursuant to the requirements of the Securities Exchange Act of 1934, the Registrant has duly caused this Report to be signed on its behalf by the undersigned hereunto duly authorized.</span></div><div style="margin-bottom:10pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.282%"><tr><td style="width:1.0%"></td><td style="width:9.212%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.588%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">HUMANA INC.</span></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">BY:</span></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">/s/ John-Paul W. Felter</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">John-Paul W. Felter</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">Senior Vice President, Chief Accounting Officer and Controller</span></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:middle"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">(Principal Accounting Officer)</span></td></tr></table></div><div style="margin-bottom:10pt"><span style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Dated: November 9, 2023</span></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><span><br/></span></div></div></div></body></html>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.2
<SEQUENCE>2
<FILENAME>exhibit42-closing8xk.htm
<DESCRIPTION>EX-4.2
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="if8c777b4654b47bfb99aafef8fbb4cac_39"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 4.2</font></div></div><div style="margin-bottom:80pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">HUMANA INC.,</font></div><div style="margin-bottom:36pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Issuer</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A.,</font></div><div style="margin-bottom:36pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Trustee</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">TWENTY-SIXTH SUPPLEMENTAL INDENTURE</font></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Dated as of November 9, 2023</font></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:42.788%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:24pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.750% Senior Notes due 2028</font></div><div style="margin-bottom:36pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:42.788%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Supplemental to Indenture dated as of August 5, 2003</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="if8c777b4654b47bfb99aafef8fbb4cac_42"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">THIS TWENTY-SIXTH SUPPLEMENTAL INDENTURE (the &#8220;Twenty-Sixth Supplemental Indenture&#8221;) is made the 9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> day of November, 2023, between HUMANA INC., a corporation duly incorporated and existing under the laws of Delaware and having its principal executive office at 500 West Main Street, Louisville, Kentucky 40202 (hereinafter called &#8220;the Company&#8221;), and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A. (formerly known as The Bank of New York Trust Company, N.A. and as successor to The Bank of New York), a national banking association, as Trustee (hereinafter called the &#8220;Trustee&#8221;).</font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">RECITALS OF THE COMPANY</font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, the Company entered into an Indenture, dated as of August 5, 2003 with the Trustee (the &#8220;Original Indenture,&#8221; and together with this Twenty-Sixth Supplemental Indenture, referred to herein as the &#8220;Indenture&#8221;) (all capitalized terms used in this Twenty-Sixth Supplemental Indenture and not otherwise defined herein have the meanings assigned to such terms in the Original Indenture), for the purposes of issuing its Securities, evidencing its senior unsecured indebtedness, unlimited as to principal amount, to bear such rates of interest, to mature at such time or times, to be issued in one or more series and to have such other provisions as authorized by or pursuant to the authority granted in one or more resolutions of the Board of Directors of the Company&#59; and</font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, Section 901 of the Original Indenture provides that without the consent of the Holders of the Securities of any series issued under the Original Indenture, the Company, when authorized by a Board Resolution, and the Trustee may, in certain circumstances, enter into one or more indentures supplemental to the Original Indenture&#59; and</font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, the Company proposes to issue a series of Securities designated as its 5.750% Senior Notes due 2028, the terms of which shall be set forth in, or determined in the manner provided in, an Officers&#8217; Certificate of the Company as provided in Section 301 of the Original Indenture (such senior notes being referred to herein as the &#8220;2028 Senior Notes&#8221; and all references to Securities in the Original Indenture shall be deemed to refer also to the 2028 Senior Notes unless the context otherwise provides)&#59; and</font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, the entry into this Twenty-Sixth Supplemental Indenture by the parties hereto is in all respect authorized by the provisions of the Original Indenture&#59; and</font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, all conditions necessary to authorize the execution and delivery of this Twenty-Sixth Supplemental Indenture and to make it a valid and binding obligation of the Company have been done or performed&#59; and</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">NOW, THEREFORE, THIS TWENTY-SIXTH SUPPLEMENTAL INDENTURE WITNESSETH&#58;</font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For and in consideration of the promises and the purchase of the 2028 Senior Notes by the Holders thereof, it is mutually covenanted and agreed, for the equal and proportionate benefit of all Holders of the 2028 Senior Notes, as follows&#58;</font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.03pt">The Original Indenture is hereby amended solely with respect to the 2028 Senior Notes as follows&#58;</font></div><div style="margin-bottom:9pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt">By amending Section 101 to insert the following definitions in their entirety in the appropriate alphabetical order as follows&#58;</font></div><div style="margin-bottom:9pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Change of Control&#8221; means the occurrence of any one of the following&#58; (1) the direct or indirect sale, lease, transfer, conveyance or other disposition (other than by way of merger or consolidation), in one or a series of related transactions, of all or substantially all of the Company&#8217;s and its subsidiaries assets taken as a whole to any Person other than to the Company or a Subsidiary&#59; (2) the consummation of any transaction (including without limitation, any merger or consolidation) the result of which is that any Person becomes the &#8220;beneficial owner&#8221; (as defined in Rules 13d-3 and 13d-5 under the Exchange Act), directly or indirectly, of more than 50% of the outstanding Voting Stock of the Company or the Voting Stock of any Parent Company (as defined below) or other Voting Stock into which the Voting Stock of the Company or the Voting Stock of any Parent Company is reclassified, consolidated, exchanged or changed, measured by voting power rather than number of shares&#59; (3) the Company or any Parent Company consolidates with, or merges with or into, any Person, or any Person consolidates with, or merges with or into, the Company or any Parent Company, in any such event pursuant to a transaction in which any of the outstanding Voting Stock of the Company, the Voting Stock of such Parent Company or the Voting Stock of such other Person is converted into or exchanged for cash, securities or other property, other than any such transaction where the shares of the Voting Stock of the Company or the Voting Stock of such Parent Company outstanding immediately prior to such transaction constitute, or are converted into or exchanged for, a majority of the Voting Stock of the surviving Person or any Parent Company of the surviving Person immediately after giving effect to such transaction&#59; or (4) the adoption of a plan relating to the liquidation or dissolution of the Company. Notwithstanding the foregoing, a transaction will not be deemed to involve a Change of Control under clause (2) above if (i) the Company becomes a subsidiary of a Parent Company and (ii) the holders of the Voting Stock of the Company or the Voting Stock of any Parent Company immediately prior to such transaction hold at least a majority of the Voting Stock of such Parent Company immediately following such transaction&#59; provided that any series of related transactions shall be treated as a single transaction. The term &#8220;Person,&#8221; solely as used in this definition, has the meaning given thereto in Section 13(d)(3) of the Exchange Act.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></div></div><div style="margin-bottom:9pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Change of Control Triggering Event&#8221; means the occurrence of both a Change of Control and a related Rating Event.  </font></div><div style="margin-bottom:9pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Common Stock&#8221; means, with respect to any Principal Subsidiary, Capital Stock of any class, however designated, except Capital Stock which is non-participating beyond fixed dividend and liquidation preferences and the holders of which have either no voting rights or limited voting rights entitling them, only in the case of certain contingencies, to elect less than a majority of the directors (or persons performing similar functions) of such Principal Subsidiary, and also includes securities of any class, however designated, which are convertible into Common Stock.</font></div><div style="margin-bottom:9pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Corporate Trust Office&#8221; means the office of the Trustee at which at any particular time its corporate trust business shall be administered, which office of The Bank of New York Mellon Trust Company, N.A., as of the Issue Date, is located at 2 N. LaSalle Street, Suite 700, Chicago, Illinois 60602, Attention&#58; Corporate Trust Department and, as of December 1, 2023, shall be located at 311 South Wacker Drive, Suite 6200B, Mailbox #44, Chicago, Illinois 60606, Attention&#58; Corporate Trust Department or such other address as the Trustee may designate from time to time by notice to the Holders and the Company, or the principal corporate trust office of any successor Trustee (or such other address as such successor Trustee may designate from time to time by notice to the Holders and the Company).</font></div><div style="margin-bottom:9pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Electronic Means&#8221; means the following communications methods&#58; e-mail, facsimile transmission, secure electronic transmission containing applicable authorization codes, passwords and&#47;or authentication keys issued by the Trustee, or another method or system specified by the Trustee as available for use in connection with its services hereunder.</font></div><div style="margin-bottom:9pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Indebtedness&#8221; means, with respect to any Person (without duplication)&#58;</font></div><div style="margin-bottom:9pt;padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">any liability of that Person (A) for borrowed money, or under any reimbursement obligation relating to a letter of credit or similar instrument&#59; (B) evidenced by a bond, note, debenture or similar instrument&#59; (C) to pay the deferred purchase price of property or services, except trade accounts payable arising in the ordinary course of business&#59; or (D) for the payment of money relating to any obligations under any capital lease of real or personal property which has been recorded as a capitalized lease obligation&#59;</font></div><div style="margin-bottom:9pt;padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">any liability of others described in the preceding clause (1) that the Person has guaranteed or that is otherwise its legal liability or which is secured by a lien on that Person&#8217;s Property&#59; and</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4</font></div></div><div style="margin-bottom:9pt;padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">any amendment, supplement, modification, deferral, renewal, extension or refunding of any liability of the types referred to in clauses (1) or (2) above.</font></div><div style="margin-bottom:9pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Investment Grade&#8221; means a rating of Baa3 or better by Moody&#8217;s (or its equivalent under any successor rating category) and a rating of BBB- or better by S&#38;P Global Ratings (or its equivalent under any successor rating category).  </font></div><div style="margin-bottom:9pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Issue Date&#8221; means the first date on which 2028 Senior Notes are issued, which shall be November 9, 2023.</font></div><div style="margin-bottom:9pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Moody&#8217;s&#8221; means Moody&#8217;s Investors Service, Inc., or any successor thereto.</font></div><div style="margin-bottom:9pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Parent Company&#8221; means any holding company that, directly or indirectly, owns 100% of the Voting Stock of the Company.  </font></div><div style="margin-bottom:9pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Principal Subsidiary&#8221; means a consolidated subsidiary of the Company that, as of the relevant time of determination, is a &#8220;significant subsidiary&#8221; as defined under Rule 405 under the Securities Act of 1933, as amended (as that Rule is in effect on November 2, 2023, without giving effect to any further amendment of that Rule).</font></div><div style="margin-bottom:9pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Rating Agency&#8221; means&#58;</font></div><div style="margin-bottom:9pt;padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">each of Moody&#8217;s and S&#38;P Global Ratings, and</font></div><div style="margin-bottom:9pt;padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">if either or both of Moody&#8217;s or S&#38;P Global Ratings ceases to rate the 2028 Senior Notes or fails to make a rating of the 2028 Senior Notes publicly available for reasons outside of the Company&#8217;s control, a Substitute Rating Agency in lieu thereof.</font></div><div style="margin-bottom:9pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Rating Event&#8221; means (i) the rating of the 2028 Senior Notes is lowered by both Rating Agencies during the related Trigger Period and (ii) the 2028 Senior Notes are rated below an Investment Grade rating by both Rating Agencies on any day during such Trigger Period. If either Rating Agency is not providing a rating of the 2028 Senior Notes on any day during such Trigger Period for any reason, the rating of such Rating Agency shall be deemed to be below Investment Grade on such day and such Rating Agency will be deemed to have lowered its rating of the 2028 Senior Notes during the Trigger Period.  For the avoidance of doubt, the Trustee shall not be charged with knowledge of any Rating Event nor have any duty to monitor the ratings of the Securities.</font></div><div style="margin-bottom:9pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;S&#38;P Global Ratings&#8221; means S&#38;P Global Ratings, a division of S&#38;P Global Inc.  </font></div><div style="margin-bottom:9pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Substitute Rating Agency&#8221; means a &#8220;nationally recognized statistical rating organization&#8221; as that term is defined in Section 3(a)(62) of the Exchange Act, selected by the Company (as certified by a resolution of the Board of Directors delivered to the Trustee) as a replacement agency for Moody&#8217;s or S&#38;P Global Ratings, or both of them, as the case may be.  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5</font></div></div><div style="margin-bottom:9pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Trigger Period&#8221; means the period commencing on the earlier of the first public notice of (a) the occurrence of a Change of Control or (b) the Company&#8217;s intention to effect a Change of Control and ending 60 days following consummation of such Change of Control (which period shall be extended so long as the rating of the 2028 Senior Notes is under publicly announced consideration for a possible downgrade by either of the Rating Agencies).  </font></div><div style="margin-bottom:9pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Voting Stock&#8221; means, with respect to any Person as of any date, the Capital Stock of such Person that is at the time entitled to vote generally in the election of the board of directors (or other analogous managing body) of such Person.</font></div><div style="margin-bottom:9pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.02pt">By replacing the definition of &#8220;Notice of Default&#8221; in Section 101 of the Original Indenture in its entirety as follows&#58;</font></div><div style="margin-bottom:9pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Notice of Default&#8221; has the meaning specified in Sections 501(3) and 501(4).</font></div><div style="margin-bottom:9pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.02pt">By replacing Section 105(2) of the Original Indenture in its entirety as follows&#58;</font></div><div style="margin-bottom:9pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">the Company by such Trustee or by any Holder shall be sufficient for every purpose hereunder (except as provided in paragraphs (3) and (4) of Section 501) if furnished in writing and mailed, first class postage prepaid, addressed to it, to the attention of the Chief Financial Officer, at the address of its principal office specified in the first paragraph of this instrument or at any other address previously furnished in writing to such Trustee by the Company, or if sent by facsimile transmission, to a facsimile number provided to the Trustee by the Company, with a copy mailed, first class postage prepaid, to the Company addressed to it as provided above.</font></div><div style="margin-bottom:9pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt">By replacing the sixth paragraph of Section 303 of the Original Indenture in its entirety as follows&#58;</font></div><div style="margin-bottom:9pt;padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">No Security or coupon appertaining thereto shall be entitled to any benefit under this Indenture or be valid or obligatory for any purpose unless there appears on such Security a certificate of authentication substantially in the form provided for herein executed by the Trustee, either by manual, facsimile or electronic execution, for such Security or on its behalf pursuant to Section 614, and such certificate upon any Security shall be conclusive evidence, and the only evidence, that such Security has been duly authenticated and delivered hereunder.</font></div><div style="margin-bottom:9pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.69pt">By deleting the eighth paragraph of Section 305 of the Original Indenture in its entirety.   </font></div><div style="margin-bottom:9pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.35pt">By replacing Section 403 of the Original Indenture in its entirety as follows&#58;</font></div><div style="margin-bottom:9pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 403. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Covenant Defeasance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.</font></div><div style="margin-bottom:9pt;padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Upon the Company&#8217;s exercise under Section 401 of the option applicable to this Section 403, the Company shall be released from any obligations under the covenants contained in Sections 704, 801 and 1007 hereof with respect to the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6</font></div></div><div style="margin-bottom:9pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Outstanding 2028 Senior Notes, on and after the date the conditions set forth in Section 404 are satisfied (hereinafter, &#8220;Covenant Defeasance&#8221;), and the 2028 Senior Notes and any coupons appertaining thereto shall thereafter be deemed not &#8220;Outstanding&#8221; for the purposes of any direction, waiver, consent or declaration or act of Holders (and the consequences of any thereof) in connection with such covenants, but shall continue to be deemed &#8220;Outstanding&#8221; for all other purposes hereunder (it being understood that such 2028 Senior Notes shall not be deemed outstanding for accounting purposes). For this purpose, such Covenant Defeasance means that, with respect to the Outstanding 2028 Senior Notes and any coupons appertaining thereto, the Company may omit to comply with and shall have no liability in respect of any term, condition or limitation set forth in any such covenant, whether directly or indirectly, by reason of any reference elsewhere herein to any such covenant or by reason of any reference in any such covenant to any other provision herein or in any other document and such omission to comply shall not constitute a default or Event of Default under subsection 501(3) but, except as specified above, the remainder of this Indenture and the 2028 Senior Notes shall be unaffected thereby.</font></div><div style="margin-bottom:9pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(G)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt">By replacing Section 404(b) of the Original Indenture in its entirety as follows&#58;</font></div><div style="margin-bottom:9pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">in the case of Legal Defeasance, the Company shall have delivered to the Trustee for the Securities of that series an Opinion of Counsel in the United States reasonably acceptable to such Trustee confirming that, subject to customary assumptions and exclusions, (1) the Company has received from, or there has been published by, the U.S. Internal Revenue Service a ruling or (2) since the Issue Date, there has been a change in the applicable U.S. federal income tax law, in either case to the effect that, and based thereon such Opinion of Counsel in the United States shall confirm that, subject to customary assumptions and exclusions, the Holders and beneficial owners of the Outstanding Securities of that series will not recognize income, gain or loss for U.S. federal income tax purposes as a result of such Legal Defeasance and will be subject to U.S. federal income tax on the same amounts, in the same manner and at the same times as would have been the case if such Legal Defeasance had not occurred&#59;</font></div><div style="margin-bottom:9pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(H)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt">By replacing Section 404(c) of the Original Indenture in its entirety as follows&#58;</font></div><div style="margin-bottom:9pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt">in the case of Covenant Defeasance, the Company shall have delivered to the Trustee for the Securities of that series an Opinion of Counsel in the United States reasonably acceptable to such Trustee confirming that, subject to customary assumptions and exclusions, the Holders and beneficial owners of the Outstanding Securities of that series will not recognize income, gain or loss for U.S. federal income tax purposes as a result of such Covenant Defeasance and will be subject to U.S. federal income tax on the same amounts, in the same manner and at the same times as would have been the case if such Covenant Defeasance had not occurred&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7</font></div></div><div style="margin-bottom:9pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(I)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.03pt">By replacing Section 404(d) of the Original Indenture in its entirety as follows&#58;</font></div><div style="margin-bottom:9pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">no Event of Default or event which with the giving of notice or the lapse of time, or both, would become an Event of Default with respect to the 2028 Senior Notes shall have occurred and be continuing on the date of such deposit and no Event of Default under Section 501(5) or Section 501(6) shall have occurred and be continuing on the 123rd day after such date&#59;</font></div><div style="margin-bottom:9pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(J)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:23.36pt">By replacing Section 405(ii)(B) of the Original Indenture in its entirety as follows&#58;</font></div><div style="margin-bottom:9pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.02pt">no Event of Default or event which with the giving of notice or the lapse of time, or both, would become an Event of Default shall have occurred and be continuing on the date of such deposit and no Event of Default under Section 501(5) or Section 501(6) shall have occurred and be continuing on the 123rd day after such date&#59;</font></div><div style="margin-bottom:9pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(K)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt">By replacing Section 501 of the Original Indenture in its entirety as follows&#58;</font></div><div style="margin-bottom:9pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Event of Default&#8221; wherever used herein with respect to the 2028 Senior Notes means any one of the following events (whatever the reason for such Event of Default and whether it shall be voluntary or involuntary or be effected by operation of law pursuant to any judgment, decree or order of any court or any order, rule or regulation of any administrative or governmental body)&#58;</font></div><div style="margin-bottom:9pt;padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(1)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">default in the payment of any installment of interest upon any 2028 Senior Note and any related coupon when it becomes due and payable, and continuance of such default for a period of 30 days&#59; or</font></div><div style="margin-bottom:9pt;padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(2)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">default in the payment of the principal of (or premium, if any, on) any 2028 Senior Note at its Maturity&#59; or</font></div><div style="margin-bottom:9pt;padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(3)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">default in the performance of, or breach of, any covenant or warranty of the Company in respect of any 2028 Senior Note contained in this Indenture or in such 2028 Senior Notes (other than a covenant or warranty a default in whose performance or whose breach is elsewhere in this Section specifically dealt with) and continuance of such default or breach for a period of 60 days after there has been given, by registered or certified mail, to the Company by the Trustee for the 2028 Senior Notes or to the Company and such Trustee by the Holders of at least 25% in aggregate principal amount of the Outstanding 2028 Senior Notes a written notice specifying such default or breach and requiring it to be remedied and stating that such notice is a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Notice of Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; hereunder&#59; or</font></div><div style="margin-bottom:9pt;padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(4)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">(A) the Company or any of its Subsidiaries fails to pay indebtedness for money borrowed by the Company or any of its Subsidiaries in an aggregate principal amount of at least $150,000,000, at </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8</font></div></div><div style="margin-bottom:9pt;padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the later of final maturity or the expiration of any related applicable grace period and such payment shall not have been made, waived or extended within 30 days after written notice from the Trustee or the Holders of at least 25% in aggregate principal amount of the Outstanding 2028 Senior Notes as provided below or (B) acceleration of maturity of Securities of another series or any other indebtedness for borrowed money of the Company or any of its Subsidiaries, in an aggregate principal amount exceeding $150,000,000, under the terms of the instrument or instruments under which such indebtedness arises or is secured, if such indebtedness has not been discharged in full or such acceleration is not rescinded or annulled within 30 days after there has been given, by registered or certified mail, to the Company by the Trustee or to the Company and such Trustee by the Holders of at least 25% in aggregate principal amount of the Outstanding 2028 Senior Notes a written notice specifying such default and requiring it to be remedied and stating that such notice is a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Notice of Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; hereunder&#59; or</font></div><div style="margin-bottom:9pt;padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(5)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">the Company shall commence any case or proceeding seeking to have an order for relief entered on its behalf as debtor or to adjudicate it as bankrupt or insolvent or seeking reorganization, liquidation, dissolution, winding-up, arrangement, composition or readjustment of its debts or any other relief under any bankruptcy, insolvency, reorganization, liquidation, dissolution, arrangement, composition, readjustment of debt or other similar act or law of any jurisdiction, domestic or foreign, now or hereafter existing&#59; or the Company shall apply for a receiver, custodian or trustee (other than any trustee appointed as a mortgagee or secured party in connection with the issuance of indebtedness for borrowed money of the Company) of it or for all or a substantial part of its property&#59; or the Company shall make a general assignment for the benefit of creditors&#59; or the Company shall take any corporate action in furtherance of any of the foregoing&#59; or</font></div><div style="margin-bottom:9pt;padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(6)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">an involuntary case or other proceeding shall be commenced against the Company with respect to it or its debts under any bankruptcy, insolvency or other similar law now or hereafter in effect seeking the appointment of a trustee, receiver, liquidator, custodian or similar official of the Company or any substantial part of its property&#59; and such case or other proceeding (A) results in the entry of an order for relief or a similar order against the Company or (B) shall continue unstayed and in effect for a period of 60 consecutive days.</font></div><div style="margin-bottom:9pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(L)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.69pt">By replacing the first and second paragraphs of Section 502 of the Original Indenture in their entirety as follows&#58;</font></div><div style="margin-bottom:9pt;padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If an Event of Default with respect to the 2028 Senior Notes and any related coupons occurs and is continuing (other than an Event of Default </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9</font></div></div><div style="margin-bottom:9pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">described in Section 501(5) or 501(6) with respect to the Company), then and in every such case either the Trustee for the 2028 Senior Notes or the Holders of not less than 25% in aggregate principal amount of the Outstanding 2028 Senior Notes may declare the entire principal amount of all the 2028 Senior Notes, to be due and payable immediately, by a notice in writing to the Company (and to such Trustee if given by Holders), and upon any such declaration of acceleration such principal, together with accrued interest and all other amounts owing hereunder, shall become immediately due and payable, without presentment, demand, protest or notice of any kind, all of which are hereby expressly waived.</font></div><div style="margin-bottom:9pt;padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If any Event of Default specified in Section 501(5) or 501(6) occurs with respect to the Company, all of the unpaid principal amount and accrued interest on all Securities of each series then outstanding shall </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">ipso facto</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> become and be immediately due and payable without any declaration or other act by the Trustee or any Holder.</font></div><div style="margin-bottom:9pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(M)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:17.36pt">By replacing the last paragraph of Section 607 of the Original Indenture in its entirety as follows&#58;</font></div><div style="margin-bottom:9pt;padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">When the Trustee incurs expenses or renders services in connection with an Event of Default specified in Section 501(5) or Section 501(6) the expenses (including the reasonable charges and expenses of its counsel) and the compensation for the services are intended to constitute expenses of administration under any applicable Federal or state bankruptcy, insolvency or other similar law.</font></div><div style="margin-bottom:9pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(N)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt">By replacing Section 1007 of the Original Indenture in its entirety as follows&#58;</font></div><div style="margin-bottom:9pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 1007. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Limitation on Liens</font></div><div style="margin-bottom:9pt;padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company shall not, and shall not permit any of its Principal Subsidiaries to, issue, assume, Incur or guarantee any Indebtedness secured by a mortgage, pledge, lien or other encumbrance, directly or indirectly, on any of the Common Stock of a Principal Subsidiary owned by the Company or any of its Principal Subsidiaries, unless the Company&#8217;s obligations under the 2028 Senior Notes and, if the Company so elects, any other Indebtedness of the Company ranking on a parity with, or prior to, the 2028 Senior Notes, shall be secured equally and ratably with, or prior to, such secured Indebtedness so long as it is outstanding and is so secured.</font></div><div style="margin-bottom:9pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(O)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt">By replacing Section 1008 of the Original Indenture in its entirety as follows&#58;</font></div><div style="margin-bottom:9pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 1008. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Waiver of Certain Covenants.</font></div><div style="margin-bottom:9pt;padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company may omit in any particular instance to comply with any covenant or condition set forth in Sections 1005 to 1007, inclusive, if before or after the time for such compliance the Holders of more than 50% in aggregate principal amount of the Outstanding Securities of each series of Securities </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10</font></div></div><div style="margin-bottom:9pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">affected by the omission shall, in each case by Act of such Holders, either waive such compliance in such instance or generally waive compliance with such covenant or condition, but no such waiver shall extend to or affect such covenant or condition except to the extent so expressly waived, and, until such waiver shall become effective, the obligations of the Company and the duties of the Trustee for the Securities of each series with respect to any such covenant or condition shall remain in full force and effect.</font></div><div style="margin-bottom:9pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(P)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.35pt">By deleting Section 1009 from the Original Indenture in its entirety.</font></div><div style="margin-bottom:9pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(Q)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt">By adding Section 1109 to the Original Indenture as follows&#58;</font></div><div style="margin-bottom:9pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 1109.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Offer to Repurchase Upon Change of Control Triggering Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  </font></div><div style="margin-bottom:9pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt">If a Change of Control Triggering Event occurs with respect to the 2028 Senior Notes, unless the Company shall have exercised its option to redeem the 2028 Senior Notes pursuant to Section 1102, the Company shall be required to make an offer (the &#8220;Change of Control Offer&#8221;) to each Holder of 2028 Senior Notes to repurchase all or any part (equal to $2,000 or any integral multiple of $1,000 in excess thereof) of such Holder&#8217;s 2028 Senior Notes on the terms set forth in this Section 1109. In the Change of Control Offer, the Company shall be required to offer payment in cash equal to 101% of the principal amount of the 2028 Senior Notes to be repurchased, </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">plus</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> accrued and unpaid interest, if any, on the 2028 Senior Notes up to, but not including, the date of repurchase (the &#8220;Change of Control Payment&#8221;) subject to the rights of the Holder on the relevant Regular Record Date to receive interest due on the relevant Interest Payment Date. Within 30 days following any Change of Control Triggering Event or, at the option of the Company, prior to any Change of Control, but after the public announcement of the transaction that constitutes or may constitute the Change of Control, the Company shall deliver a notice to Holders of the 2028 Senior Notes, with a copy to the Trustee, which notice shall govern the terms of the Change of Control Offer, describing the transaction that constitutes or may constitute the Change of Control Triggering Event and offering to repurchase the 2028 Senior Notes on the date specified in the notice, which date shall be no earlier than 10 days and no later than 60 days from the date such notice is sent other than as may be required by law or, if the notice is sent prior to the Change of Control, no earlier than 10 days and no later than 60 days from the date on which the Change of Control Triggering Event occurs (the &#8220;Change of Control Payment Date&#8221;). The notice shall, if sent prior to the date of consummation of the Change of Control, state that the Change of Control Offer is conditioned on the Change of Control Triggering Event occurring on or prior to the Change of Control Payment Date.</font></div><div style="margin-bottom:9pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">On the Change of Control Payment Date, the Company shall, to the extent lawful&#58;</font></div><div style="margin-bottom:9pt;padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.69pt">accept for payment all 2028 Senior Notes or portions of 2028 Senior Notes properly tendered pursuant to the Change of Control Offer&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11</font></div></div><div style="margin-bottom:9pt;padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.36pt">deposit with the Paying Agent an amount equal to the Change of Control Payment in respect of all 2028 Senior Notes or portions of 2028 Senior Notes properly tendered in accordance with the procedures set forth in the Global Securities representing the 2028 Senior Notes&#59; and </font></div><div style="margin-bottom:9pt;padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iii)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18.03pt">deliver or cause to be delivered to the Trustee the 2028 Senior Notes properly accepted together with an Officer&#8217;s Certificate stating the principal amount of 2028 Senior Notes or portions of 2028 Senior Notes being repurchased.</font></div><div style="margin-bottom:9pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company shall publicly announce the results of the Change of Control Offer on or as soon as possible after the date of purchase.</font></div><div style="margin-bottom:9pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.7pt">The Company shall not be required to make a Change of Control Offer upon the occurrence of a Change of Control Triggering Event if a third party makes such an offer in the manner, at the times and otherwise in compliance with the requirements for an offer made by the Company and the third party repurchases all 2028 Senior Notes properly tendered and not withdrawn under its offer.</font></div><div style="margin-bottom:9pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:22.02pt">The Company shall comply in all material respects with the requirements of Rule 14e-1 under the Exchange Act and any other securities laws and regulations thereunder to the extent such laws and regulations are applicable in connection with the repurchase of the 2028 Senior Notes as a result of a Change of Control Triggering Event. To the extent that the provisions of any such securities laws or regulations conflict with the Change of Control Offer provisions of the 2028 Senior Notes, the Company shall comply with the applicable securities laws and regulations and shall not be deemed to have breached its obligations under this Section 1109 by virtue of any such conflict.</font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.03pt">The recitals and statements in this Twenty-Sixth Supplemental Indenture are made by the Company only and not by the Trustee, and the Trustee makes no representation as to the validity or sufficiency of this Twenty-Sixth Supplemental Indenture (other than with respect to the due authorization, execution and delivery of this Twenty-Sixth Supplemental Indenture by the Trustee).  All of the provisions contained in the Original Indenture in respect of the rights, privileges, immunities, powers and duties of the Trustee shall be applicable in respect of the 2028 Senior Notes and of this Twenty-Sixth Supplemental Indenture as fully and with like effect as if set forth herein in full.</font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.03pt">As supplemented hereby, the Original Indenture is in all respects ratified and confirmed, and the Original Indenture and this Twenty-Sixth Supplemental Indenture shall be read, taken and construed as one and the same instrument and all references to Securities in the Original Indenture shall be deemed to refer also to the 2028 Senior Notes unless the context otherwise provides.</font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.03pt">This Twenty-Sixth Supplemental Indenture shall be governed by, and construed in accordance with, the laws of the State of New York.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">12</font></div></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.03pt">In the event of a conflict between the terms and conditions of the Original Indenture and the terms and conditions of this Twenty-Sixth Supplemental Indenture, then the terms and conditions of this Twenty-Sixth Supplemental Indenture shall prevail&#59; provided that if and to the extent that any provision of this Twenty-Sixth Supplemental Indenture limits, qualifies or conflicts with another provision which is required to be included herein or in the Original Indenture by the Trust Indenture Act of 1939, as amended, such required provision shall control.</font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.03pt">All covenants and agreements in this Twenty-Sixth Supplemental Indenture by the Company shall bind its successors and assigns, whether so expressed or not.</font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.03pt">In case any provision in this Twenty-Sixth Supplemental Indenture shall be invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired hereby.</font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.03pt">Nothing in this Twenty-Sixth Supplemental Indenture, expressed or implied, shall give to any Person, other than the parties hereto and any Paying Agent, any Security Registrar and any Authenticating Agent for the 2028 Senior Notes and their successors under the Indenture, and the Holders of the 2028 Senior Notes any benefit or any legal or equitable right, remedy or claim under this Twenty-Sixth Supplemental Indenture.</font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.03pt">This Twenty-Sixth Supplemental Indenture may be simultaneously executed in several counterparts, each of which shall be deemed to be an original, and such counterparts shall together constitute but one and the same instrument.  The words &#8220;execution,&#8221; signed,&#8221; &#8220;signature,&#8221; and words of like import in this Supplemental Indenture or in any other certificate, agreement or document related to this Supplemental Indenture shall include images of manually executed signatures transmitted by facsimile or other electronic format (including, without limitation, &#8220;pdf&#8221;, &#8220;tif&#8221; or &#8220;jpg&#8221;) and other electronic signatures (including, without limitation, DocuSign and AdobeSign).  The use of electronic signatures and electronic records (including, without limitation, any contract or other record created, generated, sent, communicated, received, or stored by electronic means) shall be of the same legal effect, validity and enforceability as a manually executed signature or use of a paper-based record-keeping system to the fullest extent permitted by applicable law, including the Federal Electronic Signatures in Global and National Commerce Act, the New York State Electronic Signatures and Records Act and any other applicable law, including, without limitation, any state law based on the Uniform Electronic Transactions Act or the Uniform Commercial Code.</font></div><div style="margin-bottom:9pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:18.03pt">The Trustee shall have the right to accept and act upon instructions, including funds transfer instructions (for the purposes of this Section, &#8220;Instructions&#8221;) given pursuant to the Indenture and delivered using Electronic Means&#59; provided, however, that the Company shall provide to the Trustee an incumbency certificate listing authorized officers and containing specimen signatures of such authorized officers, which incumbency certificate shall be amended by the Company whenever a person is to be added or deleted from the listing.  If the Company elects to give the Trustee Instructions using Electronic Means and the Trustee in its discretion elects to act upon such Instructions, the Trustee&#8217;s understanding of such Instructions shall be deemed controlling.  The Company understands and agrees that the Trustee cannot determine the identity of the actual sender of such Instructions and that the Trustee shall conclusively presume that directions that purport to have been sent by an authorized officer listed </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">13</font></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">on the incumbency certificate provided to the Trustee have been sent by such authorized officer.  The Company shall be responsible for ensuring that only authorized officers transmit such Instructions to the Trustee and that the Company and all authorized officers are solely responsible to safeguard the use and confidentiality of applicable user and authorization codes, passwords and&#47;or authentication keys upon receipt by the Company.  The Trustee shall not be liable for any losses, costs or expenses arising directly or indirectly from the Trustee&#8217;s reliance upon and compliance with such Instructions notwithstanding such directions conflict or are inconsistent with a subsequent written instruction.  The Company agrees&#58; (i) to assume all risks arising out of the use of Electronic Means to submit Instructions to the Trustee, including without limitation the risk of the Trustee acting on unauthorized Instructions, and the risk of interception and misuse by third parties&#59; (ii) that it is fully informed of the protections and risks associated with the various methods of transmitting Instructions to the Trustee and that there may be more secure methods of transmitting Instructions than the method(s) selected by the Company&#59; (iii) that the security procedures (if any) to be followed in connection with its transmission of Instructions provide to it a commercially reasonable degree of protection in light of its particular needs and circumstances&#59; and (iv) to notify the Trustee immediately upon learning of any compromise or unauthorized use of the security procedures.</font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(signature page follows)</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="if8c777b4654b47bfb99aafef8fbb4cac_45"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">IN WITNESS WHEREOF, the parties hereto have caused this Twenty-Sixth Supplemental Indenture dated as of November 9, 2023 to be duly executed, as of November 9, 2023.</font></div><div style="text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:58.012%"><tr><td style="width:1.0%"></td><td style="width:8.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.154%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:55.530%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">HUMANA INC.,</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Issuer</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Susan Diamond</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58; Susan Diamond</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58; Chief Financial Officer</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;Signature Page to Twenty-Sixth Supplemental Indenture&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:24pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:58.012%"><tr><td style="width:1.0%"></td><td style="width:8.016%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.154%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:55.530%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">THE BANK OF NEW YORK MELLON TRUST</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">COMPANY, N.A.,</font></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Trustee</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Ann M. Dolezal</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58; Ann M. Dolezal</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58;   Vice President</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Dated&#58; November 9, 2023</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:100%">&#91;Signature Page to Twenty-Sixth Supplemental Indenture&#93;</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.3
<SEQUENCE>3
<FILENAME>exhibit43-closing8xk.htm
<DESCRIPTION>EX-4.3
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i53c0c9e0a81949e381557b476d63d56d_39"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">Exhibit 4.3</font></div></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:120%">HUMANA INC.</font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.750% Senior Notes due 2028</font></div><div style="margin-bottom:27pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.233%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:32.234%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">PRINCIPAL AMOUNT</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">REGISTERED</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">$&#91;&#160;&#160;&#160;&#160;&#160;&#93;</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">CUSIP No.&#58; 444859 BZ4</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">ISIN No.&#58; US444859BZ42</font></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">No. &#91;&#160;&#160;&#160;&#160;&#160;&#93;</font></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">THIS NOTE IS A GLOBAL SECURITY WITHIN THE MEANING OF THE INDENTURE HEREINAFTER REFERRED TO AND IS REGISTERED IN THE NAME OF A DEPOSITARY OR A NOMINEE THEREOF.  UNLESS AND UNTIL IT IS EXCHANGED IN WHOLE OR IN PART FOR NOTES IN CERTIFICATED FORM, THIS NOTE MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY THE DEPOSITORY TRUST COMPANY (THE &#8220;DEPOSITARY&#8221;) TO A NOMINEE OF THE DEPOSITARY OR BY THE DEPOSITARY OR ANY SUCH NOMINEE TO A SUCCESSOR DEPOSITARY OR A NOMINEE OF SUCH SUCCESSOR DEPOSITARY.  UNLESS THIS NOTE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITARY TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY NOTE ISSUED IS REGISTERED IN THE NAME OF CEDE &#38; CO. OR IN SUCH OTHER NAME AS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITARY (AND ANY PAYMENT IS MADE TO CEDE &#38; CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITARY), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE &#38; CO., HAS AN INTEREST HEREIN.  </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">HUMANA INC., a Delaware corporation (the &#8220;Issuer&#8221; or the &#8220;Company,&#8221; which terms include any successor corporation under the Indenture hereinafter referred to), for value received, hereby promises to pay to CEDE &#38; CO., or registered assigns, the principal sum of &#91;  &#93; DOLLARS on December 1, 2028 and to pay interest thereon (computed on the basis of a 360-day year of twelve 30-day months), semi-annually in arrears on June 1 and December 1 (the &#8220;Interest Payment Dates&#8221;) of each year, commencing on June 1, 2024, at the rate per annum specified in the title of this Note from November 9, 2023 or the most recent Interest Payment Date to which interest had been paid or duly provided for.</font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The interest so payable and punctually paid or duly provided for on any Interest Payment Date will, as provided in the Indenture, be paid to the Person in whose name this Note (or one or more Predecessor Securities) is registered at the close of business on May 15</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">or November 15 (the &#8220;Record Date&#8221;) immediately preceding such Interest Payment Date. Except as provided herein, payment of the principal of (and premium, if any) and interest on this Note will be made at the office or agency of the Company maintained by the Company for such purpose, in </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the Borough of Manhattan, The City of New York, which initially will be in the corporate trust office of an affiliate of The Bank of New York Mellon Trust Company, N.A., the Trustee for this Note under the Indenture, located at 240 Greenwich Street, New York, New York 10286, in such coin or currency of the United States of America as at the time of payment is legal tender for payment of public and private debts.  </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Reference is hereby made to the further provisions of this Note as set forth on the reverse hereof, which further provisions shall for all purposes have the same effect as if set forth at this place. </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Unless the certificate of authentication hereon has been executed by or on behalf of The Bank of New York Mellon Trust Company, N.A., the Trustee for this Note under the Indenture, or its successor thereunder, by the manual, facsimile or electronic signature of one of its authorized officers, this Note shall not be entitled to any benefit under the Indenture or be valid or obligatory for any purpose.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="i53c0c9e0a81949e381557b476d63d56d_42"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the Company has caused this instrument to be duly executed, manually or in facsimile, and an imprint or facsimile of its corporate seal to be imprinted hereon.</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:32.692%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Dated&#58;November 9, 2023</font></div></td></tr></table></div><div style="margin-bottom:9pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:50.480%"><tr><td style="width:1.0%"></td><td style="width:9.058%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.742%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">HUMANA INC.</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58; </font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58;</font></td></tr></table></div><div style="margin-bottom:9pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:31.250%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#91;FACSIMILE OF SEAL&#93;</font></div></td></tr></table></div><div style="margin-bottom:9pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:50.480%"><tr><td style="width:1.0%"></td><td style="width:9.058%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.742%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Attest&#58;</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58; </font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58;</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#91;Signature Page to 2028 Global Note No. &#91;&#160;&#160;&#160;&#160;&#160;&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt;padding-left:121.67pt;padding-right:121.67pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">CERTIFICATE OF AUTHENTICATION</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This is one of the Securities of the series designated therein described in the within-mentioned Indenture.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A.,</font></div><div style="margin-bottom:9pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">as Trustee</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:51.923%"><tr><td style="width:1.0%"></td><td style="width:8.467%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:89.333%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Authorized Signatory</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Dated&#58;</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#91;Signature Page to 2028 Global Note No. &#91;&#160;&#160;&#160;&#160;&#160;&#93;&#93;</font></div></div></div><div id="i53c0c9e0a81949e381557b476d63d56d_45"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(Reverse of Note)</font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">HUMANA INC.</font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> This Note is one of a duly authorized issue of Securities of the Company designated as its 5.750% Senior Notes due 2028 (the &#8220;Notes&#8221;).  The Notes are one of an indefinite number of series of debt securities of the Company (the &#8220;Securities&#8221;), issued or issuable under and pursuant to a base indenture, dated as of August 5, 2003 (the &#8220;Base Indenture&#8221;), between the Company and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.) (as successor to The Bank of New York) (herein called the &#8220;Trustee,&#8221; which term includes any successor Trustee under the Indenture), as supplemented by a twenty-sixth supplemental indenture, dated as of November 9, 2023 (the &#8220;Twenty-Sixth Supplemental Indenture&#8221;&#59; the Base Indenture as supplemented by the Twenty-Sixth Supplemental Indenture is herein called the &#8220;Indenture&#8221;), to which Indenture and all indentures supplemental thereto (other than supplemental indentures creating a different series of notes) reference is hereby made for a statement of the respective rights thereunder of the Company, the Trustee and the Holders of the Notes and the terms upon which the Notes are to be authenticated and delivered.  The terms, conditions and provisions of the Notes are those stated in the Indenture, those made part of the Indenture by reference to the Trust Indenture Act of 1939, as amended, and those set forth in this Note.  This Note is one of a series designated on the face hereof initially issued in an aggregate principal amount of $500,000,000.  The Company may, from time to time, without the consent of the Holders, issue and sell additional Securities ranking equally with the Notes and otherwise identical in all respects (except for their date of issue, issue price and, if applicable, the first payment of interest on the additional Securities) so that such additional Securities shall be consolidated and form a single series with the Notes.  If any additional Securities are not fungible with the Notes for U.S. federal income tax purposes, they will be issued with a different CUSIP number (or other applicable identifying number).</font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The terms of other series of Securities issued under the Base Indenture may vary with respect to interest rates or interest rate formulas, issue dates, maturity, redemption, repayment, currency of payment and otherwise as provided in the Base Indenture.  The Base Indenture further provides that Securities of a single series may be issued at various times, with different maturity dates and may bear interest at different rates.  All terms used in this Note which are defined in the Indenture shall have the meanings assigned to them in the Indenture.</font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Note is not subject to any sinking fund.</font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If an Event of Default (other than an Event of Default described in Section 501(5) or 501(6) of the Indenture, with respect to the Company) with respect to the Notes shall occur and be continuing, then either the Trustee or the Holders of not less than 25% in aggregate principal amount of the Notes of this series then Outstanding may declare the aggregate principal amount of the Notes of this series due and payable in the manner and with the effect provided in the Indenture.  If an Event of Default specified in Section 501(5) or 501(6) occurs with respect to the Company, all of the unpaid principal amount and accrued interest thereon shall ipso facto become and be immediately due and payable in the manner and with the effect provided in the Indenture without any declaration or other act by the Trustee or any Holder.  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Prior to November 1, 2028 (one month prior to their maturity date) (the &#8220;Par Call Date&#8221;), the Company may redeem the Notes at its option, in whole or in part, at any time and from time to time, at a Redemption Price (expressed as a percentage of principal amount and rounded to three decimal places) equal to the greater of&#58; </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(1) (a) the sum of the present values of the remaining scheduled payments of principal and interest thereon discounted to the Redemption Date (assuming the Notes matured on the Par Call Date) on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at the Treasury Rate plus 20 basis points less (b) interest accrued to the date of redemption, and</font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(2) 100% of the principal amount of the notes to be redeemed, </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">plus, in either case, accrued and unpaid interest thereon to the Redemption Date. </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">On or after the Par Call Date, the Company may redeem the notes, in whole or in part, at any time and from time to time, at a Redemption Price equal to 100% of the principal amount of the notes being redeemed plus accrued and unpaid interest thereon to the Redemption Date. </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Treasury Rate&#8221; means, with respect to any Redemption Date, the yield determined by the Company in accordance with the following two paragraphs.</font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Treasury Rate shall be determined by the Company after 4&#58;15 p.m., New York City time (or after such time as yields on U.S. government securities are posted daily by the Board of Governors of the Federal Reserve System), on the third business day preceding the Redemption Date based upon the yield or yields for the most recent day that appear after such time on such day in the most recent statistical release published by the Board of Governors of the Federal Reserve System designated as &#8220;Selected Interest Rates (Daily) - H.15&#8221; (or any successor designation or publication) (&#8220;H.15&#8221;) under the caption &#8220;U.S. government securities&#8211;Treasury constant maturities&#8211;Nominal&#8221; (or any successor caption or heading) (&#8220;H.15 TCM&#8221;). In determining the Treasury Rate, the Company shall select, as applicable&#58; (1) the yield for the Treasury constant maturity on H.15 exactly equal to the period from the Redemption Date to the Par Call Date (the &#8220;Remaining Life&#8221;)&#59; or (2) if there is no such Treasury constant maturity on H.15 exactly equal to the Remaining Life, the two yields &#8211; one yield corresponding to the Treasury constant maturity on H.15 immediately shorter than and one yield corresponding to the Treasury constant maturity on H.15 immediately longer than the Remaining Life &#8211; and shall interpolate to the Par Call Date on a straight-line basis (using the actual number of days) using such yields and rounding the result to three decimal places&#59; or (3) if there is no such Treasury constant maturity on H.15 shorter than or longer than the Remaining Life, the yield for the single Treasury constant maturity on H.15 closest to the Remaining Life. For purposes of this paragraph, the applicable Treasury constant maturity or maturities on H.15 shall be deemed to have a maturity date equal to the relevant number of months or years, as applicable, of such Treasury constant maturity from the Redemption Date.</font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If on the third business day preceding the Redemption Date H.15 TCM or any successor designation or publication is no longer published, the Company shall calculate the </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Treasury Rate based on the rate per annum equal to the semi-annual equivalent yield to maturity at 11&#58;00 a.m., New York City time, on the second business day preceding such Redemption Date of the United States Treasury security maturing on, or with a maturity that is closest to, the Par Call Date, as applicable.  If there is no United States Treasury security maturing on the Par Call Date but there are two or more United States Treasury securities with a maturity date equally distant from the Par Call Date, one with a maturity date preceding the Par Call Date, and one with a maturity date following the Par Call Date, the Company shall select the United States Treasury security with a maturity date preceding the Par Call Date. If there are two or more United States Treasury securities maturing on the Par Call Date, or two or more United States Treasury securities meeting the criteria of the preceding sentence, the Company shall select from among these two or more United States Treasury securities the United States Treasury security that is trading closest to par based upon the average of the bid and asked prices for such United States Treasury securities at 11&#58;00 a.m., New York City time.  In determining the Treasury Rate in accordance with the terms of this paragraph, the semi-annual yield to maturity of the applicable United States Treasury security shall be based upon the average of the bid and asked prices (expressed as a percentage of principal amount) at 11&#58;00 a.m., New York City time, of such United States Treasury security, and rounded to three decimal places.</font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company&#8217;s actions and determinations in determining the Redemption Price shall be conclusive and binding for all purposes, absent manifest error. The Trustee shall have no responsibility for the calculation of the Redemption Price. </font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notice of any redemption will be mailed or electronically delivered (or otherwise transmitted in accordance with the depositary&#8217;s procedures) at least 10 days but not more than 60 days before the Redemption Date to each Holder of the Notes to be redeemed.</font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In the case of a partial redemption, selection of the Notes for redemption will be made, in the case of Global Securities, in accordance with the Depositary&#8217;s procedures, and in the case of definitive Securities, by lot or by such other method as the Trustee deems appropriate. No Notes of a principal amount of $2,000 or less will be redeemed in part. If any Note is to be redeemed in part only, the notice of redemption that relates to the note will state the portion of the principal amount of the Note to be redeemed. A new Note in a principal amount equal to the unredeemed portion of the Note will be issued in the name of the Holder of the note upon surrender for cancellation of the original Note. For so long as the Notes are held by Depository Trust Company (or another depositary), the redemption of the Notes shall be done in accordance with the policies and procedures of the Depositary.</font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Unless the Company defaults in payment of the Redemption Price, on and after the Redemption Date interest will cease to accrue on the notes or portions thereof called for redemption.</font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">As provided in the Indenture, the Notes shall be subject to repurchase by the Company or a third party at the option of the Holders at a purchase price of 101% upon the occurrence of a Change of Control Triggering Event.  Upon receipt of notice of a Change of Control Offer, Holders electing to have Notes repurchased pursuant to the Change of Control Offer shall either (i) surrender this Note with the form of &#8220;Option of Holder to Elect Repurchase&#8221; attached hereto completed or (ii) transfer its Notes to the Paying Agent by book-entry transfer </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">pursuant to the applicable procedures of the Paying Agent, in either case prior to the close of business on the third Business Day prior to the Change of Control Payment Date.</font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Indenture permits, with certain exceptions as therein provided, the Company and the Trustee with the consent of the Holders of more than 50% in aggregate principal amount of the Securities at the time Outstanding of each series issued under the Indenture to be affected thereby, to execute supplemental indentures for the purpose of adding any provisions to or changing in any manner or eliminating any of the provisions of the Indenture or of modifying in any manner the rights of the Holders of the Securities of such series&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided, however,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that no such supplemental indenture shall, among other things, (i) change the Stated Maturity of the principal of, or any installment of principal of or interest on, any Security, or reduce the principal amount thereof or interest thereon, if any, or any premium payable upon redemption thereof&#59; (ii) change the Place of Payment on any Security or the currency or currency unit in which any Security or the principal or interest thereon is payable&#59; (iii) impair the right to institute suit for the enforcement of any such payment on or after the Stated Maturity thereof&#59; (iv) reduce or alter the method of computation of any amount payable upon redemption, repayment or purchase of any Securities by the Company (or the time when such redemption, repayment or purchase may be made)&#59; or (v) reduce the percentage in principal amount of the Securities, the Holders of which are required to consent to any supplemental indenture, without the consent of the Holder of each Security affected thereby.  The Indenture also contains provisions permitting the Holders of more than 50% in aggregate principal amount of the Securities of each series at the time outstanding, on behalf of the Holders of all the Securities of that series, to waive compliance by the Company with certain provisions of the Indenture and certain past defaults under the Indenture and their consequences with respect to such series, except a default in the payment of principal of or interest, if any, on any Security of that series or a default with respect to a covenant or provision of the Indenture which cannot be amended without the consent of such Holder.</font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Notes are issuable only in registered form without coupons in denominations of $2,000 and integral multiples of $1,000 in excess thereof.  The Notes shall be initially issued in the form of a Global Security.  All payments of principal of (and premium, if any) and interest on the Notes will be made to the Trustee so long as the Notes are in the form of a Global Security.  As provided in the Indenture and subject to certain limitations therein set forth, the Notes are exchangeable for a like aggregate principal amount of Notes as requested by the Holder surrendering the same.  If (x)&#160;the Depositary is at any time unwilling or unable to continue as depository and a successor depository is not appointed by the Company within 90 days after the Company receives such notice or becomes aware of such ineligibility, (y)&#160;the Company delivers to the Trustee a Company Order to the effect that this Note shall be exchangeable or (z)&#160;an Event of Default has occurred and is continuing with respect to the Notes, this Note shall be exchangeable for Notes in definitive form and in an equal aggregate principal amount.  Such definitive Notes shall be registered in such name or names as the Depositary shall instruct the Trustee.</font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">As provided in the Indenture and subject to certain limitations set forth therein and above, the transfer of this Note may be registered on the Security Register of the Company, upon surrender of this Note for registration of transfer at the office or agency of the Company in </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the Borough of Manhattan, The City of New York, duly endorsed by, or accompanied by a written instrument of transfer in form satisfactory to the Company duly executed by, the Holder hereof or by his attorney duly authorized in writing, and thereupon one or more new Notes of authorized denominations and for the same aggregate principal amount will be issued to the designated transferee or transferees.</font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">No reference herein to the Indenture and no provisions of this Note or of the Indenture shall alter or impair the obligation of the Company, which is absolute and unconditional, to pay the principal of (and premium, if any) and interest on this Note at the time, place and rate, and in the coin or currency, herein and in the Indenture prescribed.</font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">No service charge shall be made for any such registration of transfer or exchange, but the Company may require payment of a sum sufficient to cover any tax or other governmental charge payable in connection therewith.</font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Prior to due presentment of this Note for registration of transfer, the Company, the Trustee and any agent of the Company or the Trustee may treat the Person in whose name this Note is registered as the owner hereof for all purposes, whether or not this Note be overdue, and neither the Company, the Trustee nor any such agent shall be affected by notice to the contrary.</font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Certain of the Company&#8217;s obligations under the Indenture with respect to Notes may be terminated if the Company irrevocably deposits with the Trustee money or Government Obligations sufficient to pay and discharge the entire indebtedness on all Notes, as provided in the Indenture.</font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">No recourse shall be had for the payment of the principal of (and premium, if any), or the interest, if any, on this Note, or for any claim based thereon, or upon any obligation, covenant or agreement of the Company in the Indenture, against any incorporator, stockholder, officer or director, as such, past, present or future, of the Company or of any successor corporation, whether by virtue of any constitution, statute or rule of law or by the enforcement of any assessment of penalty or otherwise&#59; and all such personal liability is expressly released and waived as a condition of, and as part of the consideration for, the issuance of this Note.</font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Indenture and the Notes shall be governed by and construed in accordance with the laws of the State of New York.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="i53c0c9e0a81949e381557b476d63d56d_48"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:54pt;text-align:center"><font><br></font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ASSIGNMENT&#47;TRANSFER FORM</font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">FOR VALUE RECEIVED the undersigned registered Holder hereby sell(s), assign(s) and transfer(s) unto (insert Taxpayer Identification No.) _________________________</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">______________________________________________________________________</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">______________________________________________________________________</font></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(Please print or typewrite name and address including postal zip code of assignee)</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the within Note and all rights thereunder, hereby irrevocably constituting and appointing</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">______________________________________________________ attorney to transfer said </font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Note on the books of the Company with full power of substitution in the premises.</font></div><div style="margin-bottom:9pt;padding-left:36pt;text-indent:36pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">________________________________________________</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Date&#58;  __________________</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">NOTICE&#58;  The signature of the registered Holder to this assignment must correspond with the name as written upon the face of the within instrument in every particular, without alteration or enlargement or any change whatsoever.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:9pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">OPTION OF HOLDER TO ELECT PURCHASE</font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If you elect to have this Note purchased by the Company pursuant to Section&#160;1109 of the Indenture, check this box&#58; </font><font style="color:#000000;font-family:'Wingdings',sans-serif;font-size:12pt;font-weight:700;line-height:120%">&#9744;</font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If you want to elect to have only part of this Note purchased by the Company pursuant to Section 1109 of the Indenture, state the amount in principal amount (must be integral multiple of $1,000)&#58;  $____________________________________________</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Date&#58; __________ Your Signature _________________________________________________</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(Sign exactly as your name appears on the other&#160;side of the Security)</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Signature Guarantee&#58; ____________________________________________________________</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(Signature must be guaranteed)</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The signature(s) should be guaranteed by an eligible guarantor institution (banks, stockbrokers, savings and loan associations and credit unions with membership in an approved signature guarantee medallion program), pursuant to S.E.C. Rule 17Ad-15.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.4
<SEQUENCE>4
<FILENAME>exhibit44-closing8xk.htm
<DESCRIPTION>EX-4.4
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="id0b45946fc2343c589b0d95ed242956a_1"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 4.4</font></div></div><div style="margin-bottom:40pt;text-align:center"><font><br></font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">HUMANA INC.,</font></div><div style="margin-bottom:36pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Issuer</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A.,</font></div><div style="margin-bottom:36pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Trustee</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">TWENTY-SEVENTH SUPPLEMENTAL INDENTURE</font></div><div style="margin-bottom:20pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Dated as of November 9, 2023</font></div><div style="margin-bottom:12pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:39.583%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:20pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">5.950% Senior Notes due 2034</font></div><div style="margin-bottom:36pt;text-align:center"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:39.583%"><tr><td style="width:1.0%"></td><td style="width:98.900%"></td><td style="width:0.1%"></td></tr><tr style="height:3pt"><td colspan="3" style="border-bottom:1pt solid #000;padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Supplemental to Indenture dated as of August 5, 2003</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font><br></font></div></div></div><div id="id0b45946fc2343c589b0d95ed242956a_36"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">THIS TWENTY-SEVENTH SUPPLEMENTAL INDENTURE (the &#8220;Twenty-Seventh Supplemental Indenture&#8221;) is made the 9</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7.8pt;font-weight:400;line-height:120%;position:relative;top:-4.2pt;vertical-align:baseline">th</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> day of November, 2023, between HUMANA INC., a corporation duly incorporated and existing under the laws of Delaware and having its principal executive office at 500 West Main Street, Louisville, Kentucky 40202 (hereinafter called &#8220;the Company&#8221;), and THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A. (formerly known as The Bank of New York Trust Company, N.A. and as successor to The Bank of New York), a national banking association, as Trustee (hereinafter called the &#8220;Trustee&#8221;).</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">RECITALS OF THE COMPANY</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, the Company entered into an Indenture, dated as of August 5, 2003 with the Trustee (the &#8220;Original Indenture,&#8221; and together with this Twenty-Seventh Supplemental Indenture, referred to herein as the &#8220;Indenture&#8221;) (all capitalized terms used in this Twenty-Seventh Supplemental Indenture and not otherwise defined herein have the meanings assigned to such terms in the Original Indenture), for the purposes of issuing its Securities, evidencing its senior unsecured indebtedness, unlimited as to principal amount, to bear such rates of interest, to mature at such time or times, to be issued in one or more series and to have such other provisions as authorized by or pursuant to the authority granted in one or more resolutions of the Board of Directors of the Company&#59; and</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, Section 901 of the Original Indenture provides that without the consent of the Holders of the Securities of any series issued under the Original Indenture, the Company, when authorized by a Board Resolution, and the Trustee may, in certain circumstances, enter into one or more indentures supplemental to the Original Indenture&#59; and</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, the Company proposes to issue a series of Securities designated as its 5.950% Senior Notes due 2034, the terms of which shall be set forth in, or determined in the manner provided in, an Officers&#8217; Certificate of the Company as provided in Section 301 of the Original Indenture (such senior notes being referred to herein as the &#8220;2034 Senior Notes&#8221; and all references to Securities in the Original Indenture shall be deemed to refer also to the 2034 Senior Notes unless the context otherwise provides)&#59; and</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, the entry into this Twenty-Seventh Supplemental Indenture by the parties hereto is in all respect authorized by the provisions of the Original Indenture&#59; and</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">WHEREAS, all conditions necessary to authorize the execution and delivery of this Twenty-Seventh Supplemental Indenture and to make it a valid and binding obligation of the Company have been done or performed&#59; and</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">2</font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">NOW, THEREFORE, THIS TWENTY-SEVENTH SUPPLEMENTAL INDENTURE WITNESSETH&#58;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">For and in consideration of the promises and the purchase of the 2034 Senior Notes by the Holders thereof, it is mutually covenanted and agreed, for the equal and proportionate benefit of all Holders of the 2034 Senior Notes, as follows&#58;</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 1.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Original Indenture is hereby amended solely with respect to the 2034 Senior Notes as follows&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(A)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt">By amending Section 101 to insert the following definitions in their entirety in the appropriate alphabetical order as follows&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Change of Control&#8221; means the occurrence of any one of the following&#58; (1) the direct or indirect sale, lease, transfer, conveyance or other disposition (other than by way of merger or consolidation), in one or a series of related transactions, of all or substantially all of the Company&#8217;s and its subsidiaries assets taken as a whole to any Person other than to the Company or a Subsidiary&#59; (2) the consummation of any transaction (including without limitation, any merger or consolidation) the result of which is that any Person becomes the &#8220;beneficial owner&#8221; (as defined in Rules 13d-3 and 13d-5 under the Exchange Act), directly or indirectly, of more than 50% of the outstanding Voting Stock of the Company or the Voting Stock of any Parent Company (as defined below) or other Voting Stock into which the Voting Stock of the Company or the Voting Stock of any Parent Company is reclassified, consolidated, exchanged or changed, measured by voting power rather than number of shares&#59; (3) the Company or any Parent Company consolidates with, or merges with or into, any Person, or any Person consolidates with, or merges with or into, the Company or any Parent Company, in any such event pursuant to a transaction in which any of the outstanding Voting Stock of the Company, the Voting Stock of such Parent Company or the Voting Stock of such other Person is converted into or exchanged for cash, securities or other property, other than any such transaction where the shares of the Voting Stock of the Company or the Voting Stock of such Parent Company outstanding immediately prior to such transaction constitute, or are converted into or exchanged for, a majority of the Voting Stock of the surviving Person or any Parent Company of the surviving Person immediately after giving effect to such transaction&#59; or (4) the adoption of a plan relating to the liquidation or dissolution of the Company. Notwithstanding the foregoing, a transaction will not be deemed to involve a Change of Control under clause (2) above if (i) the Company becomes a subsidiary of a Parent Company and (ii) the holders of the Voting Stock of the Company or the Voting Stock of any Parent Company immediately prior to such transaction hold at least a majority of the Voting Stock of such Parent Company immediately following such transaction&#59; provided that any series of related transactions shall be treated as a single transaction. The term &#8220;Person,&#8221; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">3</font></div></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">solely as used in this definition, has the meaning given thereto in Section 13(d)(3) of the Exchange Act.</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Change of Control Triggering Event&#8221; means the occurrence of both a Change of Control and a related Rating Event.  </font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Common Stock&#8221; means, with respect to any Principal Subsidiary, Capital Stock of any class, however designated, except Capital Stock which is non-participating beyond fixed dividend and liquidation preferences and the holders of which have either no voting rights or limited voting rights entitling them, only in the case of certain contingencies, to elect less than a majority of the directors (or persons performing similar functions) of such Principal Subsidiary, and also includes securities of any class, however designated, which are convertible into Common Stock.</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Corporate Trust Office&#8221; means the office of the Trustee at which at any particular time its corporate trust business shall be administered, which office of The Bank of New York Mellon Trust Company, N.A., as of the Issue Date, is located at 2 N. LaSalle Street, Suite 700, Chicago, Illinois 60602, Attention&#58; Corporate Trust Department and, as of December 1, 2023, shall be located at 311 South Wacker Drive, Suite 6200B, Mailbox #44, Chicago, Illinois 60606, Attention&#58; Corporate Trust Department or such other address as the Trustee may designate from time to time by notice to the Holders and the Company, or the principal corporate trust office of any successor Trustee (or such other address as such successor Trustee may designate from time to time by notice to the Holders and the Company).</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Electronic Means&#8221; means the following communications methods&#58; e-mail, facsimile transmission, secure electronic transmission containing applicable authorization codes, passwords and&#47;or authentication keys issued by the Trustee, or another method or system specified by the Trustee as available for use in connection with its services hereunder.</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Indebtedness&#8221; means, with respect to any Person (without duplication)&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;any liability of that Person (A) for borrowed money, or under any reimbursement obligation relating to a letter of credit or similar instrument&#59; (B) evidenced by a bond, note, debenture or similar instrument&#59; (C) to pay the deferred purchase price of property or services, except trade accounts payable arising in the ordinary course of business&#59; or (D) for the payment of money relating to any obligations under any capital lease of real or personal property which has been recorded as a capitalized lease obligation&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">4</font></div></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;any liability of others described in the preceding clause (1) that the Person has guaranteed or that is otherwise its legal liability or which is secured by a lien on that Person&#8217;s Property&#59; and</font></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;any amendment, supplement, modification, deferral, renewal, extension or refunding of any liability of the types referred to in clauses (1) or (2) above.</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Investment Grade&#8221; means a rating of Baa3 or better by Moody&#8217;s (or its equivalent under any successor rating category) and a rating of BBB- or better by S&#38;P Global Ratings (or its equivalent under any successor rating category).  </font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Issue Date&#8221; means the first date on which 2034 Senior Notes are issued, which shall be November 9, 2023.</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Moody&#8217;s&#8221; means Moody&#8217;s Investors Service, Inc., or any successor thereto.</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Parent Company&#8221; means any holding company that, directly or indirectly, owns 100% of the Voting Stock of the Company.  </font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Principal Subsidiary&#8221; means a consolidated subsidiary of the Company that, as of the relevant time of determination, is a &#8220;significant subsidiary&#8221; as defined under Rule 405 under the Securities Act of 1933, as amended (as that Rule is in effect on November 2, 2023, without giving effect to any further amendment of that Rule).</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Rating Agency&#8221; means&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;each of Moody&#8217;s and S&#38;P Global Ratings, and</font></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;if either or both of Moody&#8217;s or S&#38;P Global Ratings ceases to rate the 2034 Senior Notes or fails to make a rating of the 2034 Senior Notes publicly available for reasons outside of the Company&#8217;s control, a Substitute Rating Agency in lieu thereof.</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Rating Event&#8221; means (i) the rating of the 2034 Senior Notes is lowered by both Rating Agencies during the related Trigger Period and (ii) the 2034 Senior Notes are rated below an Investment Grade rating by both Rating Agencies on any day during such Trigger Period. If either Rating Agency is not providing a rating of the 2034 Senior Notes on any day during such Trigger Period for any reason, the rating of such Rating Agency shall be deemed to be below Investment Grade on such day and such Rating Agency will be deemed to have lowered its rating of the 2034 Senior Notes during the Trigger Period.  For the avoidance of doubt, the Trustee shall not be charged with knowledge of any Rating Event nor have any duty to monitor the ratings of the Securities.</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;S&#38;P Global Ratings&#8221; means S&#38;P Global Ratings, a division of S&#38;P Global Inc.  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">5</font></div></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Substitute Rating Agency&#8221; means a &#8220;nationally recognized statistical rating organization&#8221; as that term is defined in Section 3(a)(62) of the Exchange Act, selected by the Company (as certified by a resolution of the Board of Directors delivered to the Trustee) as a replacement agency for Moody&#8217;s or S&#38;P Global Ratings, or both of them, as the case may be.  </font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Trigger Period&#8221; means the period commencing on the earlier of the first public notice of (a) the occurrence of a Change of Control or (b) the Company&#8217;s intention to effect a Change of Control and ending 60 days following consummation of such Change of Control (which period shall be extended so long as the rating of the 2034 Senior Notes is under publicly announced consideration for a possible downgrade by either of the Rating Agencies).  </font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Voting Stock&#8221; means, with respect to any Person as of any date, the Capital Stock of such Person that is at the time entitled to vote generally in the election of the board of directors (or other analogous managing body) of such Person.  </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(B)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.02pt">By replacing the definition of &#8220;Notice of Default&#8221; in Section 101 of the Original Indenture in its entirety as follows&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Notice of Default&#8221; has the meaning specified in Sections 501(3) and 501(4).</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(C)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.02pt">By replacing Section 105(2) of the Original Indenture in its entirety as follows&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;the Company by such Trustee or by any Holder shall be sufficient for every purpose hereunder (except as provided in paragraphs (3) and (4) of Section 501) if furnished in writing and mailed, first class postage prepaid, addressed to it, to the attention of the Chief Financial Officer, at the address of its principal office specified in the first paragraph of this instrument or at any other address previously furnished in writing to such Trustee by the Company, or if sent by facsimile transmission, to a facsimile number provided to the Trustee by the Company, with a copy mailed, first class postage prepaid, to the Company addressed to it as provided above.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(D)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt">By replacing the sixth paragraph of Section 303 of the Original Indenture in its entirety as follows&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">No Security or coupon appertaining thereto shall be entitled to any benefit under this Indenture or be valid or obligatory for any purpose unless there appears on such Security a certificate of authentication substantially in the form provided for herein executed by the Trustee, either by manual, facsimile or electronic execution, for such Security or on its behalf pursuant to Section 614, and such certificate upon any Security shall be conclusive evidence, and the only evidence, that such Security has been duly authenticated and delivered hereunder.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">6</font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(E)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.69pt">By deleting the eighth paragraph of Section 305 of the Original Indenture in its entirety. </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(F)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.35pt">By replacing Section 403 of the Original Indenture in its entirety as follows&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 403. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Covenant Defeasance</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  </font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Upon the Company&#8217;s exercise under Section 401 of the option applicable to this Section 403, the Company shall be released from any obligations under the covenants contained in Sections 704, 801 and 1007 hereof with respect to the Outstanding 2034 Senior Notes, on and after the date the conditions set forth in Section 404 are satisfied (hereinafter, &#8220;Covenant Defeasance&#8221;), and the 2034 Senior Notes and any coupons appertaining thereto shall thereafter be deemed not &#8220;Outstanding&#8221; for the purposes of any direction, waiver, consent or declaration or act of Holders (and the consequences of any thereof) in connection with such covenants, but shall continue to be deemed &#8220;Outstanding&#8221; for all other purposes hereunder (it being understood that such 2034 Senior Notes shall not be deemed outstanding for accounting purposes). For this purpose, such Covenant Defeasance means that, with respect to the Outstanding 2034 Senior Notes and any coupons appertaining thereto, the Company may omit to comply with and shall have no liability in respect of any term, condition or limitation set forth in any such covenant, whether directly or indirectly, by reason of any reference elsewhere herein to any such covenant or by reason of any reference in any such covenant to any other provision herein or in any other document and such omission to comply shall not constitute a default or Event of Default under subsection 501(3) but, except as specified above, the remainder of this Indenture and the 2034 Senior Notes shall be unaffected thereby.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(G)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt">By replacing Section 404(b) of the Original Indenture in its entirety as follows&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;in the case of Legal Defeasance, the Company shall have delivered to the Trustee for the Securities of that series an Opinion of Counsel in the United States reasonably acceptable to such Trustee confirming that, subject to customary assumptions and exclusions, (1) the Company has received from, or there has been published by, the U.S. Internal Revenue Service a ruling or (2) since the Issue Date, there has been a change in the applicable U.S. federal income tax law, in either case to the effect that, and based thereon such Opinion of Counsel in the United States shall confirm that, subject to customary assumptions and exclusions, the Holders and beneficial owners of the Outstanding Securities of that series will not recognize income, gain or loss for U.S. federal income tax purposes as a result of such Legal Defeasance and will be subject to U.S. federal income tax on the same amounts, in the same manner and at the same times as would have been the case if such Legal Defeasance had not occurred&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">7</font></div></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(H)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt">By replacing Section 404(c) of the Original Indenture in its entirety as follows&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;in the case of Covenant Defeasance, the Company shall have delivered to the Trustee for the Securities of that series an Opinion of Counsel in the United States reasonably acceptable to such Trustee confirming that, subject to customary assumptions and exclusions, the Holders and beneficial owners of the Outstanding Securities of that series will not recognize income, gain or loss for U.S. federal income tax purposes as a result of such Covenant Defeasance and will be subject to U.S. federal income tax on the same amounts, in the same manner and at the same times as would have been the case if such Covenant Defeasance had not occurred&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(I)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:24.03pt">By replacing Section 404(d) of the Original Indenture in its entirety as follows&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;no Event of Default or event which with the giving of notice or the lapse of time, or both, would become an Event of Default with respect to the 2034 Senior Notes shall have occurred and be continuing on the date of such deposit and no Event of Default under Section 501(5) or Section 501(6) shall have occurred and be continuing on the 123rd day after such date&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(J)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:23.36pt">By replacing Section 405(ii)(B) of the Original Indenture in its entirety as follows&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(B)&#160;&#160;&#160;&#160;no Event of Default or event which with the giving of notice or the lapse of time, or both, would become an Event of Default shall have occurred and be continuing on the date of such deposit and no Event of Default under Section 501(5) or Section 501(6) shall have occurred and be continuing on the 123rd day after such date&#59;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(K)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt">By replacing Section 501 of the Original Indenture in its entirety as follows&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Event of Default&#8221; wherever used herein with respect to the 2034 Senior Notes means any one of the following events (whatever the reason for such Event of Default and whether it shall be voluntary or involuntary or be effected by operation of law pursuant to any judgment, decree or order of any court or any order, rule or regulation of any administrative or governmental body)&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(1)&#160;&#160;&#160;&#160;default in the payment of any installment of interest upon any 2034 Senior Note and any related coupon when it becomes due and payable, and continuance of such default for a period of 30 days&#59; or</font></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(2)&#160;&#160;&#160;&#160;default in the payment of the principal of (or premium, if any, on) any 2034 Senior Note at its Maturity&#59; or</font></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(3)&#160;&#160;&#160;&#160;default in the performance of, or breach of, any covenant or warranty of the Company in respect of any 2034 Senior Note contained in </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">8</font></div></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">this Indenture or in such 2034 Senior Notes (other than a covenant or warranty a default in whose performance or whose breach is elsewhere in this Section specifically dealt with) and continuance of such default or breach for a period of 60 days after there has been given, by registered or certified mail, to the Company by the Trustee for the 2034 Senior Notes or to the Company and such Trustee by the Holders of at least 25% in aggregate principal amount of the Outstanding 2034 Senior Notes a written notice specifying such default or breach and requiring it to be remedied and stating that such notice is a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Notice of Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; hereunder&#59; or</font></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(4)&#160;&#160;&#160;&#160;(A) the Company or any of its Subsidiaries fails to pay indebtedness for money borrowed by the Company or any of its Subsidiaries in an aggregate principal amount of at least $150,000,000, at the later of final maturity or the expiration of any related applicable grace period and such payment shall not have been made, waived or extended within 30 days after written notice from the Trustee or the Holders of at least 25% in aggregate principal amount of the Outstanding 2034 Senior Notes as provided below or (B) acceleration of maturity of Securities of another series or any other indebtedness for borrowed money of the Company or any of its Subsidiaries, in an aggregate principal amount exceeding $150,000,000, under the terms of the instrument or instruments under which such indebtedness arises or is secured, if such indebtedness has not been discharged in full or such acceleration is not rescinded or annulled within 30 days after there has been given, by registered or certified mail, to the Company by the Trustee or to the Company and such Trustee by the Holders of at least 25% in aggregate principal amount of the Outstanding 2034 Senior Notes a written notice specifying such default and requiring it to be remedied and stating that such notice is a &#8220;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Notice of Default</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8221; hereunder&#59; or</font></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(5)&#160;&#160;&#160;&#160;the Company shall commence any case or proceeding seeking to have an order for relief entered on its behalf as debtor or to adjudicate it as bankrupt or insolvent or seeking reorganization, liquidation, dissolution, winding-up, arrangement, composition or readjustment of its debts or any other relief under any bankruptcy, insolvency, reorganization, liquidation, dissolution, arrangement, composition, readjustment of debt or other similar act or law of any jurisdiction, domestic or foreign, now or hereafter existing&#59; or the Company shall apply for a receiver, custodian or trustee (other than any trustee appointed as a mortgagee or secured party in connection with the issuance of indebtedness for borrowed money of the Company) of it or for all or a substantial part of its property&#59; or the Company shall make a general assignment for the benefit of creditors&#59; or the Company shall take any corporate action in furtherance of any of the foregoing&#59; or</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">9</font></div></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(6)&#160;&#160;&#160;&#160;an involuntary case or other proceeding shall be commenced against the Company with respect to it or its debts under any bankruptcy, insolvency or other similar law now or hereafter in effect seeking the appointment of a trustee, receiver, liquidator, custodian or similar official of the Company or any substantial part of its property&#59; and such case or other proceeding (A) results in the entry of an order for relief or a similar order against the Company or (B) shall continue unstayed and in effect for a period of 60 consecutive days.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(L)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:20.69pt">By replacing the first and second paragraphs of Section 502 of the Original Indenture in their entirety as follows&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If an Event of Default with respect to the 2034 Senior Notes and any related coupons occurs and is continuing (other than an Event of Default described in Section 501(5) or 501(6) with respect to the Company), then and in every such case either the Trustee for the 2034 Senior Notes or the Holders of not less than 25% in aggregate principal amount of the Outstanding 2034 Senior Notes may declare the entire principal amount of all the 2034 Senior Notes, to be due and payable immediately, by a notice in writing to the Company (and to such Trustee if given by Holders), and upon any such declaration of acceleration such principal, together with accrued interest and all other amounts owing hereunder, shall become immediately due and payable, without presentment, demand, protest or notice of any kind, all of which are hereby expressly waived.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If any Event of Default specified in Section 501(5) or 501(6) occurs with respect to the Company, all of the unpaid principal amount and accrued interest on all Securities of each series then outstanding shall </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">ipso facto</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> become and be immediately due and payable without any declaration or other act by the Trustee or any Holder.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(M)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:17.36pt">By replacing the last paragraph of Section 607 of the Original Indenture in its entirety as follows&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">When the Trustee incurs expenses or renders services in connection with an Event of Default specified in Section 501(5) or Section 501(6) the expenses (including the reasonable charges and expenses of its counsel) and the compensation for the services are intended to constitute expenses of administration under any applicable Federal or state bankruptcy, insolvency or other similar law.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(N)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt">By replacing Section 1007 of the Original Indenture in its entirety as follows&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 1007. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Limitation on Liens</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company shall not, and shall not permit any of its Principal Subsidiaries to, issue, assume, Incur or guarantee any Indebtedness secured by a </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">10</font></div></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">mortgage, pledge, lien or other encumbrance, directly or indirectly, on any of the Common Stock of a Principal Subsidiary owned by the Company or any of its Principal Subsidiaries, unless the Company&#8217;s obligations under the 2034 Senior Notes and, if the Company so elects, any other Indebtedness of the Company ranking on a parity with, or prior to, the 2034 Senior Notes, shall be secured equally and ratably with, or prior to, such secured Indebtedness so long as it is outstanding and is so secured.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(O)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt">By replacing Section 1008 of the Original Indenture in its entirety as follows&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 1008. </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Waiver of Certain Covenants.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company may omit in any particular instance to comply with any covenant or condition set forth in Sections 1005 to 1007, inclusive, if before or after the time for such compliance the Holders of more than 50% in aggregate principal amount of the Outstanding Securities of each series of Securities affected by the omission shall, in each case by Act of such Holders, either waive such compliance in such instance or generally waive compliance with such covenant or condition, but no such waiver shall extend to or affect such covenant or condition except to the extent so expressly waived, and, until such waiver shall become effective, the obligations of the Company and the duties of the Trustee for the Securities of each series with respect to any such covenant or condition shall remain in full force and effect.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(P)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:21.35pt">By deleting Section 1009 from the Original Indenture in its entirety.</font></div><div style="margin-bottom:12pt;padding-left:72pt;text-indent:-36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(Q)</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;padding-left:19.36pt">By adding Section 1109 to the Original Indenture as follows&#58;</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Section 1109.  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">Offer to Repurchase Upon Change of Control Triggering Event</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">.  </font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;If a Change of Control Triggering Event occurs with respect to the 2034 Senior Notes, unless the Company shall have exercised its option to redeem the 2034 Senior Notes pursuant to Section 1102, the Company shall be required to make an offer (the &#8220;Change of Control Offer&#8221;) to each Holder of 2034 Senior Notes to repurchase all or any part (equal to $2,000 or any integral multiple of $1,000 in excess thereof) of such Holder&#8217;s 2034 Senior Notes on the terms set forth in this Section 1109. In the Change of Control Offer, the Company shall be required to offer payment in cash equal to 101% of the principal amount of the 2034 Senior Notes to be repurchased, plus accrued and unpaid interest, if any, on the 2034 Senior Notes up to, but not including, the date of repurchase (the &#8220;Change of Control Payment&#8221;) subject to the rights of the Holder on the relevant Regular Record Date to receive interest due on the relevant Interest Payment Date. Within 30 days following any Change of Control Triggering Event or, at the option of the Company, prior to any Change of Control, but after the public announcement of the transaction that constitutes or may constitute the Change of Control, the Company shall deliver a notice to Holders of the 2034 Senior Notes, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">11</font></div></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">with a copy to the Trustee, which notice shall govern the terms of the Change of Control Offer, describing the transaction that constitutes or may constitute the Change of Control Triggering Event and offering to repurchase the 2034 Senior Notes on the date specified in the notice, which date shall be no earlier than 10 days and no later than 60 days from the date such notice is sent other than as may be required by law or, if the notice is sent prior to the Change of Control, no earlier than 10 days and no later than 60 days from the date on which the Change of Control Triggering Event occurs (the &#8220;Change of Control Payment Date&#8221;). The notice shall, if sent prior to the date of consummation of the Change of Control, state that the Change of Control Offer is conditioned on the Change of Control Triggering Event occurring on or prior to the Change of Control Payment Date.</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;On the Change of Control Payment Date, the Company shall, to the extent lawful&#58;</font></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;accept for payment all 2034 Senior Notes or portions of 2034 Senior Notes properly tendered pursuant to the Change of Control Offer&#59;</font></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;deposit with the Paying Agent an amount equal to the Change of Control Payment in respect of all 2034 Senior Notes or portions of 2034 Senior Notes properly tendered in accordance with the procedures set forth in the Global Securities representing the 2034 Senior Notes&#59; and </font></div><div style="margin-bottom:12pt;padding-left:108pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;deliver or cause to be delivered to the Trustee the 2034 Senior Notes properly accepted together with an Officer&#8217;s Certificate stating the principal amount of 2034 Senior Notes or portions of 2034 Senior Notes being repurchased.</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company shall publicly announce the results of the Change of Control Offer on or as soon as possible after the date of purchase.</font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;The Company shall not be required to make a Change of Control Offer upon the occurrence of a Change of Control Triggering Event if a third party makes such an offer in the manner, at the times and otherwise in compliance with the requirements for an offer made by the Company and the third party repurchases all 2034 Senior Notes properly tendered and not withdrawn under its offer. </font></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(d)&#160;&#160;&#160;&#160;The Company shall comply in all material respects with the requirements of Rule 14e-1 under the Exchange Act and any other securities laws and regulations thereunder to the extent such laws and regulations are applicable in connection with the repurchase of the 2034 Senior Notes as a result of a Change of Control Triggering Event. To the extent that the provisions of any such securities laws or regulations conflict with the Change of Control Offer provisions of the 2034 Senior Notes, the Company shall comply with the applicable </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">12</font></div></div><div style="margin-bottom:12pt;padding-left:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">securities laws and regulations and shall not be deemed to have breached its obligations under this Section 1109 by virtue of any such conflict.  </font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 2.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The recitals and statements in this Twenty-Seventh Supplemental Indenture are made by the Company only and not by the Trustee, and the Trustee makes no representation as to the validity or sufficiency of this Twenty-Seventh Supplemental Indenture (other than with respect to the due authorization, execution and delivery of this Twenty-Seventh Supplemental Indenture by the Trustee).  All of the provisions contained in the Original Indenture in respect of the rights, privileges, immunities, powers and duties of the Trustee shall be applicable in respect of the 2034 Senior Notes and of this Twenty-Seventh Supplemental Indenture as fully and with like effect as if set forth herein in full.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 3.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;As supplemented hereby, the Original Indenture is in all respects ratified and confirmed, and the Original Indenture and this Twenty-Seventh Supplemental Indenture shall be read, taken and construed as one and the same instrument and all references to Securities in the Original Indenture shall be deemed to refer also to the 2034 Senior Notes unless the context otherwise provides.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 4.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;This Twenty-Seventh Supplemental Indenture shall be governed by, and construed in accordance with, the laws of the State of New York.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 5.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In the event of a conflict between the terms and conditions of the Original Indenture and the terms and conditions of this Twenty-Seventh Supplemental Indenture, then the terms and conditions of this Twenty-Seventh Supplemental Indenture shall prevail&#59; provided that if and to the extent that any provision of this Twenty-Seventh Supplemental Indenture limits, qualifies or conflicts with another provision which is required to be included herein or in the Original Indenture by the Trust Indenture Act of 1939, as amended, such required provision shall control.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 6.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;All covenants and agreements in this Twenty-Seventh Supplemental Indenture by the Company shall bind its successors and assigns, whether so expressed or not.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 7.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;In case any provision in this Twenty-Seventh Supplemental Indenture shall be invalid, illegal or unenforceable, the validity, legality and enforceability of the remaining provisions shall not in any way be affected or impaired hereby.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 8.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;Nothing in this Twenty-Seventh Supplemental Indenture, expressed or implied, shall give to any Person, other than the parties hereto and any Paying Agent, any Security Registrar and any Authenticating Agent for the 2034 Senior Notes and their successors under the Indenture, and the Holders of the 2034 Senior Notes any benefit or any legal or equitable right, remedy or claim under this Twenty-Seventh Supplemental Indenture.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 9.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;This Twenty-Seventh Supplemental Indenture may be simultaneously executed in several counterparts, each of which shall be deemed to be an original, and such counterparts shall together constitute but one and the same instrument.  The words &#8220;execution,&#8221; signed,&#8221; &#8220;signature,&#8221; and words of like import in this Supplemental Indenture or in any other </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">13</font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">certificate, agreement or document related to this Supplemental Indenture shall include images of manually executed signatures transmitted by facsimile or other electronic format (including, without limitation, &#8220;pdf&#8221;, &#8220;tif&#8221; or &#8220;jpg&#8221;) and other electronic signatures (including, without limitation, DocuSign and AdobeSign).  The use of electronic signatures and electronic records (including, without limitation, any contract or other record created, generated, sent, communicated, received, or stored by electronic means) shall be of the same legal effect, validity and enforceability as a manually executed signature or use of a paper-based record-keeping system to the fullest extent permitted by applicable law, including the Federal Electronic Signatures in Global and National Commerce Act, the New York State Electronic Signatures and Records Act and any other applicable law, including, without limitation, any state law based on the Uniform Electronic Transactions Act or the Uniform Commercial Code.</font></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">Section 10.</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#160;&#160;&#160;&#160;The Trustee shall have the right to accept and act upon instructions, including funds transfer instructions (for the purposes of this Section, &#8220;Instructions&#8221;) given pursuant to the Indenture and delivered using Electronic Means&#59; provided, however, that the Company shall provide to the Trustee an incumbency certificate listing authorized officers and containing specimen signatures of such authorized officers, which incumbency certificate shall be amended by the Company whenever a person is to be added or deleted from the listing.  If the Company elects to give the Trustee Instructions using Electronic Means and the Trustee in its discretion elects to act upon such Instructions, the Trustee&#8217;s understanding of such Instructions shall be deemed controlling.  The Company understands and agrees that the Trustee cannot determine the identity of the actual sender of such Instructions and that the Trustee shall conclusively presume that directions that purport to have been sent by an authorized officer listed on the incumbency certificate provided to the Trustee have been sent by such authorized officer.  The Company shall be responsible for ensuring that only authorized officers transmit such Instructions to the Trustee and that the Company and all authorized officers are solely responsible to safeguard the use and confidentiality of applicable user and authorization codes, passwords and&#47;or authentication keys upon receipt by the Company.  The Trustee shall not be liable for any losses, costs or expenses arising directly or indirectly from the Trustee&#8217;s reliance upon and compliance with such Instructions notwithstanding such directions conflict or are inconsistent with a subsequent written instruction.  The Company agrees&#58; (i) to assume all risks arising out of the use of Electronic Means to submit Instructions to the Trustee, including without limitation the risk of the Trustee acting on unauthorized Instructions, and the risk of interception and misuse by third parties&#59; (ii) that it is fully informed of the protections and risks associated with the various methods of transmitting Instructions to the Trustee and that there may be more secure methods of transmitting Instructions than the method(s) selected by the Company&#59; (iii) that the security procedures (if any) to be followed in connection with its transmission of Instructions provide to it a commercially reasonable degree of protection in light of its particular needs and circumstances&#59; and (iv) to notify the Trustee immediately upon learning of any compromise or unauthorized use of the security procedures.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(signature page follows)</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="id0b45946fc2343c589b0d95ed242956a_52"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the parties hereto have caused this Twenty-Seventh Supplemental Indenture dated as of November 9, 2023 to be duly executed, as of November 9, 2023.</font></div><div style="margin-bottom:12pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:53.685%"><tr><td style="width:1.0%"></td><td style="width:8.153%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.123%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:74.424%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">HUMANA INC.,</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Issuer</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Susan Diamond</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58; Susan Diamond</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58; Chief Financial Officer</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#91;Signature Page to Twenty-Seventh Supplemental Indenture&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:53.685%"><tr><td style="width:1.0%"></td><td style="width:8.153%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:14.123%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:74.424%"></td><td style="width:0.1%"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A.,</font></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Trustee</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">By&#58;</font></td><td colspan="6" style="border-bottom:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#47;s&#47; Ann M. Dolezal</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Name&#58; Ann M. Dolezal</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Title&#58;   Vice President</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="9" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Dated&#58; November 9, 2023</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:112%">&#91;Signature Page to Twenty-Seventh Supplemental Indenture&#93;</font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-4.5
<SEQUENCE>5
<FILENAME>exhibit45-closing8xk.htm
<DESCRIPTION>EX-4.5
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i144ff43f75e74080a8c85a2966720612_1"></div><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:92%">Exhibit 4.5</font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:115%">HUMANA INC.</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">5.950% Senior Notes due 2034</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:69.893%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:27.907%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">PRINCIPAL AMOUNT</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">REGISTERED</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">$&#91;&#160;&#160;&#160;&#160;&#160;&#93;</font></div></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">CUSIP No.&#58; 444859 BY7</font></div></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">ISIN No.&#58; US444859BY76</font></div></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">No. &#91;&#160;&#160;&#160;&#160;&#160;&#93;</font></div></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">THIS NOTE IS A GLOBAL SECURITY WITHIN THE MEANING OF THE INDENTURE HEREINAFTER REFERRED TO AND IS REGISTERED IN THE NAME OF A DEPOSITARY OR A NOMINEE THEREOF.  UNLESS AND UNTIL IT IS EXCHANGED IN WHOLE OR IN PART FOR NOTES IN CERTIFICATED FORM, THIS NOTE MAY NOT BE TRANSFERRED EXCEPT AS A WHOLE BY THE DEPOSITORY TRUST COMPANY (THE &#8220;DEPOSITARY&#8221;) TO A NOMINEE OF THE DEPOSITARY OR BY THE DEPOSITARY OR ANY SUCH NOMINEE TO A SUCCESSOR DEPOSITARY OR A NOMINEE OF SUCH SUCCESSOR DEPOSITARY.  UNLESS THIS NOTE IS PRESENTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITARY TO THE COMPANY OR ITS AGENT FOR REGISTRATION OF TRANSFER, EXCHANGE OR PAYMENT, AND ANY NOTE ISSUED IS REGISTERED IN THE NAME OF CEDE &#38; CO. OR IN SUCH OTHER NAME AS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITARY (AND ANY PAYMENT IS MADE TO CEDE &#38; CO. OR TO SUCH OTHER ENTITY AS IS REQUESTED BY AN AUTHORIZED REPRESENTATIVE OF THE DEPOSITARY), ANY TRANSFER, PLEDGE OR OTHER USE HEREOF FOR VALUE OR OTHERWISE BY OR TO ANY PERSON IS WRONGFUL INASMUCH AS THE REGISTERED OWNER HEREOF, CEDE &#38; CO., HAS AN INTEREST HEREIN.  </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">HUMANA INC., a Delaware corporation (the &#8220;Issuer&#8221; or the &#8220;Company,&#8221; which terms include any successor corporation under the Indenture hereinafter referred to), for value received, hereby promises to pay to CEDE &#38; CO., or registered assigns, the principal sum of &#91;&#160;&#160;&#93; DOLLARS on March 15, 2034 and to pay interest thereon (computed on the basis of a 360-day year of twelve 30-day months), semi-annually in arrears on March 15 and September 15 (the &#8220;Interest Payment Dates&#8221;) of each year, commencing on March 15, 2024, at the rate per annum specified in the title of this Note from November 9, 2023 or the most recent Interest Payment Date to which interest had been paid or duly provided for. </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The interest so payable and punctually paid or duly provided for on any Interest Payment Date will, as provided in the Indenture, be paid to the Person in whose name this Note (or one or more Predecessor Securities) is registered at the close of business on March 1 or September 1 (the &#8220;Record Date&#8221;) immediately preceding such Interest Payment Date. Except as provided herein, payment of the principal of (and premium, if any) and interest on this Note will be made at the office or agency of the Company maintained by the Company for such purpose, in the Borough of Manhattan, The City of New York, which initially will be in the corporate trust </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">office of an affiliate of The Bank of New York Mellon Trust Company, N.A., the Trustee for this Note under the Indenture, located at 240 Greenwich Street, New York, New York 10286, in such coin or currency of the United States of America as at the time of payment is legal tender for payment of public and private debts.  </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Reference is hereby made to the further provisions of this Note as set forth on the reverse hereof, which further provisions shall for all purposes have the same effect as if set forth at this place. </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Unless the certificate of authentication hereon has been executed by or on behalf of The Bank of New York Mellon Trust Company, N.A., the Trustee for this Note under the Indenture, or its successor thereunder, by the manual, facsimile or electronic signature of one of its authorized officers, this Note shall not be entitled to any benefit under the Indenture or be valid or obligatory for any purpose.  </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i144ff43f75e74080a8c85a2966720612_4"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">IN WITNESS WHEREOF, the Company has caused this instrument to be duly executed, manually or in facsimile, and an imprint or facsimile of its corporate seal to be imprinted hereon.</font></div><div style="margin-bottom:24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Dated&#58; November 9, 2023</font></div><div style="margin-bottom:12pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:53.525%"><tr><td style="width:1.0%"></td><td style="width:9.379%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.421%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:24pt;text-indent:-0.27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">HUMANA INC.</font></div></td></tr><tr style="height:32pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.43pt;text-align:left;text-indent:-0.27pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:92%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 3.43pt;text-align:left;text-indent:-0.27pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:92%">Name&#58;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.43pt;text-align:left;text-indent:-0.27pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:92%">Title&#58;</font></td></tr></table></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#91;FACSIMILE OF SEAL&#93;</font></div><div style="margin-bottom:12pt;text-align:right"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:53.525%"><tr><td style="width:1.0%"></td><td style="width:9.379%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.421%"></td><td style="width:0.1%"></td></tr><tr><td colspan="6" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:24pt;text-indent:-0.27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Attest&#58;</font></div></td></tr><tr style="height:32pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:2px 1pt 2px 3.43pt;text-align:left;text-indent:-0.27pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:92%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt 2px 3.43pt;text-align:left;text-indent:-0.27pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:92%">Name&#58;</font></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 3.43pt;text-align:left;text-indent:-0.27pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:92%">Title&#58;</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#91;Signature Page to 2034 Global Note No. &#91;&#160;&#160;&#93;&#93;</font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">CERTIFICATE OF AUTHENTICATION</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">This is one of the Securities of the series designated therein described in the within-mentioned Indenture.  </font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">THE BANK OF NEW YORK MELLON TRUST COMPANY, N.A.,</font></div><div style="margin-bottom:24pt;text-indent:18pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">as Trustee</font></div><div style="margin-bottom:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:53.525%"><tr><td style="width:1.0%"></td><td style="width:9.379%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:88.421%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;text-indent:-0.27pt;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:92%">By&#58;</font></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="border-top:1pt solid #000;padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:92%">Authorized Signatory</font></td></tr></table></div><div style="margin-bottom:12pt;padding-left:27pt;text-indent:-27pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:115%">Dated&#58; </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:139%">&#91;Signature Page to 2034 Global Note No. &#91;&#160;&#160;&#93;&#93;</font></div></div></div><div id="i144ff43f75e74080a8c85a2966720612_7"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(Reverse of Note)</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">HUMANA INC.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Note is one of a duly authorized issue of Securities of the Company designated as its 5.950% Senior Notes due 2034 (the &#8220;Notes&#8221;).  The Notes are one of an indefinite number of series of debt securities of the Company (the &#8220;Securities&#8221;), issued or issuable under and pursuant to a base indenture, dated as of August 5, 2003 (the &#8220;Base Indenture&#8221;), between the Company and The Bank of New York Mellon Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.) (as successor to The Bank of New York) (herein called the &#8220;Trustee,&#8221; which term includes any successor Trustee under the Indenture), as supplemented by a twenty-seventh supplemental indenture, dated as of November 9, 2023 (the &#8220;Twenty-Seventh Supplemental Indenture&#8221;&#59; the Base Indenture as supplemented by the Twenty-Seventh Supplemental Indenture is herein called the &#8220;Indenture&#8221;), to which Indenture and all indentures supplemental thereto (other than supplemental indentures creating a different series of notes) reference is hereby made for a statement of the respective rights thereunder of the Company, the Trustee and the Holders of the Notes and the terms upon which the Notes are to be authenticated and delivered.  The terms, conditions and provisions of the Notes are those stated in the Indenture, those made part of the Indenture by reference to the Trust Indenture Act of 1939, as amended, and those set forth in this Note.  This Note is one of a series designated on the face hereof initially issued in an aggregate principal amount of $850,000,000.  The Company may, from time to time, without the consent of the Holders, issue and sell additional Securities ranking equally with the Notes and otherwise identical in all respects (except for their date of issue, issue price and, if applicable, the first payment of interest on the additional Securities) so that such additional Securities shall be consolidated and form a single series with the Notes.  If any additional Securities are not fungible with the Notes for U.S. federal income tax purposes, they will be issued with a different CUSIP number (or other applicable identifying number).</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The terms of other series of Securities issued under the Base Indenture may vary with respect to interest rates or interest rate formulas, issue dates, maturity, redemption, repayment, currency of payment and otherwise as provided in the Base Indenture.  The Base Indenture further provides that Securities of a single series may be issued at various times, with different maturity dates and may bear interest at different rates.  All terms used in this Note which are defined in the Indenture shall have the meanings assigned to them in the Indenture.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">This Note is not subject to any sinking fund. </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If an Event of Default (other than an Event of Default described in Section 501(5) or 501(6) of the Indenture, with respect to the Company) with respect to the Notes shall occur and be continuing, then either the Trustee or the Holders of not less than 25% in aggregate principal amount of the Notes of this series then Outstanding may declare the aggregate principal amount of the Notes of this series due and payable in the manner and with the effect provided in the Indenture.  If an Event of Default specified in Section 501(5) or 501(6) occurs with respect to the Company, all of the unpaid principal amount and accrued interest thereon shall ipso facto </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">become and be immediately due and payable in the manner and with the effect provided in the Indenture without any declaration or other act by the Trustee or any Holder.  </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Prior to December 15, 2033 (three months prior to their maturity date) (the &#8220;Par Call Date&#8221;), the Company may redeem the Notes at its option, in whole or in part, at any time and from time to time, at a Redemption Price (expressed as a percentage of principal amount and rounded to three decimal places) equal to the greater of&#58; </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(1) (a) the sum of the present values of the remaining scheduled payments of principal and interest thereon discounted to the Redemption Date (assuming the Notes matured on the Par Call Date) on a semi-annual basis (assuming a 360-day year consisting of twelve 30-day months) at the Treasury Rate plus 25 basis points less (b) interest accrued to the date of redemption, and</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(2) 100% of the principal amount of the notes to be redeemed, </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">plus, in either case, accrued and unpaid interest thereon to the Redemption Date. </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">On or after the Par Call Date, the Company may redeem the notes, in whole or in part, at any time and from time to time, at a Redemption Price equal to 100% of the principal amount of the notes being redeemed plus accrued and unpaid interest thereon to the Redemption Date. </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8220;Treasury Rate&#8221; means, with respect to any Redemption Date, the yield determined by the Company in accordance with the following two paragraphs.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Treasury Rate shall be determined by the Company after 4&#58;15 p.m., New York City time (or after such time as yields on U.S. government securities are posted daily by the Board of Governors of the Federal Reserve System), on the third business day preceding the Redemption Date based upon the yield or yields for the most recent day that appear after such time on such day in the most recent statistical release published by the Board of Governors of the Federal Reserve System designated as &#8220;Selected Interest Rates (Daily) - H.15&#8221; (or any successor designation or publication) (&#8220;H.15&#8221;) under the caption &#8220;U.S. government securities&#8211;Treasury constant maturities&#8211;Nominal&#8221; (or any successor caption or heading) (&#8220;H.15 TCM&#8221;). In determining the Treasury Rate, the Company shall select, as applicable&#58; (1) the yield for the Treasury constant maturity on H.15 exactly equal to the period from the Redemption Date to the Par Call Date (the &#8220;Remaining Life&#8221;)&#59; or (2) if there is no such Treasury constant maturity on H.15 exactly equal to the Remaining Life, the two yields &#8211; one yield corresponding to the Treasury constant maturity on H.15 immediately shorter than and one yield corresponding to the Treasury constant maturity on H.15 immediately longer than the Remaining Life &#8211; and shall interpolate to the Par Call Date on a straight-line basis (using the actual number of days) using such yields and rounding the result to three decimal places&#59; or (3) if there is no such Treasury constant maturity on H.15 shorter than or longer than the Remaining Life, the yield for the single Treasury constant maturity on H.15 closest to the Remaining Life. For purposes of this paragraph, the applicable Treasury constant maturity or maturities on H.15 shall be deemed to </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">have a maturity date equal to the relevant number of months or years, as applicable, of such Treasury constant maturity from the Redemption Date.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If on the third business day preceding the Redemption Date H.15 TCM or any successor designation or publication is no longer published, the Company shall calculate the Treasury Rate based on the rate per annum equal to the semi-annual equivalent yield to maturity at 11&#58;00 a.m., New York City time, on the second business day preceding such Redemption Date of the United States Treasury security maturing on, or with a maturity that is closest to, the Par Call Date, as applicable.  If there is no United States Treasury security maturing on the Par Call Date but there are two or more United States Treasury securities with a maturity date equally distant from the Par Call Date, one with a maturity date preceding the Par Call Date, and one with a maturity date following the Par Call Date, the Company shall select the United States Treasury security with a maturity date preceding the Par Call Date. If there are two or more United States Treasury securities maturing on the Par Call Date, or two or more United States Treasury securities meeting the criteria of the preceding sentence, the Company shall select from among these two or more United States Treasury securities the United States Treasury security that is trading closest to par based upon the average of the bid and asked prices for such United States Treasury securities at 11&#58;00 a.m., New York City time.  In determining the Treasury Rate in accordance with the terms of this paragraph, the semi-annual yield to maturity of the applicable United States Treasury security shall be based upon the average of the bid and asked prices (expressed as a percentage of principal amount) at 11&#58;00 a.m., New York City time, of such United States Treasury security, and rounded to three decimal places.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Company&#8217;s actions and determinations in determining the Redemption Price shall be conclusive and binding for all purposes, absent manifest error. The Trustee shall have no responsibility for the calculation of the Redemption Price. </font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Notice of any redemption will be mailed or electronically delivered (or otherwise transmitted in accordance with the depositary&#8217;s procedures) at least 10 days but not more than 60 days before the Redemption Date to each Holder of the Notes to be redeemed.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In the case of a partial redemption, selection of the Notes for redemption will be made, in the case of Global Securities, in accordance with the Depositary&#8217;s procedures, and in the case of definitive Securities, by lot or by such other method as the Trustee deems appropriate. No Notes of a principal amount of $2,000 or less will be redeemed in part. If any Note is to be redeemed in part only, the notice of redemption that relates to the note will state the portion of the principal amount of the Note to be redeemed. A new Note in a principal amount equal to the unredeemed portion of the Note will be issued in the name of the Holder of the note upon surrender for cancellation of the original Note. For so long as the Notes are held by Depository Trust Company (or another depositary), the redemption of the Notes shall be done in accordance with the policies and procedures of the Depositary.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Unless the Company defaults in payment of the Redemption Price, on and after the Redemption Date interest will cease to accrue on the notes or portions thereof called for redemption.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">As provided in the Indenture, the Notes shall be subject to repurchase by the Company or a third party at the option of the Holders at a purchase price of 101% upon the occurrence of a Change of Control Triggering Event.  Upon receipt of notice of a Change of Control Offer, Holders electing to have Notes repurchased pursuant to the Change of Control Offer shall either (i) surrender this Note with the form of &#8220;Option of Holder to Elect Repurchase&#8221; attached hereto completed or (ii) transfer its Notes to the Paying Agent by book-entry transfer pursuant to the applicable procedures of the Paying Agent, in either case prior to the close of business on the third Business Day prior to the Change of Control Payment Date.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Indenture permits, with certain exceptions as therein provided, the Company and the Trustee with the consent of the Holders of more than 50% in aggregate principal amount of the Securities at the time Outstanding of each series issued under the Indenture to be affected thereby, to execute supplemental indentures for the purpose of adding any provisions to or changing in any manner or eliminating any of the provisions of the Indenture or of modifying in any manner the rights of the Holders of the Securities of such series&#59; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">provided, however,</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> that no such supplemental indenture shall, among other things, (i) change the Stated Maturity of the principal of, or any installment of principal of or interest on, any Security, or reduce the principal amount thereof or interest thereon, if any, or any premium payable upon redemption thereof&#59; (ii) change the Place of Payment on any Security or the currency or currency unit in which any Security or the principal or interest thereon is payable&#59; (iii) impair the right to institute suit for the enforcement of any such payment on or after the Stated Maturity thereof&#59; (iv) reduce or alter the method of computation of any amount payable upon redemption, repayment or purchase of any Securities by the Company (or the time when such redemption, repayment or purchase may be made)&#59; or (v) reduce the percentage in principal amount of the Securities, the Holders of which are required to consent to any supplemental indenture, without the consent of the Holder of each Security affected thereby.  The Indenture also contains provisions permitting the Holders of more than 50% in aggregate principal amount of the Securities of each series at the time outstanding, on behalf of the Holders of all the Securities of that series, to waive compliance by the Company with certain provisions of the Indenture and certain past defaults under the Indenture and their consequences with respect to such series, except a default in the payment of principal of or interest, if any, on any Security of that series or a default with respect to a covenant or provision of the Indenture which cannot be amended without the consent of such Holder.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Notes are issuable only in registered form without coupons in denominations of $2,000 and integral multiples of $1,000 in excess thereof.  The Notes shall be initially issued in the form of a Global Security.  All payments of principal of (and premium, if any) and interest on the Notes will be made to the Trustee so long as the Notes are in the form of a Global Security.  As provided in the Indenture and subject to certain limitations therein set forth, the Notes are exchangeable for a like aggregate principal amount of Notes as requested by the Holder surrendering the same.  If (x)&#160;the Depositary is at any time unwilling or unable to continue as depository and a successor depository is not appointed by the Company within 90 days after the Company receives such notice or becomes aware of such ineligibility, (y)&#160;the Company delivers to the Trustee a Company Order to the effect that this Note shall be exchangeable or (z)&#160;an Event of Default has occurred and is continuing with respect to the Notes, </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">this Note shall be exchangeable for Notes in definitive form and in an equal aggregate principal amount.  Such definitive Notes shall be registered in such name or names as the Depositary shall instruct the Trustee.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">As provided in the Indenture and subject to certain limitations set forth therein and above, the transfer of this Note may be registered on the Security Register of the Company, upon surrender of this Note for registration of transfer at the office or agency of the Company in the Borough of Manhattan, The City of New York, duly endorsed by, or accompanied by a written instrument of transfer in form satisfactory to the Company duly executed by, the Holder hereof or by his attorney duly authorized in writing, and thereupon one or more new Notes of authorized denominations and for the same aggregate principal amount will be issued to the designated transferee or transferees.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">No reference herein to the Indenture and no provisions of this Note or of the Indenture shall alter or impair the obligation of the Company, which is absolute and unconditional, to pay the principal of (and premium, if any) and interest on this Note at the time, place and rate, and in the coin or currency, herein and in the Indenture prescribed.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">No service charge shall be made for any such registration of transfer or exchange, but the Company may require payment of a sum sufficient to cover any tax or other governmental charge payable in connection therewith.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Prior to due presentment of this Note for registration of transfer, the Company, the Trustee and any agent of the Company or the Trustee may treat the Person in whose name this Note is registered as the owner hereof for all purposes, whether or not this Note be overdue, and neither the Company, the Trustee nor any such agent shall be affected by notice to the contrary.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Certain of the Company&#8217;s obligations under the Indenture with respect to Notes may be terminated if the Company irrevocably deposits with the Trustee money or Government Obligations sufficient to pay and discharge the entire indebtedness on all Notes, as provided in the Indenture.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">No recourse shall be had for the payment of the principal of (and premium, if any), or the interest, if any, on this Note, or for any claim based thereon, or upon any obligation, covenant or agreement of the Company in the Indenture, against any incorporator, stockholder, officer or director, as such, past, present or future, of the Company or of any successor corporation, whether by virtue of any constitution, statute or rule of law or by the enforcement of any assessment of penalty or otherwise&#59; and all such personal liability is expressly released and waived as a condition of, and as part of the consideration for, the issuance of this Note.</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Indenture and the Notes shall be governed by and construed in accordance with the laws of the State of New York.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><div id="i144ff43f75e74080a8c85a2966720612_10"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:30pt;margin-top:108pt;text-align:center"><font><br></font></div><div style="margin-bottom:24pt;margin-top:108pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">ASSIGNMENT&#47;TRANSFER FORM</font></div><div style="margin-bottom:9pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">FOR VALUE RECEIVED the undersigned registered Holder hereby sell(s), assign(s) and transfer(s) unto (insert Taxpayer Identification</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:13pt;font-weight:400;line-height:100%"> No.) _________________________</font></div><div style="margin-bottom:9pt;text-indent:0.72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:13pt;font-weight:400;line-height:100%">______________________________________________________________________</font></div><div style="margin-bottom:9pt;text-indent:0.72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:13pt;font-weight:400;line-height:100%">______________________________________________________________________</font></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-style:italic;font-weight:400;line-height:120%">(Please print or typewrite name and address including postal zip code of assignee)</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the within Note and all rights thereunder, hereby irrevocably constituting and appointing</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:13pt;font-weight:400;line-height:120%">__________________________________________________</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">attorney to transfer said </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Note on the books of the Company with full power of substitution in the premises.</font></div><div style="margin-bottom:9pt;padding-left:18pt;padding-right:18pt;text-align:center;text-indent:36pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:13pt;font-weight:400;line-height:120%">________________________________________________</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Date&#58; __________________</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">NOTICE&#58;  The signature of the registered Holder to this assignment must correspond with the name as written upon the face of the within instrument in every particular, without alteration or enlargement or any change whatsoever.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt;text-align:right"><font><br></font></div></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">OPTION OF HOLDER TO ELECT PURCHASE</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If you elect to have this Note purchased by the Company pursuant to Section&#160;1109 of the Indenture, check this box&#58;  &#9744;</font></div><div style="margin-bottom:12pt;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">If you want to elect to have only part of this Note purchased by the Company pursuant to Section&#160;1109 of the Indenture, state the amount in principal amount (must be integral multiple of $1,000)&#58;  $</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%;text-decoration:underline">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Date&#58; __________ Your Signature _________________________________________________</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:13pt;font-weight:400;line-height:92%"> &#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:92%">(Sign exactly as your name appears on the other&#160;side of the Security)</font></div><div style="margin-bottom:0.12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Signature Guarantee&#58; ____________________________________________________________</font></div><div style="margin-bottom:9pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;&#160;(Signature must be guaranteed)</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The signature(s) should be guaranteed by an eligible guarantor institution (banks, stockbrokers, savings and loan associations and credit unions with membership in an approved signature guarantee medallion program), pursuant to S.E.C. Rule 17Ad-15. </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div style="text-align:right"><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-5.1
<SEQUENCE>6
<FILENAME>exhibit51-closing8xk.htm
<DESCRIPTION>EX-5.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i60a21ab65bdf41feb26f126bc2a511da_1"></div><div style="min-height:115.92pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 5.1</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:85.598%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:12.202%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div><font style="color:#000000;font-family:'IBM Plex Sans',sans-serif;font-size:8pt;font-weight:400;line-height:100%">FRIED, FRANK, HARRIS, SHRIVER &#38; JACOBSON LLP</font></div></td><td colspan="3" style="padding:0 1pt"><div style="margin-bottom:0.08pt;text-align:right"><img alt="friedfranklogo.jpg" src="friedfranklogo.jpg" style="height:99px;margin-bottom:5pt;vertical-align:text-bottom;width:74px"></div></td></tr></table></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:right;text-indent:36pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:31.089%"><tr><td style="width:1.0%"></td><td style="width:64.363%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:33.437%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">November 9, 2023</font></td><td colspan="3" style="padding:0 1pt"></td></tr></table></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">Humana Inc.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:100%">500 West Main Street</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Louisville, Kentucky 40202</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Ladies and Gentlemen&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We are acting as counsel to Humana Inc., a Delaware corporation (the &#8220;Company&#8221;), in connection with the Registration Statement on Form S-3 (File No. 333-254041) (the &#8220;Registration Statement&#8221;), under the Securities Act of 1933, as amended (the &#8220;Securities Act&#8221;), with respect to the issuance of $500,000,000 in aggregate principal amount of 5.750% Senior Notes due 2028 (the &#8220;2028 Notes&#8221;) and $850,000,000 in aggregate principal amount of 5.950% Senior Notes due 2034 (the &#8220;2034 Notes&#8221; and together with the 2028 Notes, the &#8220;Debt Securities&#8221;) of the Company. The Debt Securities are being offered and sold by the Company in a public offering pursuant to an underwriting agreement dated November 2, 2023 by and between the Company and Barclays Capital Inc., BofA Securities, Inc., Goldman Sachs &#38; Co. LLC, J.P. Morgan Securities LLC and Truist Securities, Inc., as representatives of the underwriters named therein (the &#8220;Underwriting Agreement&#8221;). With your permission, all assumptions and statements of reliance herein have been made without any independent investigation or verification on our part, and we express no opinion with respect to the subject matter or accuracy of such assumptions or items relied upon.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The Debt Securities have been issued pursuant to a senior debt indenture, dated as of August 5, 2003, by and between the Company and The Bank of New York Trust Company, N.A. (formerly known as The Bank of New York Trust Company, N.A.) (as successor to The Bank of New York), as trustee (the &#8220;Trustee&#8221;) (as supplemented, in the case of the 2028 Notes by the Twenty-Sixth Supplemental Indenture dated as of November 9, 2023, the &#8220;2028 Indenture&#8221;, and as supplemented, in the case of the 2034 Notes, by the Twenty-Seventh Supplemental Indenture, dated as of November 9, 2023, the &#8220;2034 Indenture&#8221;&#59; the 2028 Indenture and the 2034 Indenture are collectively referred to herein as</font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%"> </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">the &#8220;Indentures&#8221;).</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In connection with this opinion, we have (i) investigated such questions of law, (ii)&#160;examined originals or certified, conformed, electronic or reproduction copies of such agreements, instruments, documents and records of the Company, such certificates of public officials and such other documents and (iii) received such information from officers and representatives of the Company and others, in each case as we have deemed necessary or appropriate for the purposes of this opinion. We have examined, among other documents, the following&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(a)&#160;&#160;&#160;&#160;the Underwriting Agreement&#59;</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font style="color:#000000;font-family:'IBM Plex Sans',sans-serif;font-size:7pt;font-weight:400;line-height:139%">One New York Plaza, New York, New York 10004&#8212;1089</font></div><div><font style="color:#000000;font-family:'IBM Plex Sans',sans-serif;font-size:7pt;font-weight:400;line-height:100%">T&#58;  +1.212.859.8000</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-weight:400;line-height:100%">  </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:7pt;font-style:italic;font-weight:400;line-height:100%">friedfrank.com</font></div></div></div><div id="i60a21ab65bdf41feb26f126bc2a511da_60"></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fried, Frank, Harris, Shriver &#38; Jacobson LLP</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Page 2</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">November 9, 2023</font></td></tr></table></div></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(b)&#160;&#160;&#160;&#160;the Indentures&#59; and</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(c)&#160;&#160;&#160;&#160;specimen forms of the Debt Securities.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The documents referred to in items (a) through (c) above, inclusive, are referred to herein collectively as the &#8220;Documents.&#8221;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">In all such examinations, we have assumed the legal capacity of all natural persons executing the Documents, the genuineness of all signatures, the authenticity of original and certified documents and the conformity to original or certified documents of all copies submitted to us as certified, conformed, electronic or reproduction copies. As to various questions of fact relevant to the opinion expressed herein, we have relied upon, and assume the accuracy of, the statements, representations and warranties contained in the Documents, certificates and oral or written statements and other information of or from officers or other appropriate representatives of the Company and others and assume compliance on the part of all parties to the Documents with their respective covenants and agreements contained therein.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We have assumed, for purposes of the opinion expressed herein, that&#58; (i) all of the parties to the Documents (other than the Company) are validly existing and in good standing under the laws of their respective jurisdictions of organization&#59; (ii) all of the parties to the Documents (other than the Company) have the power and authority to (a) execute and deliver the Documents, (b)&#160;perform their obligations thereunder and (c) consummate the transactions contemplated thereby&#59; (iii) each of the Documents has been duly authorized, executed and delivered by all of the parties thereto (other than the Company)&#59; (iv) each of the Documents constitutes a valid and binding obligation of all the parties thereto (other than as expressly addressed in the opinion below as to the Company), enforceable against such parties in accordance with its terms&#59; (v) the Debt Securities have been duly authenticated and delivered by the Trustee against payment therefor in accordance with the Documents&#59; (vi) all of the parties to the Documents will comply with all laws applicable thereto&#59; and (vii) the Debt Securities conform to the specimens thereof examined by us.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">Based upon the foregoing, and subject to the limitations, qualifications and assumptions set forth herein, we are of the opinion that the Debt Securities, when paid for by the Underwriters in accordance with the terms of the Underwriting Agreement, will constitute valid and binding obligations of the Company.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We express no opinion as to the validity, binding effect or enforceability of any provision of the Documents&#58;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(i)&#160;&#160;&#160;&#160;relating to indemnification, contribution or exculpation&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ii)&#160;&#160;&#160;&#160;containing any purported waiver, release, variation, disclaimer, consent or other agreement of similar effect (all of the foregoing, collectively, a &#8220;Waiver&#8221;) by any party under any of such agreements or instruments to the extent limited by provisions of applicable law (including judicial decisions), or to the extent that such a Waiver applies to a right, claim, duty, defense or ground for discharge otherwise existing or occurring as a matter of law (including </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fried, Frank, Harris, Shriver &#38; Jacobson LLP</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Page 3</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">November 9, 2023</font></td></tr></table></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">judicial decisions), except to the extent that such a Waiver is effective under, and is not prohibited by or void or invalid under, provisions of applicable law (including judicial decisions)&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iii)&#160;&#160;&#160;&#160;related to (I) forum selection or submission to jurisdiction (including, without limitation, any waiver of any objection to venue in any court or of any objection that a court is an inconvenient forum) to the extent the validity, binding effect or enforceability of any such provision is to be determined by any court other than a court of the State of New York, (II)&#160;choice of governing law to the extent that the validity, binding effect or enforceability of any such provision is to be considered by any court other than a court of the State of New York or a federal district court sitting in the State of New York and applying the law of the State of New York, in each case, applying the choice of law principles of the State of New York, (III) service of process or (IV) waiver of any rights to trial by jury&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(iv)&#160;&#160;&#160;&#160;specifying that provisions thereof may be waived only in writing&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(v)&#160;&#160;&#160;&#160;purporting to give any person or entity the power to accelerate obligations without any notice to the obligor&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(vi)&#160;&#160;&#160;&#160;which may be construed to be in the nature of a penalty&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(vii)&#160;&#160;&#160;&#160;specifying that any person may exercise set-off or similar rights other than in accordance with applicable law&#59;</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(viii)&#160;&#160;&#160;&#160;relating to payment of late charges, interest (or discount or equivalent amounts), premium, &#8220;make-whole&#8221; payments, collection costs or fees at a rate or in an amount, after or upon the maturity or acceleration of the liabilities evidenced or secured thereby or after or during the continuance of any default or other circumstance, or upon prepayment, that a court would determine in the circumstances to be unreasonable, a penalty or a forfeiture&#59; or</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">(ix)&#160;&#160;&#160;&#160;requiring that any unearned portion of the Debt Securities issued at a discount be paid upon acceleration or otherwise earlier than the stated final maturity.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We express no opinion as to the effect of any law of any jurisdiction other than the State of New York wherein any party to the Documents may be located or wherein enforcement of any Documents may be sought that limits the rates or interest legally chargeable or collectible.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We express no opinion as to any agreement, instrument or other document (including any agreement, instrument or other document referred to, or incorporated by reference in, the Documents) other than the Documents.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The opinion set forth above is subject to the following qualifications&#58; (i) applicable bankruptcy, insolvency, reorganization, moratorium, fraudulent conveyance and other similar laws affecting creditors&#8217; rights and remedies generally, and (ii) general principles of equity including, without limitation, standards of materiality, good faith, fair dealing and </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Fried, Frank, Harris, Shriver &#38; Jacobson LLP</font></div><div><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:48.900%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><div style="margin-bottom:0.08pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">Page 4</font></div></td><td colspan="3" style="padding:2px 1pt;text-align:right;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:11pt;font-weight:400;line-height:125%">November 9, 2023</font></td></tr></table></div></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">reasonableness, equitable defenses and limits as to the availability of equitable remedies, whether such principles are considered in a proceeding at law or in equity.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">The opinion expressed herein is limited to the laws of the State of New York and, to the extent relevant to the opinions expressed herein, the applicable provisions of the General Corporation Law of the State of Delaware, in each case, as currently in effect, and no opinion is expressed with respect to any other laws or any effect that such other laws may have on the opinion expressed herein. The opinion expressed herein is limited to the matters stated herein, and no opinion is implied or may be inferred beyond the matters expressly stated herein. This letter is given only as of the time of its delivery, and we undertake no responsibility to update or supplement this letter after its delivery.</font></div><div style="margin-bottom:12pt;text-align:justify;text-indent:72pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:120%">We hereby consent to the filing of this opinion as an exhibit to the report on Form 8-K filed by the Company on the date hereof and its incorporation by reference into the Registration Statement and to references to this firm under the caption &#8220;Legal Matters&#8221; in the Registration Statement and prospectus supplements related to the Debt Securities. In giving this consent, we do not hereby admit that we are in the category of persons whose consent is required under Section 7 of the Securities Act.</font></div><div style="margin-bottom:12pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:30.470%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:67.330%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">Very truly yours,</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:bottom"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">&#47;s&#47; FRIED, FRANK, HARRIS, SHRIVER &#38; JACOBSON LLP</font></td></tr><tr style="height:15pt"><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:0 1pt"></td></tr><tr><td colspan="3" style="padding:0 1pt"></td><td colspan="3" style="padding:2px 1pt 2px 1.37pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:400;line-height:125%">FRIED, FRANK, HARRIS, SHRIVER &#38; JACOBSON LLP</font></td></tr></table></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-99.1
<SEQUENCE>7
<FILENAME>exhibit991-closing8xk.htm
<DESCRIPTION>EX-99.1
<TEXT>
<html><head>
<!-- Document created using Wdesk -->
<!-- Copyright 2023 Workiva -->
<title>Document</title></head><body><div id="i1a091de5e27f49d59436a50ddd084240_39"></div><div style="min-height:72pt;width:100%"><div style="text-align:right"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:12pt;font-weight:700;line-height:100%">Exhibit 99.1</font></div></div><div style="margin-bottom:10pt"><table style="border-collapse:collapse;display:inline-table;margin-bottom:5pt;vertical-align:text-bottom;width:100.000%"><tr><td style="width:1.0%"></td><td style="width:72.137%"></td><td style="width:0.1%"></td><td style="width:1.0%"></td><td style="width:25.663%"></td><td style="width:0.1%"></td></tr><tr><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:100%">news release</font></td><td colspan="3" style="padding:2px 1pt;text-align:left;vertical-align:top"><div style="text-indent:-0.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Humana Inc.</font></div><div style="text-indent:-0.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">500 West Main Street</font></div><div style="text-indent:-0.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">P.O. Box 1438</font></div><div style="text-indent:-0.01pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Louisville, KY 40202</font></div></td></tr></table></div><div style="margin-bottom:12pt;text-align:center"><img alt="humanalogo.jpg" src="humanalogo.jpg" style="height:44px;margin-bottom:5pt;vertical-align:text-bottom;width:210px"></div><div style="margin-bottom:12pt;text-align:center"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Humana Completes Aggregate $1.35 Billion Debt Offering</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%">Louisville, KY &#8211; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">November 9, 2023 - Humana Inc. (the &#8220;company&#8221;) (NYSE&#58; HUM) announced today the completion of its public offering of $1.35 billion in aggregate principal amount of senior notes. These senior notes are comprised of $500 million </font><font style="background-color:#ffffff;color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">the company&#8217;s 5.750 percent senior notes, due 2028, at 99.830 percent of the principal amount, and $850 million of the company&#8217;s 5.950 percent senior notes, due 2034, at 98.525 percent of the principal amount (collectively, the &#8220;Senior Notes Offerings&#8221;). </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The company expects net proceeds from the Senior Notes Offerings will be approximately $1.324 billion after deducting underwriters&#8217; discounts and estimated offering expenses. The company intends to use the net proceeds from the Senior Notes Offerings for general corporate purposes, which may include the repayment of existing indebtedness, including borrowings under its commercial paper program. </font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Barclays Capital Inc., BofA Securities, Inc., Goldman Sachs &#38; Co. LLC, J.P. Morgan Securities LLC and Truist Securities, Inc. acted as active joint book-running managers for the Senior Notes Offerings.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">The Senior Notes Offerings were made pursuant to an effective shelf registration statement (including a base prospectus) filed with the Securities and Exchange Commission (the &#8220;SEC&#8221;). The Senior Notes Offerings were made by means of a prospectus and related prospectus supplement, copies of which may be obtained by calling Barclays Capital Inc. toll-free at (888) 603-5847, BofA Securities, Inc. toll-free at (800) 294-1322, Goldman Sachs&#8239;&#38; Co. LLC toll-free at (866) 471-2526, J.P. Morgan Securities LLC collect at (212) 834-4533 or Truist Securities, Inc. toll-free at (800) 685-4786. An electronic copy of the registration statement and prospectus supplement, together with the base prospectus, is available on the SEC&#8217;s website at www.sec.gov.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This news release does not constitute an offer to sell or a solicitation of an offer to buy the securities described herein, nor shall there be any sale of these securities in any state or jurisdiction in which such an offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of any such jurisdiction.</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">Cautionary Statement</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">This news release includes forward-looking statements regarding Humana within the meaning of the Private Securities Litigation Reform Act of 1995. When used in investor presentations, press releases, SEC filings, and in oral statements made by or with the approval of one of Humana&#8217;s executive officers, the words or phrases like &#8220;expects,&#8221; &#8220;believes,&#8221; &#8220;anticipates,&#8221; &#8220;intends,&#8221; &#8220;likely will result,&#8221; &#8220;estimates,&#8221; &#8220;projects&#8221; or variations of such words and similar expressions are intended to identify such forward-looking statements.</font></div><div style="margin-bottom:12pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">These forward-looking statements are not guarantees of future performance and are subject to risks, uncertainties, and assumptions, including, among other things, information set forth in the &#8220;Risk Factors&#8221; section of the company&#8217;s SEC filings, a summary of which includes but is not limited to the following&#58;</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">If Humana does not design and price its products properly and competitively, if the premiums Humana receives are insufficient to cover the cost of healthcare services delivered to its members, if the company is unable to implement clinical initiatives to provide a better healthcare experience for its members, lower </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">costs and appropriately document the risk profile of its members, or if its estimates of benefits expense are inadequate, Humana&#8217;s profitability could be materially adversely affected. Humana estimates the costs of its benefit expense payments, and designs and prices its products accordingly, using actuarial methods and assumptions based upon, among other relevant factors, claim payment patterns, medical cost inflation, and historical developments such as claim inventory levels and claim receipt patterns. The company continually reviews estimates of future payments relating to benefit expenses for services incurred in the current and prior periods and makes necessary adjustments to its reserves, including premium deficiency reserves, where appropriate. These estimates involve extensive judgment, and have considerable inherent variability because they are extremely sensitive to changes in claim payment patterns and medical cost trends. Accordingly, Humana&#8217;s reserves may be insufficient. </font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">If Humana fails to effectively implement its operational and strategic initiatives, including its Medicare initiatives, which are of particular importance given the concentration of the company's revenues in these products, state-based contract strategy, the growth of its CenterWell business, and its integrated care delivery model, the company&#8217;s business may be materially adversely affected. In addition, there can be no assurances that the company will be successful in maintaining or improving its Star ratings in future years.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">If Humana fails to properly maintain the integrity of its data, to strategically maintain existing or implement new information systems, to protect Humana&#8217;s proprietary rights to its systems, or to defend against cyber-security attacks or prevent other privacy or data security incidents that result in security breaches that disrupt the company&#8217;s operations or in the unintentional dissemination of sensitive personal information or proprietary or confidential information, the company&#8217;s business may be materially adversely affected.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Humana is involved in various legal actions, or disputes that could lead to legal actions (such as, among other things, provider contract disputes and qui tam litigation brought by individuals on behalf of the government), governmental and internal investigations, and routine internal review of business processes any of which, if resolved unfavorably to the company, could result in substantial monetary damages or changes in its business practices. Increased litigation and negative publicity could also increase the company&#8217;s cost of doing business.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">As a government contractor, Humana is exposed to risks that may materially adversely affect its business or its willingness or ability to participate in government healthcare programs including, among other things, loss of material government contracts&#59; governmental audits and investigations&#59; potential inadequacy of government determined payment rates&#59; potential restrictions on profitability, including by comparison of profitability of the company&#8217;s Medicare Advantage business to non-Medicare Advantage business&#59; or other changes in the governmental programs in which Humana participates. Changes to the risk-adjustment model utilized by CMS to adjust premiums paid to Medicare Advantage plans or retrospective recovery by CMS of previously paid premiums as a result of the final rule related to the risk adjustment data validation audit methodology published by CMS on January 30, 2023 (Final RADV Rule), which Humana believes fails to address adequately the statutory requirement of actuarial equivalence and violates the Administrative Procedure Act due to its failure to include a &#8220;Fee For Service Adjuster (FFS Adjuster)&#8221;, could have a material adverse effect on the company&#8217;s operating results, financial position and cash flows.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Humana&#8217;s business activities are subject to substantial government regulation. New laws or regulations, or legislative, judicial, or regulatory changes in existing laws or regulations or their manner of application could increase the company's cost of doing business and have a material adverse effect on Humana&#8217;s results </font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">of operations (including restricting revenue, enrollment and premium growth in certain products and market segments, restricting the company&#8217;s ability to expand into new markets, increasing the company&#8217;s medical and operating costs by, among other things, requiring a minimum benefit ratio on insured products, lowering the company&#8217;s Medicare payment rates and increasing the company&#8217;s expenses associated with a non-deductible health insurance industry fee and other assessments)&#59; the company&#8217;s financial position (including the company&#8217;s ability to maintain the value of its goodwill)&#59; and the company&#8217;s cash flows.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Humana&#8217;s failure to manage acquisitions, divestitures and other significant transactions successfully may have a material adverse effect on the company&#8217;s results of operations, financial position, and cash flows.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">If Humana fails to develop and maintain satisfactory relationships with the providers of care to its members, the company&#8217;s business may be adversely affected.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Humana faces significant competition in attracting and retaining talented employees. Further, managing succession for, and retention of, key executives is critical to the company&#8217;s success, and its failure to do so could adversely affect the company&#8217;s businesses, operating results and&#47;or future performance.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Humana&#8217;s pharmacy business is highly competitive and subjects it to regulations and supply chain risks in addition to those the company faces with its core health benefits businesses.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Changes in the prescription drug industry pricing benchmarks may adversely affect Humana&#8217;s financial performance.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Humana&#8217;s ability to obtain funds from certain of its licensed subsidiaries is restricted by state insurance regulations.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Downgrades in Humana&#8217;s debt ratings, should they occur, may adversely affect its business, results of operations, and financial condition.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">The securities and credit markets may experience volatility and disruption, which may adversely affect Humana&#8217;s business.</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-align:justify;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">The spread of, and response to, the novel coronavirus, or COVID-19, underscores certain risks Humana faces, including those discussed above, and the ongoing, heightened uncertainty created by the pandemic precludes any prediction as to the ultimate adverse impact to Humana of COVID-19.</font></div><div style="margin-bottom:12pt;padding-right:10.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">In making forward-looking statements, Humana is not undertaking to address or update them in future filings or communications regarding its business or results. In light of these risks, uncertainties, and assumptions, the forward-looking events discussed herein may or may not occur. There also may be other risks that the company is unable to predict at this time. Any of these risks and uncertainties may cause actual results to differ materially from the results discussed in the forward-looking statements.</font></div><div style="margin-bottom:12pt;padding-right:10.8pt;text-align:justify"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Humana advises investors to read the following documents as filed by the company with the SEC for further discussion both of the risks it faces and its historical performance&#58;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Form 10-K for the year ended December 31, 2022&#59;</font></div><div style="padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Form 10-Qs for the quarters ended March 31, 2023, June 30, 2023 and September 30, 2023&#59; and</font></div><div style="margin-bottom:12pt;padding-left:36pt;text-indent:-18pt"><font style="color:#000000;font-family:'Arial',sans-serif;font-size:12pt;font-weight:400;line-height:120%">&#8226;</font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;padding-left:13.8pt">Form 8-Ks filed during 2023.</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div><hr style="page-break-after:always"><div style="min-height:72pt;width:100%"><div><font><br></font></div></div><div style="margin-bottom:6pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:700;line-height:120%;text-decoration:underline">About Humana</font></div><div style="margin-bottom:24pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Humana Inc. (NYSE&#58; HUM) is committed to putting health first &#8211; for our teammates, our customers, and our company. Through our Humana insurance services, and our CenterWell health care services, we make it easier for the millions of people we serve to achieve their best health &#8211; delivering the care and service they need, when they need it. These efforts are leading to a better quality of life for people with Medicare, Medicaid, families, individuals, military service personnel, and communities at large.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Lisa Stoner</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Investor Relations</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Humana Inc.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">502-580-2652</font></div><div style="margin-bottom:12pt"><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e-mail&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">lstamper&#64;humana.com</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Mark Taylor</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Corporate Communications</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">Humana Inc.</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">317-753-0345</font></div><div><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%">e-mail&#58; </font><font style="color:#000000;font-family:'Times New Roman',sans-serif;font-size:10pt;font-weight:400;line-height:120%;text-decoration:underline">mtaylor108&#64;humana.com</font></div><div style="height:72pt;position:relative;width:100%"><div style="bottom:0;position:absolute;width:100%"><div><font><br></font></div></div></div></body></html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.SCH
<SEQUENCE>8
<FILENAME>hum-20231109.xsd
<DESCRIPTION>XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:5e4f0834-9750-4616-a45d-5233f2e47910,g:0ce8afb9-70ce-4fd1-b2fd-315c99189c78-->
<xs:schema xmlns:xs="http://www.w3.org/2001/XMLSchema" xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:hum="http://www.humana.com/20231109" attributeFormDefault="unqualified" elementFormDefault="qualified" targetNamespace="http://www.humana.com/20231109">
  <xs:import namespace="http://www.w3.org/1999/xlink" schemaLocation="http://www.xbrl.org/2003/xlink-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/instance" schemaLocation="http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd"/>
  <xs:import namespace="http://www.xbrl.org/2003/linkbase" schemaLocation="http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd"/>
  <xs:import namespace="http://xbrl.sec.gov/dei/2023" schemaLocation="https://xbrl.sec.gov/dei/2023/dei-2023.xsd"/>
  <xs:annotation>
    <xs:appinfo>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hum-20231109_lab.xml" xlink:role="http://www.xbrl.org/2003/role/labelLinkbaseRef" xlink:type="simple"/>
      <link:linkbaseRef xmlns:xlink="http://www.w3.org/1999/xlink" xlink:arcrole="http://www.w3.org/1999/xlink/properties/linkbase" xlink:href="hum-20231109_pre.xml" xlink:role="http://www.xbrl.org/2003/role/presentationLinkbaseRef" xlink:type="simple"/>
      <link:roleType id="CoverPage" roleURI="http://www.humana.com/role/CoverPage">
        <link:definition>0000001 - Document - Cover Page</link:definition>
        <link:usedOn>link:presentationLink</link:usedOn>
        <link:usedOn>link:calculationLink</link:usedOn>
        <link:usedOn>link:definitionLink</link:usedOn>
      </link:roleType>
    </xs:appinfo>
  </xs:annotation>
</xs:schema>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.LAB
<SEQUENCE>9
<FILENAME>hum-20231109_lab.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:5e4f0834-9750-4616-a45d-5233f2e47910,g:0ce8afb9-70ce-4fd1-b2fd-315c99189c78-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodStartLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodStartLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/netLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/net-2009-12-16.xsd#netLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedNetLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedNetLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTerseLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTerseLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedPeriodEndLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedPeriodEndLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedLabel"/>
  <link:roleRef roleURI="http://www.xbrl.org/2009/role/negatedTotalLabel" xlink:type="simple" xlink:href="http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd#negatedTotalLabel"/>
  <link:labelLink xlink:role="http://www.xbrl.org/2003/role/link" xlink:type="extended">
    <link:label id="lab_dei_SecurityExchangeName_b6f885c1-4e6c-4a7c-8678-4323030d7b44_terseLabel_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:label id="lab_dei_SecurityExchangeName_label_en-US" xlink:label="lab_dei_SecurityExchangeName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Security Exchange Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SecurityExchangeName" xlink:to="lab_dei_SecurityExchangeName" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_Security12bTitle_8c3ecbb2-ddc0-4f8c-942a-7c3837ee9804_terseLabel_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:label id="lab_dei_Security12bTitle_label_en-US" xlink:label="lab_dei_Security12bTitle" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Title of 12(b) Security</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_Security12bTitle" xlink:to="lab_dei_Security12bTitle" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_WrittenCommunications_2f79d8d7-9ebc-4449-b345-693a489dd8f9_terseLabel_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:label id="lab_dei_WrittenCommunications_label_en-US" xlink:label="lab_dei_WrittenCommunications" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Written Communications</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_WrittenCommunications" xlink:to="lab_dei_WrittenCommunications" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_LocalPhoneNumber_6da92a39-0ffa-4d8a-a57c-0bc93fa9b992_terseLabel_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:label id="lab_dei_LocalPhoneNumber_label_en-US" xlink:label="lab_dei_LocalPhoneNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Local Phone Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_LocalPhoneNumber" xlink:to="lab_dei_LocalPhoneNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_TradingSymbol_2b2ca88e-314a-4022-8c1d-bb564098d188_terseLabel_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:label id="lab_dei_TradingSymbol_label_en-US" xlink:label="lab_dei_TradingSymbol" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Trading Symbol</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_TradingSymbol" xlink:to="lab_dei_TradingSymbol" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_bdbe15ec-6d45-4d04-95c8-9193bec3eb5d_terseLabel_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:label id="lab_dei_EntityIncorporationStateCountryCode_label_en-US" xlink:label="lab_dei_EntityIncorporationStateCountryCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Incorporation, State or Country Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityIncorporationStateCountryCode" xlink:to="lab_dei_EntityIncorporationStateCountryCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressStateOrProvince_b2288d3e-eebb-4ed8-b659-1cda34672d88_terseLabel_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:label id="lab_dei_EntityAddressStateOrProvince_label_en-US" xlink:label="lab_dei_EntityAddressStateOrProvince" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, State or Province</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressStateOrProvince" xlink:to="lab_dei_EntityAddressStateOrProvince" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_9257c1ad-a8a6-40bf-af06-0df3792b6123_terseLabel_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementIssuerTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementIssuerTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Issuer Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementIssuerTenderOffer" xlink:to="lab_dei_PreCommencementIssuerTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentPeriodEndDate_9c57acbc-544e-4657-99cb-e387eda32df4_terseLabel_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:label id="lab_dei_DocumentPeriodEndDate_label_en-US" xlink:label="lab_dei_DocumentPeriodEndDate" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Period End Date</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentPeriodEndDate" xlink:to="lab_dei_DocumentPeriodEndDate" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CoverAbstract_0b94762a-8f37-440f-99f1-95b99c210fe4_terseLabel_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:label id="lab_dei_CoverAbstract_label_en-US" xlink:label="lab_dei_CoverAbstract" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Cover [Abstract]</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CoverAbstract" xlink:to="lab_dei_CoverAbstract" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_195a865e-3a56-4f20-b9d3-aabf8cbbb959_terseLabel_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:label id="lab_dei_EntityEmergingGrowthCompany_label_en-US" xlink:label="lab_dei_EntityEmergingGrowthCompany" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Emerging Growth Company</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityEmergingGrowthCompany" xlink:to="lab_dei_EntityEmergingGrowthCompany" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_PreCommencementTenderOffer_e9ab9c84-2196-42be-9754-661010ea7b0a_terseLabel_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:label id="lab_dei_PreCommencementTenderOffer_label_en-US" xlink:label="lab_dei_PreCommencementTenderOffer" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Pre-commencement Tender Offer</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_PreCommencementTenderOffer" xlink:to="lab_dei_PreCommencementTenderOffer" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_SolicitingMaterial_33bbc483-922c-4bd7-a076-b11b393ee69e_terseLabel_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:label id="lab_dei_SolicitingMaterial_label_en-US" xlink:label="lab_dei_SolicitingMaterial" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Soliciting Material</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_SolicitingMaterial" xlink:to="lab_dei_SolicitingMaterial" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_CityAreaCode_6f68741b-950c-4b45-8227-671a00dfd2ed_terseLabel_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:label id="lab_dei_CityAreaCode_label_en-US" xlink:label="lab_dei_CityAreaCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">City Area Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_CityAreaCode" xlink:to="lab_dei_CityAreaCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressPostalZipCode_29026889-5769-472b-97d6-b33238f076d6_terseLabel_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:label id="lab_dei_EntityAddressPostalZipCode_label_en-US" xlink:label="lab_dei_EntityAddressPostalZipCode" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Postal Zip Code</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressPostalZipCode" xlink:to="lab_dei_EntityAddressPostalZipCode" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_DocumentType_9d6dd362-b0c0-4209-b2af-3ebefb5dcd6a_terseLabel_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:label id="lab_dei_DocumentType_label_en-US" xlink:label="lab_dei_DocumentType" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Document Type</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_DocumentType" xlink:to="lab_dei_DocumentType" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_AmendmentFlag_c6e3a46d-8175-413e-aac0-f67aecbd6f6e_terseLabel_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:label id="lab_dei_AmendmentFlag_label_en-US" xlink:label="lab_dei_AmendmentFlag" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Amendment Flag</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_AmendmentFlag" xlink:to="lab_dei_AmendmentFlag" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityCentralIndexKey_a1d96964-eb8f-4c73-96bf-54e89f27a9b9_terseLabel_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:label id="lab_dei_EntityCentralIndexKey_label_en-US" xlink:label="lab_dei_EntityCentralIndexKey" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Central Index Key</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityCentralIndexKey" xlink:to="lab_dei_EntityCentralIndexKey" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityFileNumber_a80408d8-ebcc-4080-82ab-5b85a4b7a684_terseLabel_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:label id="lab_dei_EntityFileNumber_label_en-US" xlink:label="lab_dei_EntityFileNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity File Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityFileNumber" xlink:to="lab_dei_EntityFileNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressCityOrTown_89954268-5a98-4e4c-94e5-0c7b99e3116d_terseLabel_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:label id="lab_dei_EntityAddressCityOrTown_label_en-US" xlink:label="lab_dei_EntityAddressCityOrTown" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, City or Town</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressCityOrTown" xlink:to="lab_dei_EntityAddressCityOrTown" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_584991e0-70b9-46a4-a3cb-695435bcb648_terseLabel_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:label id="lab_dei_EntityTaxIdentificationNumber_label_en-US" xlink:label="lab_dei_EntityTaxIdentificationNumber" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Tax Identification Number</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityTaxIdentificationNumber" xlink:to="lab_dei_EntityTaxIdentificationNumber" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityAddressAddressLine1_fd75a9d6-0be1-4709-b19f-01c72dc4bb86_terseLabel_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:label id="lab_dei_EntityAddressAddressLine1_label_en-US" xlink:label="lab_dei_EntityAddressAddressLine1" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Address, Address Line One</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityAddressAddressLine1" xlink:to="lab_dei_EntityAddressAddressLine1" xlink:type="arc" order="1"/>
    <link:label id="lab_dei_EntityRegistrantName_bbb99391-079d-4c73-82b3-3a0fb52d0728_terseLabel_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/terseLabel" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:label id="lab_dei_EntityRegistrantName_label_en-US" xlink:label="lab_dei_EntityRegistrantName" xlink:role="http://www.xbrl.org/2003/role/label" xlink:type="resource" xmlns:xml="http://www.w3.org/XML/1998/namespace" xml:lang="en-US">Entity Registrant Name</link:label>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:labelArc xlink:arcrole="http://www.xbrl.org/2003/arcrole/concept-label" xlink:from="loc_dei_EntityRegistrantName" xlink:to="lab_dei_EntityRegistrantName" xlink:type="arc" order="1"/>
  </link:labelLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-101.PRE
<SEQUENCE>10
<FILENAME>hum-20231109_pre.xml
<DESCRIPTION>XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT
<TEXT>
<XBRL>
<?xml version="1.0" encoding="UTF-8"?>

<!--XBRL Document Created with the Workiva Platform-->
<!--Copyright 2023 Workiva-->
<!--r:5e4f0834-9750-4616-a45d-5233f2e47910,g:0ce8afb9-70ce-4fd1-b2fd-315c99189c78-->
<link:linkbase xmlns:link="http://www.xbrl.org/2003/linkbase" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://www.xbrl.org/2003/linkbase http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd">
  <link:roleRef roleURI="http://www.humana.com/role/CoverPage" xlink:type="simple" xlink:href="hum-20231109.xsd#CoverPage"/>
  <link:presentationLink xlink:role="http://www.humana.com/role/CoverPage" xlink:type="extended">
    <link:loc xlink:type="locator" xlink:label="loc_dei_CoverAbstract_9f2a9b64-3a57-42f1-9fc1-12f16d08e338" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CoverAbstract"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentType_301433a8-012a-4218-b44d-aa7e70816a18" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentType"/>
    <link:presentationArc order="1" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9f2a9b64-3a57-42f1-9fc1-12f16d08e338" xlink:to="loc_dei_DocumentType_301433a8-012a-4218-b44d-aa7e70816a18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_DocumentPeriodEndDate_d6d32064-c0ec-4c4f-9f11-06c7f25ce90e" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_DocumentPeriodEndDate"/>
    <link:presentationArc order="2" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9f2a9b64-3a57-42f1-9fc1-12f16d08e338" xlink:to="loc_dei_DocumentPeriodEndDate_d6d32064-c0ec-4c4f-9f11-06c7f25ce90e" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityRegistrantName_8bb30e49-5f7a-47db-a5c2-188a9419d6db" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityRegistrantName"/>
    <link:presentationArc order="3" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9f2a9b64-3a57-42f1-9fc1-12f16d08e338" xlink:to="loc_dei_EntityRegistrantName_8bb30e49-5f7a-47db-a5c2-188a9419d6db" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityCentralIndexKey_0b69600b-983f-4ab9-87f6-f9e177569cff" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityCentralIndexKey"/>
    <link:presentationArc order="4" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9f2a9b64-3a57-42f1-9fc1-12f16d08e338" xlink:to="loc_dei_EntityCentralIndexKey_0b69600b-983f-4ab9-87f6-f9e177569cff" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_AmendmentFlag_8c275329-7b13-4009-95ff-ef5510df17aa" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_AmendmentFlag"/>
    <link:presentationArc order="5" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9f2a9b64-3a57-42f1-9fc1-12f16d08e338" xlink:to="loc_dei_AmendmentFlag_8c275329-7b13-4009-95ff-ef5510df17aa" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityIncorporationStateCountryCode_cf1d33d2-cfa3-49b3-97ad-d498c888da7d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityIncorporationStateCountryCode"/>
    <link:presentationArc order="6" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9f2a9b64-3a57-42f1-9fc1-12f16d08e338" xlink:to="loc_dei_EntityIncorporationStateCountryCode_cf1d33d2-cfa3-49b3-97ad-d498c888da7d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityFileNumber_a659df2f-8e0a-4ae0-adeb-d9b9ce26da0d" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityFileNumber"/>
    <link:presentationArc order="7" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9f2a9b64-3a57-42f1-9fc1-12f16d08e338" xlink:to="loc_dei_EntityFileNumber_a659df2f-8e0a-4ae0-adeb-d9b9ce26da0d" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityTaxIdentificationNumber_b6fc2243-6532-4fa8-98be-5cee204ce207" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityTaxIdentificationNumber"/>
    <link:presentationArc order="8" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9f2a9b64-3a57-42f1-9fc1-12f16d08e338" xlink:to="loc_dei_EntityTaxIdentificationNumber_b6fc2243-6532-4fa8-98be-5cee204ce207" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressAddressLine1_dcc8d689-48f1-40ff-b228-d2fc458e5803" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressAddressLine1"/>
    <link:presentationArc order="9" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9f2a9b64-3a57-42f1-9fc1-12f16d08e338" xlink:to="loc_dei_EntityAddressAddressLine1_dcc8d689-48f1-40ff-b228-d2fc458e5803" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressCityOrTown_ee9728ea-84e6-4299-9971-dbc173454825" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressCityOrTown"/>
    <link:presentationArc order="10" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9f2a9b64-3a57-42f1-9fc1-12f16d08e338" xlink:to="loc_dei_EntityAddressCityOrTown_ee9728ea-84e6-4299-9971-dbc173454825" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressStateOrProvince_33e610bc-9eaf-47fb-889e-d788a098d16c" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressStateOrProvince"/>
    <link:presentationArc order="11" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9f2a9b64-3a57-42f1-9fc1-12f16d08e338" xlink:to="loc_dei_EntityAddressStateOrProvince_33e610bc-9eaf-47fb-889e-d788a098d16c" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityAddressPostalZipCode_5680117c-eb31-4e59-abd3-11955c8d7e18" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityAddressPostalZipCode"/>
    <link:presentationArc order="12" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9f2a9b64-3a57-42f1-9fc1-12f16d08e338" xlink:to="loc_dei_EntityAddressPostalZipCode_5680117c-eb31-4e59-abd3-11955c8d7e18" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_CityAreaCode_92c93155-8289-45d7-a93a-4b916ff9b715" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_CityAreaCode"/>
    <link:presentationArc order="13" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9f2a9b64-3a57-42f1-9fc1-12f16d08e338" xlink:to="loc_dei_CityAreaCode_92c93155-8289-45d7-a93a-4b916ff9b715" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_LocalPhoneNumber_a38b4e1f-db92-453d-b0db-68fe0e3fede8" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_LocalPhoneNumber"/>
    <link:presentationArc order="14" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9f2a9b64-3a57-42f1-9fc1-12f16d08e338" xlink:to="loc_dei_LocalPhoneNumber_a38b4e1f-db92-453d-b0db-68fe0e3fede8" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_WrittenCommunications_b429a93c-59ea-4a49-9e4c-da3bf3a10040" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_WrittenCommunications"/>
    <link:presentationArc order="15" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9f2a9b64-3a57-42f1-9fc1-12f16d08e338" xlink:to="loc_dei_WrittenCommunications_b429a93c-59ea-4a49-9e4c-da3bf3a10040" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SolicitingMaterial_1e438505-6d4c-4bdd-85a3-6f11d3b97f47" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SolicitingMaterial"/>
    <link:presentationArc order="16" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9f2a9b64-3a57-42f1-9fc1-12f16d08e338" xlink:to="loc_dei_SolicitingMaterial_1e438505-6d4c-4bdd-85a3-6f11d3b97f47" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementTenderOffer_30a2192e-e31b-4f37-ac8c-8e5cce262cb6" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementTenderOffer"/>
    <link:presentationArc order="17" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9f2a9b64-3a57-42f1-9fc1-12f16d08e338" xlink:to="loc_dei_PreCommencementTenderOffer_30a2192e-e31b-4f37-ac8c-8e5cce262cb6" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_PreCommencementIssuerTenderOffer_f3e78bff-71b4-4d6b-83d1-1d98a5673015" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_PreCommencementIssuerTenderOffer"/>
    <link:presentationArc order="18" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9f2a9b64-3a57-42f1-9fc1-12f16d08e338" xlink:to="loc_dei_PreCommencementIssuerTenderOffer_f3e78bff-71b4-4d6b-83d1-1d98a5673015" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_Security12bTitle_caaaa003-59e4-4c25-bd36-3ffda8ddd00b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_Security12bTitle"/>
    <link:presentationArc order="19" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9f2a9b64-3a57-42f1-9fc1-12f16d08e338" xlink:to="loc_dei_Security12bTitle_caaaa003-59e4-4c25-bd36-3ffda8ddd00b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_TradingSymbol_cf140d6b-4fd8-4bc1-aecc-98dcace151ec" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_TradingSymbol"/>
    <link:presentationArc order="20" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9f2a9b64-3a57-42f1-9fc1-12f16d08e338" xlink:to="loc_dei_TradingSymbol_cf140d6b-4fd8-4bc1-aecc-98dcace151ec" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_SecurityExchangeName_0e9e719c-3ccb-41d5-ad69-afc970c4ab2b" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_SecurityExchangeName"/>
    <link:presentationArc order="21" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9f2a9b64-3a57-42f1-9fc1-12f16d08e338" xlink:to="loc_dei_SecurityExchangeName_0e9e719c-3ccb-41d5-ad69-afc970c4ab2b" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
    <link:loc xlink:type="locator" xlink:label="loc_dei_EntityEmergingGrowthCompany_b3a2733e-03d3-494f-936a-01736b8e5bdf" xlink:href="https://xbrl.sec.gov/dei/2023/dei-2023.xsd#dei_EntityEmergingGrowthCompany"/>
    <link:presentationArc order="22" xlink:arcrole="http://www.xbrl.org/2003/arcrole/parent-child" xlink:from="loc_dei_CoverAbstract_9f2a9b64-3a57-42f1-9fc1-12f16d08e338" xlink:to="loc_dei_EntityEmergingGrowthCompany_b3a2733e-03d3-494f-936a-01736b8e5bdf" xlink:type="arc" preferredLabel="http://www.xbrl.org/2003/role/terseLabel"/>
  </link:presentationLink>
</link:linkbase>
</XBRL>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>11
<FILENAME>friedfranklogo.jpg
<TEXT>
begin 644 friedfranklogo.jpg
M_]C_X  02D9)1@ ! 0( Q #$  #_X1L^17AI9@  24DJ  @    ' !(! P !
M     0   !H!!0 !    8@   !L!!0 !    :@   "@! P !     P   #$!
M @ -    <@   #(! @ 4    @    &F'!  !    E    *8   !A#P  %
M &$/   4    1TE-4" R+C$P+C(X   R,#(S.C$Q.C W(#(S.C4V.C$X  $
M : #  $    !          D _@ $  $    !      $$  $   #      0$$
M  $      0   @$#  ,    8 0   P$#  $    &    !@$#  $    &
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MG' )(7'/!QG'OTI+?X'^)_"_BG0=2B>WU*TAU"W><VQ(>)1*N6*MU&.XSWR
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MD@U*!\(I) 60,QX[  DGL 30!]NU\->,?^1WU_\ ["5Q_P"C&K[EKX:\8_\
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M?,%=EX2^)_B/P5I4NG:/);+;RSF=A+#O.XJJGGZ** /;?VCO^2>:?_V%8_\
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MJ* ?;;=.?.0+C>H_O   @=1[CGYNH **** "BBB@#Z?_ &<?^2>:A_V%9/\
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M#J>Y)ZDGN3S6A10 4444 %%%% 'P!1110 4444 %%%% !1110 4444 %%%%
M!114]G976HWD5I96\MS<RG;'%"A9F/H .30!!7H/P\^$VL>.72\?-EHP?#W3
MJ=TH&<B(?Q'(P3T'N1BO2_AY\!8+(P:IXO5+BY'S+IH(:.,@@C>P.'Z?=^[Z
MYKW%$6-%1%"HH 55& !Z"@#"\*>#=$\&:8++1[-8R5433L,RSD=W;OU)QT&3
M@"M^BB@ HHHH **** "BBB@#X HHHH **** "BBB@ HHHH **** "BE1&D=4
M12S,<!0,DGTKW+X?? .XO3%J7C /;VW5=.1MLC\_\M&'W0>>!SSU% 'G/@CX
M=Z[X[O0FG0>78QR!+B]DXCBXS]6;'8>HS@'-?4/@3X;:'X"M,V49GU&6,1W%
M]*/GDYR0HZ(N>P]!DL0#746&GV6E6,5EI]I#:VL0(2&! B+DY. /4DGZFK-
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M  !M;G1R4D="(%A96B 'YP +  @ !0 W  QA8W-P35-&5
M                    ]M8  0    #3+6QC;7,
M                                          UD97-C   !(    $!C
M<')T   !8    #9W='!T   !F    !1C:&%D   !K    "QR6%E:   !V
M !1B6%E:   ![    !1G6%E:   "     !1R5%)#   "%    "!G5%)#   "
M%    "!B5%)#   "%    "!C:')M   "-    "1D;6YD   "6    "1D;61D
M   "?    "1M;'5C          $    ,96Y54P   "0    < $< 20!- %
M( !B '4 :0!L '0 +0!I &X ( !S %( 1P!";6QU8P         !    #&5N
M55,    :    ' !0 '4 8@!L &D 8P @ $0 ;P!M &$ :0!N  !865H@
M    ]M8  0    #3+7-F,S(       $,0@  !=[___,E   'DP  _9#___NA
M___]H@   ]P  ,!N6%E:(        &^@   X]0   Y!865H@        ))\
M  ^$  "VQ%A96B        !BEP  MX<  !C9<&%R80       P    )F9@
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M 1$  A$! Q$!_\0 &@ !  ,! 0$               @)"@<&!?_$ !0! 0
M                  #_V@ , P$  A #$    <_X
M                                                          !Z
M L/('G@               2/)W@  \>58@  TNESY! QY       V^ RQ$(
M     "WXT_   C^8@P  7W&@XK0,F0      -_@,@1        M^-/P(   X
M^98@  ?0)OD,#SX /8'CP  >P/'@W^ R!$       "WXT_ P!@ %_P 7_$?S
M,$:33F!'\M_( &0([>:3BQ\] 1 ,X)  $SS2\3//GE4!;>#($0       +?C
M3\#($ #SY8^7_'CP>P( $?RW\@ 9(C9X2@(WG(";X,<1Q\VFG0#GYQ\E  9
MB       !;\:?@  1_*@2_X'#RC$@@77%OY  J -/QR\RY'GRYXM?*L",!?<
M1_,:1S N>-+P,@1        M^-/P(_@ X@5X%_P,<1" &GTM_( $,"\X  $7
MR*!:>4H&;('T#?8#($0       +?C3\# &  7_%_QY\P1@&GTM_( %8!H^(W
MF9('7SSYR M?+OB !D"!-\V.@R!$       "WXT_ P!@ %_Q?\1_,08!I]+?
MR !F!-II[ I!(WE]QV S(D<#7Z"M B@6W'< 9 B       !;\:?@8 P "_XO
M^(_F(, T^EOY  R!%GQI^.@ %4!ER/GEYQH>/H X^=@!D"(       '7R4 (
M   '?R0!Y\A  2?.P'/R( /8$_SWY# C  #OY-\\@0/)@ A^>
M           !I]!1"1@      +?C3\  "/YB#           -_@,@1
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M?@J . '7RY\$("N
M
M
M
M
M
M         ';SB                      !;<:3C"&
M    >_--Q:># &                    "P\T^G< # &
M    #T!H>+O@ # &                   2_-1I+   & ,
M     ^@7?&AX^@   8 P                 =_-/Q/\    P!@
M       %MQI..@     P!@               'OS3<6G@     P!@
M        L/-/IW       P!@              ] :'B[X       P!@
M        $OS4:2P       !@#             /H%WQH>/H        & ,
M          '?S3\3_         , 8           !;<:3CH          , 8
M          ![\TW%IX          , 8          +#S3Z=P           ,
M 8         /0&AXN^            , 8        !+\U&DL
M 8 P       #Z!=\:'CZ             !@#       !W\T_$_P
M    # &       2?-CIT               '_\0 *!   00! P4!  ,  P
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MDB716--<-CF/LLBT7Q :Q&Y>%H^=?;2KE/R+'%E&-9X18B-V:2W:E/4=)I8
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M" @$!0('   #! (%!@$3%!( !Q 5MA$6=B P-C=0AJ;6(2,UE9;&U>8D)29
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MUB-[(];5T2_2&&L5!,05@34IH!B4YYDSG[L^L,?[7_Q_:>G<5\,Y^[/K#'_
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MQA+2L.%X V["NY"HPKF9UH';)IAHOAG/W9]'X_\ /7_P!:>HL5\?H-^)L/\
MS!V^@WXFP_\ ,';Z#?B;#_S!V^@WXFP_\P=K*ZM,-XM93U[EI8L^\.*FXZ->
MN1ML^RO>%8+M+B(3; (AI]/2,<YZZ1U[T?N3_-WA>8X\1@25_3V5*X520X-#
M5M4C(L$6F81Q08@(\Y!D4!AQ)I'68B1]L-:_'\?KUZJFJE]%D45M-=L0_;*<
MY2G.4RG8.69&&VV"%:<:*9IHQF3%++MG/W9]88_VO_C^T].XKX9S]V?6&/\
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M;U] ^CZ<_AG#_P O]K*EM,RY59<5[E78K>[V*AY"-@N11L&\O1B8%NKE(/<
M49H=74,D)Z:2T\3TN'9)Y/6-6!;0ZWD]#8=;QEU5"'WK2K=8CU+I+#VX%B'3
M;ZHCTG,DI?3G\,X?^7^SV-9+E?F5)9<;FI>1XVGO<-Q=]?\ Q"%.JV/;;5 7
M]4>'7T=$^H<IPEX$>QR\N*!TJ\E"N4MD[5-$5F01IK$81, LUYE  L@RGJ.1
M BGK'J'#70C#UQ3Y**:\@Q1NJ"N J(DB"GHV.>.#H'=6(1',,8E<(KMG+K-:
M9= %"RN&KPA IUS!$\I47$VDB%'*$&UH/9"ZE)A>6NA@Q<3;5U)".C"QQ=8I
M0J\JR^PL*R/5N5RX4*=%OVF68CYBI2J5R]GL,)KG4\Q&UPC0U(ILS(76?R#Q
MP[*+"G7:W=3H>Q:PJYF-Q="-^4V@':R-A*"2P?,8*1>T7'QHL:+S(.0%&UL0
MO&!;FY:6E,Z)YKK,0D=\=+;T]9'9A.*X^-7+^T(AZFW6-2G(-A&XI\:%!>(9
M(TM!7'5*2)"SU;)/(QW[NC$XD@&41.#5VP"U@M NIRF+=91=6%Y9EZ].2^>1
M=@,V#M\1(/Z%Z^O&PTP1>N1$NBKNSBLN*&O3V^G/X9P_\O\ ;Z<_AG#_ ,O]
MGLER5[S*[LN-S7>,FGO<--=!?_#H+JJ#VU%0"_5 AU]'7/J)*<Y?9G[?S_\
M>F._E7M^W\__ 'ICOY5[9)AU*>P:K*?R?C'M"KF>GYA0U=H;?(HJDO+I8=+
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MR6KKEMP(>0]84KJB@-Y@@EQ;K!1CW#E&&'5U$)"&FLM-:J;"]CD%LQ"QR*T
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MOQM_:/;ZKOQM_:/RLH_TO[R>\GDG_P [\GX7D_F__P!HM.1R/-/_ *&UL?\
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M*2T%E%N/48_+WEAMI,I5].U(LV0NMQ.TZNI'BUO LT[F J7%Z6OHZP71KQD
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MHO'!IRZ@IJC?1C96/;!<(['GH0<;]6*N&[DMI%85J[B%/ X#SN&-;)L79"7
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M1[Q__]H # ,!  (  P   !
M                                           0              "2
M220  "        2       0  "                   "   0
M         0    000 2     0       "      " ""  2"0        0  "
M " 0"" 00"00       " 22   "    "00         0      0 " 2
M      "    " " 0 2"  "        0    0 0 2 "   0       "   "
M"   2  2" 0                     "2      "   0
M    0  "                   "   "00 2 222""0  "2    0    0 0
M  0     2     " 22   ""2 "  0" "      0  " " 00  0 " 0 "
M " 220  "" 0" 00" 0      0    0 022 0"" 0 02    "    " "0  "
M 00"   0           " 0 0"" 0""
M
M
M
M
M
M                         "                      "0
M           2                      "
M                    0
M     0                      2                     "0
M              0                                            "
M                                            "
M       "0                     2                      "
M                                       0
M                        0                      2
M   ?_\0 %!$!                    L/_:  @! P$!/Q Y'__$ !01 0
M                 +#_V@ ( 0(! 3\0.1__Q  B$  " 0$) 0$
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E=*F,5/U[Q'\W]_\ _AQ,1G2>!?(O%TRL#VD6?;8YB7N'_=__V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>GRAPHIC
<SEQUENCE>12
<FILENAME>humanalogo.jpg
<TEXT>
begin 644 humanalogo.jpg
M_]C_X  02D9)1@ ! 0$ 8 !@  #_VP!#  ," @," @,# P,$ P,$!0@%!00$
M!0H'!P8(# H,# L*"PL-#A(0#0X1#@L+$!80$1,4%145# \7&!84&!(4%13_
MVP!# 0,$! 4$!0D%!0D4#0L-%!04%!04%!04%!04%!04%!04%!04%!04%!04
M%!04%!04%!04%!04%!04%!04%!04%!3_P  1"  L -(# 2(  A$! Q$!_\0
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!V0$!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>13
<FILENAME>R1.htm
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<html>
<head>
<title></title>
<link rel="stylesheet" type="text/css" href="include/report.css">
<script type="text/javascript" src="Show.js">/* Do Not Remove This Comment */</script><script type="text/javascript">
							function toggleNextSibling (e) {
							if (e.nextSibling.style.display=='none') {
							e.nextSibling.style.display='block';
							} else { e.nextSibling.style.display='none'; }
							}</script>
</head>
<body>
<span style="display: none;">v3.23.3</span><table class="report" border="0" cellspacing="2" id="idm140190020562800">
<tr>
<th class="tl" colspan="1" rowspan="1"><div style="width: 200px;"><strong>Cover Page<br></strong></div></th>
<th class="th"><div>Nov. 09, 2023</div></th>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CoverAbstract', window );"><strong>Cover [Abstract]</strong></a></td>
<td class="text">&#160;<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentType', window );">Document Type</a></td>
<td class="text">8-K<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_DocumentPeriodEndDate', window );">Document Period End Date</a></td>
<td class="text">Nov.  09,  2023<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityRegistrantName', window );">Entity Registrant Name</a></td>
<td class="text">Humana Inc.<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityCentralIndexKey', window );">Entity Central Index Key</a></td>
<td class="text">0000049071<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_AmendmentFlag', window );">Amendment Flag</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityIncorporationStateCountryCode', window );">Entity Incorporation, State or Country Code</a></td>
<td class="text">DE<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityFileNumber', window );">Entity File Number</a></td>
<td class="text">001-05975<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityTaxIdentificationNumber', window );">Entity Tax Identification Number</a></td>
<td class="text">61-0647538<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressAddressLine1', window );">Entity Address, Address Line One</a></td>
<td class="text">500 W. Main Street,<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressCityOrTown', window );">Entity Address, City or Town</a></td>
<td class="text">Louisville<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressStateOrProvince', window );">Entity Address, State or Province</a></td>
<td class="text">KY<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityAddressPostalZipCode', window );">Entity Address, Postal Zip Code</a></td>
<td class="text">40202<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_CityAreaCode', window );">City Area Code</a></td>
<td class="text">502<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_LocalPhoneNumber', window );">Local Phone Number</a></td>
<td class="text">580-1000<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_WrittenCommunications', window );">Written Communications</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SolicitingMaterial', window );">Soliciting Material</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementTenderOffer', window );">Pre-commencement Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_PreCommencementIssuerTenderOffer', window );">Pre-commencement Issuer Tender Offer</a></td>
<td class="text">false<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_Security12bTitle', window );">Title of 12(b) Security</a></td>
<td class="text">Common Stock<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_TradingSymbol', window );">Trading Symbol</a></td>
<td class="text">HUM<span></span>
</td>
</tr>
<tr class="ro">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_SecurityExchangeName', window );">Security Exchange Name</a></td>
<td class="text">NYSE<span></span>
</td>
</tr>
<tr class="re">
<td class="pl" style="border-bottom: 0px;" valign="top"><a class="a" href="javascript:void(0);" onclick="Show.showAR( this, 'defref_dei_EntityEmergingGrowthCompany', window );">Entity Emerging Growth Company</a></td>
<td class="text">false<span></span>
</td>
</tr>
</table>
<div style="display: none;">
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_AmendmentFlag">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the XBRL content amends previously-filed or accepted submission.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_AmendmentFlag</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CityAreaCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Area code of city</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CityAreaCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_CoverAbstract">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Cover page.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_CoverAbstract</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:stringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentPeriodEndDate">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentPeriodEndDate</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:dateItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_DocumentType">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_DocumentType</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:submissionTypeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressAddressLine1">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Address Line 1 such as Attn, Building Name, Street Name</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressAddressLine1</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressCityOrTown">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the City or Town</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressCityOrTown</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressPostalZipCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Code for the postal or zip code</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressPostalZipCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityAddressStateOrProvince">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the state or province.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityAddressStateOrProvince</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:stateOrProvinceItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityCentralIndexKey">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityCentralIndexKey</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:centralIndexKeyItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityEmergingGrowthCompany">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Indicate if registrant meets the emerging growth company criteria.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityEmergingGrowthCompany</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityFileNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityFileNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:fileNumberItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityIncorporationStateCountryCode">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Two-character EDGAR code representing the state or country of incorporation.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityIncorporationStateCountryCode</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarStateCountryItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityRegistrantName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityRegistrantName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_EntityTaxIdentificationNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b-2<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_EntityTaxIdentificationNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:employerIdItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_LocalPhoneNumber">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Local phone number for entity.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_LocalPhoneNumber</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:normalizedStringItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementIssuerTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 13e<br> -Subsection 4c<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementIssuerTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_PreCommencementTenderOffer">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 14d<br> -Subsection 2b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_PreCommencementTenderOffer</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_Security12bTitle">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Title of a 12(b) registered security.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection b<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_Security12bTitle</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:securityTitleItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SecurityExchangeName">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Name of the Exchange on which a security is registered.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Number 240<br> -Section 12<br> -Subsection d1-1<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SecurityExchangeName</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:edgarExchangeCodeItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_SolicitingMaterial">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Exchange Act<br> -Section 14a<br> -Number 240<br> -Subsection 12<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_SolicitingMaterial</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_TradingSymbol">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Trading symbol of an instrument as listed on an exchange.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>No definition available.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_TradingSymbol</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>dei:tradingSymbolItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
<table border="0" cellpadding="0" cellspacing="0" class="authRefData" style="display: none;" id="defref_dei_WrittenCommunications">
<tr><td class="hide"><a style="color: white;" href="javascript:void(0);" onclick="Show.hideAR();">X</a></td></tr>
<tr><td><div class="body" style="padding: 2px;">
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">- Definition</a><div><p>Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act.</p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ References</a><div style="display: none;"><p>Reference 1: http://www.xbrl.org/2003/role/presentationRef<br> -Publisher SEC<br> -Name Securities Act<br> -Number 230<br> -Section 425<br></p></div>
<a href="javascript:void(0);" onclick="Show.toggleNext( this );">+ Details</a><div style="display: none;"><table border="0" cellpadding="0" cellspacing="0">
<tr>
<td><strong> Name:</strong></td>
<td style="white-space:nowrap;">dei_WrittenCommunications</td>
</tr>
<tr>
<td style="padding-right: 4px;white-space:nowrap;"><strong> Namespace Prefix:</strong></td>
<td>dei_</td>
</tr>
<tr>
<td><strong> Data Type:</strong></td>
<td>xbrli:booleanItemType</td>
</tr>
<tr>
<td><strong> Balance Type:</strong></td>
<td>na</td>
</tr>
<tr>
<td><strong> Period Type:</strong></td>
<td>duration</td>
</tr>
</table></div>
</div></td></tr>
</table>
</div>
</body>
</html>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>14
<FILENAME>hum-20231109_htm.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version="1.0" encoding="utf-8"?>
<xbrl
  xml:lang="en-US"
  xmlns="http://www.xbrl.org/2003/instance"
  xmlns:dei="http://xbrl.sec.gov/dei/2023"
  xmlns:link="http://www.xbrl.org/2003/linkbase"
  xmlns:xlink="http://www.w3.org/1999/xlink">
    <link:schemaRef xlink:href="hum-20231109.xsd" xlink:type="simple"/>
    <context id="c-1">
        <entity>
            <identifier scheme="http://www.sec.gov/CIK">0000049071</identifier>
        </entity>
        <period>
            <startDate>2023-11-09</startDate>
            <endDate>2023-11-09</endDate>
        </period>
    </context>
    <dei:EntityCentralIndexKey contextRef="c-1" id="f-21">0000049071</dei:EntityCentralIndexKey>
    <dei:AmendmentFlag contextRef="c-1" id="f-22">false</dei:AmendmentFlag>
    <dei:DocumentType contextRef="c-1" id="f-1">8-K</dei:DocumentType>
    <dei:DocumentPeriodEndDate contextRef="c-1" id="f-2">2023-11-09</dei:DocumentPeriodEndDate>
    <dei:EntityRegistrantName contextRef="c-1" id="f-3">Humana Inc.</dei:EntityRegistrantName>
    <dei:EntityIncorporationStateCountryCode contextRef="c-1" id="f-4">DE</dei:EntityIncorporationStateCountryCode>
    <dei:EntityFileNumber contextRef="c-1" id="f-5">001-05975</dei:EntityFileNumber>
    <dei:EntityTaxIdentificationNumber contextRef="c-1" id="f-6">61-0647538</dei:EntityTaxIdentificationNumber>
    <dei:EntityAddressAddressLine1 contextRef="c-1" id="f-7">500 W. Main Street,</dei:EntityAddressAddressLine1>
    <dei:EntityAddressCityOrTown contextRef="c-1" id="f-8">Louisville</dei:EntityAddressCityOrTown>
    <dei:EntityAddressStateOrProvince contextRef="c-1" id="f-9">KY</dei:EntityAddressStateOrProvince>
    <dei:EntityAddressPostalZipCode contextRef="c-1" id="f-10">40202</dei:EntityAddressPostalZipCode>
    <dei:CityAreaCode contextRef="c-1" id="f-11">502</dei:CityAreaCode>
    <dei:LocalPhoneNumber contextRef="c-1" id="f-12">580-1000</dei:LocalPhoneNumber>
    <dei:WrittenCommunications contextRef="c-1" id="f-13">false</dei:WrittenCommunications>
    <dei:SolicitingMaterial contextRef="c-1" id="f-14">false</dei:SolicitingMaterial>
    <dei:PreCommencementTenderOffer contextRef="c-1" id="f-15">false</dei:PreCommencementTenderOffer>
    <dei:PreCommencementIssuerTenderOffer contextRef="c-1" id="f-16">false</dei:PreCommencementIssuerTenderOffer>
    <dei:Security12bTitle contextRef="c-1" id="f-17">Common Stock</dei:Security12bTitle>
    <dei:TradingSymbol contextRef="c-1" id="f-18">HUM</dei:TradingSymbol>
    <dei:SecurityExchangeName contextRef="c-1" id="f-19">NYSE</dei:SecurityExchangeName>
    <dei:EntityEmergingGrowthCompany contextRef="c-1" id="f-20">false</dei:EntityEmergingGrowthCompany>
</xbrl>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EXCEL
<SEQUENCE>15
<FILENAME>Financial_Report.xlsx
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 Financial_Report.xlsx
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M=]W3CHG&K=!X#;[Q3X?#KHG&J]!TZVDF)_VN:Z3I%FA"1N/K>A(5M>5 TR
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M!Z.:60F]A%9JGZJ'-#ZH'C(*!?&Y'C[E>G@*-Y;&O%"N@GL!_]':-\*K^(+
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MU4#E/]O4#6CV#30<D05>,9FV-J/D3@H\W/[O#;#"Q([A[8N_ 5!+ P04
M"  JAVE7I#V&!2X$  !<$   &    'AL+W=O<FMS:&5E=',O<VAE970Q+GAM
M;*68VV[C-A"&7X50@:(%DN@0'U/;0.(D39##&K&WP;;H!2U1-A&)5$G*A[?O
M4'8D=U<>&6@N8E'6_/HT,_I)>K"6ZD,O&3-DDR9"#YVE,=F5Z^IPR5*J+V3&
M!'P32Y52 T.U<'6F&(V*H#1Q \_KN"GEPAD-BG,3-1K(W"1<L(DB.D]3JK8W
M+)'KH>,[GR?>^&)I[ EW-,CH@DV9^9I-%(S<4B7B*1.:2T$4BX?.M7]U$[1L
M0''%'YRM]<$QL8\RE_+##AZCH>-9(I:PT%@)"A\K-F9)8I6 XY^]J%/>TP8>
M'G^JWQ</#P\SIYJ-9?+.([,<.CV'1"RF>6+>Y/J![1^H;?5"F>CB/UGOKFVU
M'!+FVLAT'PP$*1>[3[K9)^(@(/".! 3[@*#@WMVHH+REAHX&2JZ)LE>#FCTH
M'K6(!C@N;%6F1L&W'.+,:"Q73)$)%&#@&M"S9]UP'WNSBPV.Q+[*U07Q^F<D
M\(++_X:[@%&R!"5+4.A=HBQ_7<^U45"MO^N(=@JM>@7;PE<ZHR$;.M"CFJD5
M<T8__^1WO-\0OLN2[Q)3']W*,(>&-&2VS6K3A8?WSI\0B%8)T3H-8L(4EQ&Y
M$Q&!RM?RX$I%^8KZ-16P7;*U4<4[8;C9DC>VX+:$ /E*TUHR7.<A3ZF@Y%&$
M%PA5IZ3JG$(UAJ0IFH!JQ#;DB6WKN' ES_ZU^E[71["Z)587%;N&*D9%)>\3
MNJB#P>-CFFB&</1*CMXIZ8%D2Y5)1:U9GI&I@9XB4I&QS"%OD#X9U582%[^]
M0PC[)6'_%,)[GC#RFJ=SINI < W/\\^]=K_;1GA\KS)-[Q2B&=V0QPA*R&,>
M%HE#^!HD.\#7:77;ESV,\,#6_5,(KZ,(?%"??1Z09[B.?!'U;H]+MCV/O%^0
M%YCJH3T4S#AG&&KE^CYJVC^@CNT(.F\FUZ(6$Y=[ECG7*YXDV,OA5Y[OXZ[]
M/5WY8DR47'$1UF<2UWSZAJ%5,X&/&_CW:!.I#1C<GSP[^K8V*+8\F DPMFHF
M\'$++XIX#>O$XRBX0!L'J<S?QSW[68:0D\E2"LP\&D3:/>_<!^_'B"K?]W'C
M?E?<&"8@,6F:B[UQZ%JJ_S<#^-44X.,V/94)#[GA8@&OMX&%!4UJ>7"51I[*
M\'W<K2>*G8>0'@;OUV[%!7,EK V_Q/&1^N%Z361!Y?P!;M,_D#UJG0-9$V"#
M;"-@9?P![M(S;F":E#'Q@U_FOY(I"W/HM]K%3H.2[4]IK5Z&'QC:P?(>=^:9
MHI%ML>DVG<O:!FL0>/CZ@H%4GA[@_ON9%'*W"9=4+-C1=6J#T.NW*;; "2HK
M#TZR\KN4J85-T>^@8);6(C(JZHN'"QYM*/=@KVCWW2_4WE&3A,4@Y%UTP9;5
M;BN[&QB9%=O'N32P&2T.E[#]9\I> -_'4IK/@=V1EC\HC/X%4$L#!!0    (
M "J':5>?H!OPL0(  .(,   -    >&PO<W1Y;&5S+GAM;-U7;6O;,!#^*T(_
M8&YB:N*1&+9 8;"-0O-A7Y58=@1Z\62Y<_KKI[-L)VEU9=V'L<VAR=T]NKM'
M=R>9KEMWDOSAR+DCO9*ZW="C<\W[)&D/1ZY8^\XT7'ND,E8QYU5;)VUC.2M;
M<%(R6=[<9(EB0M-BK3MUIUQ+#J;3;D-O:%*L*Z//EI0&@U_*%">/3&[HEDFQ
MMV)8RY20IV!>@N%@I+'$>2I\0Q=@:9\"O @:L!SC**&-!6,2,H3O_;C\&3!I
MK5>%E#/!)0V&8MTPY[C5=UX9%@_&%Q 9Y=VI\0QKRTZ+Y2T].PP_/LG>V)+;
M.<V"3J9B+7D%=*RHC_#K3), Z)Q17B@%JXUF X?)8Q1\V .7\@%:^*VZBMU7
M)/3B4PEM(+#52?2$1C&$"0K$OXP68E^$O?VML*01C\9][/QN]*!_[XSC]Y97
MHA_TOIKS8]$7>'36-/+T08I:*Q[V_LL)BS6;_,C16/'DL\&D'+R!6TH>N77B
M<&GY85FSX[V;IJFO<,[+?Y#SGZUSS36W3%Z2]J/_-U?Y+8R3\?1<'-&K SI;
M"5R$&_H5[E=YYD#VG9!.Z%$[BK+D^L4Y]>$=V_L+_"J^7U_RBG72[69P0\_R
M%UZ*3N7SJGNHR[CJ+'^&^VB1S;>PSR5TR7M>;D?5UOM!)%[P6<<'')XC=\,3
M1S"?@,41P+ \& /,)WAA>?ZG_:S0_00,X[:*(BO49X7Z!*\8LAT^6)ZX3^Z?
M^$[S/$VS#*OH=AMEL,7JEF7P%X^&<0,/+ ]D>ENM\6[C$_+Z'& ]?6U"L)WB
MDXCM%*\U(/&Z@4>>Q[N-Y0$/K O8[$#^>!Z8J;A/FD)7,6[8"<:1/,<0F,7X
MC&894IT,/O'^8*<D3?,\C@ 69Y"F& *G$4<P!L !0])T> \^>Q\ETWLJ.?]7
M4_P$4$L#!!0    ( "J':5>7BKL<P    !,"   +    7W)E;',O+G)E;'.=
MDKENPS ,0'_%T)XP!] AB#-E\18$^0%6H@_8$@6*19V_K]JE<9 +&7D]/!+<
M'FE [3BDMHNI&/T04FE:U;@!2+8ECVG.D4*NU"P>-8?20$3;8T.P6BP^0"X9
M9K>]9!:G<Z17B%S7G:4]VR]/06^ KSI,<4)I2$LS#O#-TG\R]_,,-47E2B.5
M6QIXT^7^=N!)T:$B6!::1<G3HAVE?QW']I#3Z:]C(K1Z6^CY<6A4"H[<8R6,
M<6*T_C6"R0_L?@!02P,$%     @ *H=I5QE%%?4W 0  )P(   \   !X;"]W
M;W)K8F]O:RYX;6R-4=%NPC ,_)4J'[ 6M"$-45Y VY"F#8V)]]"ZU"*)*\>%
MC:^?VZH:TE[VE-S9NMQ=%A?BTX'HE'QY%V)N:I%FGJ:QJ,';>$<-!)U4Q-Z*
M0CZFL6&P9:P!Q+MTFF6SU%L,9KD8M;:<W@(2* 0I*-D1>X1+_)UW,#ECQ ,Z
ME._<]'<')O$8T.,5RMQD)HDU75Z(\4I!K-L53,[E9C(,]L""Q1]ZUYG\M(?8
M,V(/'U:-Y&:6J6"%'*7?Z/6M>CR#+@^H%7I")\!K*_#,U#88CIV,IDAO8O0]
MC.=0XIS_4R-5%1:PIJ+U$&3HD<%U!D.LL8DF"=9#;E9T!DZV]@A=*'UE4PX!
M19W=U,5SU %ORL'C:*R$"@.4;ZH5E=>2BBTGW='K3.\?)H]:1NO<2KGW\$JV
M''..?[3\ 5!+ P04    "  JAVE7)!Z;HJT   #X 0  &@   'AL+U]R96QS
M+W=O<FMB;V]K+GAM;"YR96QSM9$]#H,P#(6O$N4 -5"I0P5,75@K+A %\R,2
M$L6N"K<OA0&0.G1ALIXM?^_)3I]H%'=NH+;S)$9K!LIDR^SO *1;M(HNSN,P
M3VH7K.)9A@:\TKUJ$)(HND'8,V2>[IFBG#S^0W1UW6E\./VR./ /,+Q=Z*E%
M9"E*%1KD3,)HMC;!4N++3):BJ#(9BBJ6<%H@XLD@;6E6?;!/3K3G>1<W]T6N
MS>,)KM\,<'AT_@%02P,$%     @ *H=I5V60>9(9 0  SP,  !,   !;0V]N
M=&5N=%]4>7!E<UTN>&ULK9--3L,P$(6O$F5;)2XL6*"F&V +77 !8T\:J_Z3
M9UK2VS-.VDJ@$A6%3:QXWKS/GI>LWH\1L.B=]=B4'5%\% )5!TYB'2)XKK0A
M.4G\FK8B2K636Q#WR^6#4,$3>*HH>Y3KU3.T<F^I>.EY&TWP39G 8ED\C<+,
M:DH9HS5*$M?%P>L?E.I$J+EST&!G(BY84(JKA%SY'7#J>SM 2D9#L9&)7J5C
ME>BM0#I:P'K:XLH90]L:!3JHO>.6&F,"J;$#(&?KT70Q32:>,(S/N]G\P68*
MR,I-"A$YL01_QYTCR=U59"-(9*:O>"&R]>S[04Y;@[Z1S>/]#&DWY(%B6.;/
M^'O&%_\;SO$1PNZ_/[&\UDX:?^:+X3]>?P%02P$"% ,4    "  JAVE7!T%-
M8H$   "Q    $               @ $     9&]C4')O<',O87!P+GAM;%!+
M 0(4 Q0    ( "J':5=FT3+9[P   "L"   1              "  :\   !D
M;V-0<F]P<R]C;W)E+GAM;%!+ 0(4 Q0    ( "J':5>97)PC$ 8  )PG   3
M              "  <T!  !X;"]T:&5M92]T:&5M93$N>&UL4$L! A0#%
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M+W=O<FMB;V]K+GAM;%!+ 0(4 Q0    ( "J':5<D'INBK0   /@!   :
M          "  9L1  !X;"]?<F5L<R]W;W)K8F]O:RYX;6PN<F5L<U!+ 0(4
M Q0    ( "J':5=ED'F2&0$  ,\#   3              "  8 2  !;0V]N
E=&5N=%]4>7!E<UTN>&UL4$L%!@     )  D /@(  ,H3      $!

end
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>16
<FILENAME>Show.js
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
// Edgar(tm) Renderer was created by staff of the U.S. Securities and Exchange Commission.  Data and content created by government employees within the scope of their employment are not subject to domestic copyright protection. 17 U.S.C. 105.
var Show={};Show.LastAR=null,Show.showAR=function(a,r,w){if(Show.LastAR)Show.hideAR();var e=a;while(e&&e.nodeName!='TABLE')e=e.nextSibling;if(!e||e.nodeName!='TABLE'){var ref=((window)?w.document:document).getElementById(r);if(ref){e=ref.cloneNode(!0);
e.removeAttribute('id');a.parentNode.appendChild(e)}}
if(e)e.style.display='block';Show.LastAR=e};Show.hideAR=function(){Show.LastAR.style.display='none'};Show.toggleNext=function(a){var e=a;while(e.nodeName!='DIV')e=e.nextSibling;if(!e.style){}else if(!e.style.display){}else{var d,p_;if(e.style.display=='none'){d='block';p='-'}else{d='none';p='+'}
e.style.display=d;if(a.textContent){a.textContent=p+a.textContent.substring(1)}else{a.innerText=p+a.innerText.substring(1)}}}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>17
<FILENAME>report.css
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
/* Updated 2009-11-04 */
/* v2.2.0.24 */

/* DefRef Styles */
..report table.authRefData{
	background-color: #def;
	border: 2px solid #2F4497;
	font-size: 1em;
	position: absolute;
}

..report table.authRefData a {
	display: block;
	font-weight: bold;
}

..report table.authRefData p {
	margin-top: 0px;
}

..report table.authRefData .hide {
	background-color: #2F4497;
	padding: 1px 3px 0px 0px;
	text-align: right;
}

..report table.authRefData .hide a:hover {
	background-color: #2F4497;
}

..report table.authRefData .body {
	height: 150px;
	overflow: auto;
	width: 400px;
}

..report table.authRefData table{
	font-size: 1em;
}

/* Report Styles */
..pl a, .pl a:visited {
	color: black;
	text-decoration: none;
}

/* table */
..report {
	background-color: white;
	border: 2px solid #acf;
	clear: both;
	color: black;
	font: normal 8pt Helvetica, Arial, san-serif;
	margin-bottom: 2em;
}

..report hr {
	border: 1px solid #acf;
}

/* Top labels */
..report th {
	background-color: #acf;
	color: black;
	font-weight: bold;
	text-align: center;
}

..report th.void	{
	background-color: transparent;
	color: #000000;
	font: bold 10pt Helvetica, Arial, san-serif;
	text-align: left;
}

..report .pl {
	text-align: left;
	vertical-align: top;
	white-space: normal;
	width: 200px;
	white-space: normal; /* word-wrap: break-word; */
}

..report td.pl a.a {
	cursor: pointer;
	display: block;
	width: 200px;
	overflow: hidden;
}

..report td.pl div.a {
	width: 200px;
}

..report td.pl a:hover {
	background-color: #ffc;
}

/* Header rows... */
..report tr.rh {
	background-color: #acf;
	color: black;
	font-weight: bold;
}

/* Calendars... */
..report .rc {
	background-color: #f0f0f0;
}

/* Even rows... */
..report .re, .report .reu {
	background-color: #def;
}

..report .reu td {
	border-bottom: 1px solid black;
}

/* Odd rows... */
..report .ro, .report .rou {
	background-color: white;
}

..report .rou td {
	border-bottom: 1px solid black;
}

..report .rou table td, .report .reu table td {
	border-bottom: 0px solid black;
}

/* styles for footnote marker */
..report .fn {
	white-space: nowrap;
}

/* styles for numeric types */
..report .num, .report .nump {
	text-align: right;
	white-space: nowrap;
}

..report .nump {
	padding-left: 2em;
}

..report .nump {
	padding: 0px 0.4em 0px 2em;
}

/* styles for text types */
..report .text {
	text-align: left;
	white-space: normal;
}

..report .text .big {
	margin-bottom: 1em;
	width: 17em;
}

..report .text .more {
	display: none;
}

..report .text .note {
	font-style: italic;
	font-weight: bold;
}

..report .text .small {
	width: 10em;
}

..report sup {
	font-style: italic;
}

..report .outerFootnotes {
	font-size: 1em;
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>XML
<SEQUENCE>18
<FILENAME>FilingSummary.xml
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
<XML>
<?xml version='1.0' encoding='utf-8'?>
<FilingSummary>
  <Version>3.23.3</Version>
  <ProcessingTime/>
  <ReportFormat>html</ReportFormat>
  <ContextCount>1</ContextCount>
  <ElementCount>22</ElementCount>
  <EntityCount>1</EntityCount>
  <FootnotesReported>false</FootnotesReported>
  <SegmentCount>0</SegmentCount>
  <ScenarioCount>0</ScenarioCount>
  <TuplesReported>false</TuplesReported>
  <UnitCount>0</UnitCount>
  <MyReports>
    <Report instance="hum-20231109.htm">
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <HtmlFileName>R1.htm</HtmlFileName>
      <LongName>0000001 - Document - Cover Page</LongName>
      <ReportType>Sheet</ReportType>
      <Role>http://www.humana.com/role/CoverPage</Role>
      <ShortName>Cover Page</ShortName>
      <MenuCategory>Cover</MenuCategory>
      <Position>1</Position>
    </Report>
    <Report>
      <IsDefault>false</IsDefault>
      <HasEmbeddedReports>false</HasEmbeddedReports>
      <LongName>All Reports</LongName>
      <ReportType>Book</ReportType>
      <ShortName>All Reports</ShortName>
    </Report>
  </MyReports>
  <InputFiles>
    <File doctype="8-K" isOnlyDei="true" original="hum-20231109.htm">hum-20231109.htm</File>
    <File>hum-20231109.xsd</File>
    <File>hum-20231109_lab.xml</File>
    <File>hum-20231109_pre.xml</File>
  </InputFiles>
  <SupplementalFiles/>
  <BaseTaxonomies>
    <BaseTaxonomy items="22">http://xbrl.sec.gov/dei/2023</BaseTaxonomy>
  </BaseTaxonomies>
  <HasPresentationLinkbase>true</HasPresentationLinkbase>
  <HasCalculationLinkbase>false</HasCalculationLinkbase>
</FilingSummary>
</XML>
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>JSON
<SEQUENCE>20
<FILENAME>MetaLinks.json
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
{
 "version": "2.2",
 "instance": {
  "hum-20231109.htm": {
   "nsprefix": "hum",
   "nsuri": "http://www.humana.com/20231109",
   "dts": {
    "inline": {
     "local": [
      "hum-20231109.htm"
     ]
    },
    "schema": {
     "local": [
      "hum-20231109.xsd"
     ],
     "remote": [
      "http://www.xbrl.org/2003/xbrl-instance-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xbrl-linkbase-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xl-2003-12-31.xsd",
      "http://www.xbrl.org/2003/xlink-2003-12-31.xsd",
      "http://www.xbrl.org/2005/xbrldt-2005.xsd",
      "http://www.xbrl.org/lrr/role/negated-2009-12-16.xsd",
      "http://www.xbrl.org/lrr/role/net-2009-12-16.xsd",
      "https://www.xbrl.org/dtr/type/2022-03-31/types.xsd",
      "https://xbrl.sec.gov/dei/2023/dei-2023.xsd"
     ]
    },
    "labelLink": {
     "local": [
      "hum-20231109_lab.xml"
     ]
    },
    "presentationLink": {
     "local": [
      "hum-20231109_pre.xml"
     ]
    }
   },
   "keyStandard": 22,
   "keyCustom": 0,
   "axisStandard": 0,
   "axisCustom": 0,
   "memberStandard": 0,
   "memberCustom": 0,
   "hidden": {
    "total": 2,
    "http://xbrl.sec.gov/dei/2023": 2
   },
   "contextCount": 1,
   "entityCount": 1,
   "segmentCount": 0,
   "elementCount": 23,
   "unitCount": 0,
   "baseTaxonomies": {
    "http://xbrl.sec.gov/dei/2023": 22
   },
   "report": {
    "R1": {
     "role": "http://www.humana.com/role/CoverPage",
     "longName": "0000001 - Document - Cover Page",
     "shortName": "Cover Page",
     "isDefault": "true",
     "groupType": "document",
     "subGroupType": "",
     "menuCat": "Cover",
     "order": "1",
     "firstAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hum-20231109.htm",
      "first": true,
      "unique": true
     },
     "uniqueAnchor": {
      "contextRef": "c-1",
      "name": "dei:DocumentType",
      "unitRef": null,
      "xsiNil": "false",
      "lang": "en-US",
      "decimals": null,
      "ancestors": [
       "span",
       "div",
       "body",
       "html"
      ],
      "reportCount": 1,
      "baseRef": "hum-20231109.htm",
      "first": true,
      "unique": true
     }
    }
   },
   "tag": {
    "dei_EntityTaxIdentificationNumber": {
     "xbrltype": "employerIdItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityTaxIdentificationNumber",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Tax Identification Number",
        "label": "Entity Tax Identification Number",
        "documentation": "The Tax Identification Number (TIN), also known as an Employer Identification Number (EIN), is a unique 9-digit value assigned by the IRS."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_TradingSymbol": {
     "xbrltype": "tradingSymbolItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "TradingSymbol",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Trading Symbol",
        "label": "Trading Symbol",
        "documentation": "Trading symbol of an instrument as listed on an exchange."
       }
      }
     },
     "auth_ref": []
    },
    "dei_AmendmentFlag": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "AmendmentFlag",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Amendment Flag",
        "label": "Amendment Flag",
        "documentation": "Boolean flag that is true when the XBRL content amends previously-filed or accepted submission."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityRegistrantName": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityRegistrantName",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Registrant Name",
        "label": "Entity Registrant Name",
        "documentation": "The exact name of the entity filing the report as specified in its charter, which is required by forms filed with the SEC."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_WrittenCommunications": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "WrittenCommunications",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Written Communications",
        "label": "Written Communications",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as written communications pursuant to Rule 425 under the Securities Act."
       }
      }
     },
     "auth_ref": [
      "r6"
     ]
    },
    "dei_SecurityExchangeName": {
     "xbrltype": "edgarExchangeCodeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SecurityExchangeName",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Security Exchange Name",
        "label": "Security Exchange Name",
        "documentation": "Name of the Exchange on which a security is registered."
       }
      }
     },
     "auth_ref": [
      "r2"
     ]
    },
    "dei_EntityCentralIndexKey": {
     "xbrltype": "centralIndexKeyItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityCentralIndexKey",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Central Index Key",
        "label": "Entity Central Index Key",
        "documentation": "A unique 10-digit SEC-issued value to identify entities that have filed disclosures with the SEC. It is commonly abbreviated as CIK."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityEmergingGrowthCompany": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityEmergingGrowthCompany",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Emerging Growth Company",
        "label": "Entity Emerging Growth Company",
        "documentation": "Indicate if registrant meets the emerging growth company criteria."
       }
      }
     },
     "auth_ref": [
      "r1"
     ]
    },
    "dei_EntityAddressAddressLine1": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressAddressLine1",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Address Line One",
        "label": "Entity Address, Address Line One",
        "documentation": "Address Line 1 such as Attn, Building Name, Street Name"
       }
      }
     },
     "auth_ref": []
    },
    "dei_DocumentType": {
     "xbrltype": "submissionTypeItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentType",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Type",
        "label": "Document Type",
        "documentation": "The type of document being provided (such as 10-K, 10-Q, 485BPOS, etc). The document type is limited to the same value as the supporting SEC submission type, or the word 'Other'."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementTenderOffer",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Tender Offer",
        "label": "Pre-commencement Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r4"
     ]
    },
    "dei_EntityAddressPostalZipCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressPostalZipCode",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, Postal Zip Code",
        "label": "Entity Address, Postal Zip Code",
        "documentation": "Code for the postal or zip code"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressStateOrProvince": {
     "xbrltype": "stateOrProvinceItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressStateOrProvince",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, State or Province",
        "label": "Entity Address, State or Province",
        "documentation": "Name of the state or province."
       }
      }
     },
     "auth_ref": []
    },
    "dei_PreCommencementIssuerTenderOffer": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "PreCommencementIssuerTenderOffer",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Pre-commencement Issuer Tender Offer",
        "label": "Pre-commencement Issuer Tender Offer",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r3"
     ]
    },
    "dei_DocumentPeriodEndDate": {
     "xbrltype": "dateItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "DocumentPeriodEndDate",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Document Period End Date",
        "label": "Document Period End Date",
        "documentation": "For the EDGAR submission types of Form 8-K: the date of the report, the date of the earliest event reported; for the EDGAR submission types of Form N-1A: the filing date; for all other submission types: the end of the reporting or transition period.  The format of the date is YYYY-MM-DD."
       }
      }
     },
     "auth_ref": []
    },
    "dei_CoverAbstract": {
     "xbrltype": "stringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CoverAbstract",
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Cover [Abstract]",
        "label": "Cover [Abstract]",
        "documentation": "Cover page."
       }
      }
     },
     "auth_ref": []
    },
    "dei_LocalPhoneNumber": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "LocalPhoneNumber",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Local Phone Number",
        "label": "Local Phone Number",
        "documentation": "Local phone number for entity."
       }
      }
     },
     "auth_ref": []
    },
    "dei_SolicitingMaterial": {
     "xbrltype": "booleanItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "SolicitingMaterial",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Soliciting Material",
        "label": "Soliciting Material",
        "documentation": "Boolean flag that is true when the Form 8-K filing is intended to satisfy the filing obligation of the registrant as soliciting material pursuant to Rule 14a-12 under the Exchange Act."
       }
      }
     },
     "auth_ref": [
      "r5"
     ]
    },
    "dei_CityAreaCode": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "CityAreaCode",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "City Area Code",
        "label": "City Area Code",
        "documentation": "Area code of city"
       }
      }
     },
     "auth_ref": []
    },
    "dei_Security12bTitle": {
     "xbrltype": "securityTitleItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "Security12bTitle",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Title of 12(b) Security",
        "label": "Title of 12(b) Security",
        "documentation": "Title of a 12(b) registered security."
       }
      }
     },
     "auth_ref": [
      "r0"
     ]
    },
    "dei_EntityFileNumber": {
     "xbrltype": "fileNumberItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityFileNumber",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity File Number",
        "label": "Entity File Number",
        "documentation": "Commission file number. The field allows up to 17 characters. The prefix may contain 1-3 digits, the sequence number may contain 1-8 digits, the optional suffix may contain 1-4 characters, and the fields are separated with a hyphen."
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityAddressCityOrTown": {
     "xbrltype": "normalizedStringItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityAddressCityOrTown",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Address, City or Town",
        "label": "Entity Address, City or Town",
        "documentation": "Name of the City or Town"
       }
      }
     },
     "auth_ref": []
    },
    "dei_EntityIncorporationStateCountryCode": {
     "xbrltype": "edgarStateCountryItemType",
     "nsuri": "http://xbrl.sec.gov/dei/2023",
     "localname": "EntityIncorporationStateCountryCode",
     "presentation": [
      "http://www.humana.com/role/CoverPage"
     ],
     "lang": {
      "en-us": {
       "role": {
        "terseLabel": "Entity Incorporation, State or Country Code",
        "label": "Entity Incorporation, State or Country Code",
        "documentation": "Two-character EDGAR code representing the state or country of incorporation."
       }
      }
     },
     "auth_ref": []
    }
   }
  }
 },
 "std_ref": {
  "r0": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b"
  },
  "r1": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "b-2"
  },
  "r2": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "12",
   "Subsection": "d1-1"
  },
  "r3": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "13e",
   "Subsection": "4c"
  },
  "r4": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Number": "240",
   "Section": "14d",
   "Subsection": "2b"
  },
  "r5": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Exchange Act",
   "Section": "14a",
   "Number": "240",
   "Subsection": "12"
  },
  "r6": {
   "role": "http://www.xbrl.org/2003/role/presentationRef",
   "Publisher": "SEC",
   "Name": "Securities Act",
   "Number": "230",
   "Section": "425"
  }
 }
}
</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>ZIP
<SEQUENCE>21
<FILENAME>0001628280-23-038312-xbrl.zip
<DESCRIPTION>IDEA: XBRL DOCUMENT
<TEXT>
begin 644 0001628280-23-038312-xbrl.zip
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M50"E5V48J"L-'\;F4<FR=)V5^ [M+E%C.+X,KGH(OZ=ZJN4T84&.\D73O,Z
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M1 W&N;[4<*'+2R2X8[SQ%9(SH*@:3A(^3A2^2B132"#L-C.W/Z&?\<B#MR2
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M-+ND 3P#0;A32YM>J4E4IU8]\Q,';BQ: R]J"<BES-H'DS,[")IVQH6+XG)
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M56#=9V&C;).'VS??G'>,!?;N>*5$R1^'"[?"M[E0F?CJ4G6%=_L]E7<IX+\
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MO.. &9XD+F5&[Q3FOC(HOKM\*'Y^9TQC)ZNTR6ZB6M=NQG>%13RFG-0<%?_
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MD!%,*)6!EC4T#)83Q0&924HG I?38TLC4XD)K;:N-(4O$UP67FJ!42 .H%9
M4J?E,E<6]W1\>K!]M'=$S.#-,74Y:.C5TP1LZFSH%"?0JNJD^FIL16?W3CW?
MI/8ZJ>5:(&()%_QW=97**ZJFLG43WCS)&=5_.6BU&BW^7P.UJ'H S%)-%>5D
MXV+AWP9%;Y)<U]< D!VBT3C7(IG6JT#J";3R$3_P:D</I2"CD&[E_^4Z(SZ;
M56B%R/\F1*$=,"E$M"P84Q.H$EN2*T<X8U:&*8D1RL;#69C)P.I]FA)7B0 O
MP6B32#+U3L,4<.@DEI>K1V3]$K:Q@ J8,^.T]_IE<J[LA(&%SJPE9Y3ZB%T
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MID%!=Z\<3BAS 8KS:QR\P!Y[9Z11L#EE170T*+'D#NBO$P(;:(GTIH]6U$:
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M<B$Q/*9],%+U08#V@3Z1 '<PL-$-6!'_#A>@Y *V:KAI[T-.(WG"^*;>C^*
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M@>K&=LTE\Z#9;9XTQ1!W\=IO.L%.^V!S7:"?)DFPA']FV3SZ^?\!4$L#!!0
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M+(*# 2P^V)JJ7.F4;EX $$]@98)8N)H7V0RH^,*@3TBKN:.T'VQ-LGRF<@#
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M)3&6H-]3JFUR45(M/R8N( 0MD ? O33R4,T"#1=_HKD("9-XN-I_"G4?PR,
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M]W4EH]Y(I[/N;I=-H"_S!'8H?VT5UB^^8(J <SMI*?B-C=\5%D#N46F[.I,
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M=R) 3B7(#K=R3@"'#U@K16$.\@EN%X<QIC8QOG6/AF.\DT-MQT#TKK/_U#F
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M$'JD?N>BB\-TQ&GW<C#JC3O#CV(PA,_]P46OW^WB7</NX%U3B*O^>7<THK%
MIO;.16^,@W;_^^2LTW_/8WXX&YQW<0#X^[(S'(MW\#>N:83?G'2'X]Z[WDEG
M#'?#E8N&*!9]T?F(?XBW\,YAIS_2LX?ANY=CT4&0\.AO/]+4]80',.'Q\&HT
M%B>#B\M._Z/8P:N__/1R?[_UNE@5?=%^O4O@L*O3$"POOOP" Q$8>71U<E8
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M.8JMK1O)TE.;3LDFBCKLC@\\F4BGS^X$;?TB&B-&2I.#\7>;9F-5BIIU$L'
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MS4J$EC<'/OO(P),I#WPZF(UG'QM8/$$8JQ*OURK;]D1+HJ^X[U](:J(9<5'
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M*PRLF3(*\H7&_!U(,;][6'(^1^GODY*@P;U%'Y =Z!J6E;2PEHKARZ+R%3R
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M;I6TGQ?=/>C?%]2_&K_'M:-E9M%#JQT$-95>]BA9&;609*I^J=X XV4/:ES
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M\=-#B9+':S1(0GF')KF2K)1H^C9I;(4K) _$&O[8$JC,9X7J5M[1@5$ 5Z'
M%$!0>P6ZK/3!EL!EO2!E"H2Y (+ZLT.@#/PXI]33&N6<;[#,\UR#T\JKPLKU
M=F2Y)D%3A48G?:T'NKF<X!UOSL0TCSK>0(ODT;<D:8AZ%6_GR726@L>#J!O,
MUMCUXRMHG[B+!NH3VK<R^4PY=P'TWI"[#Z#J?J*C\3'YE=I!/X3^7[Y<JZA
MN<@+AK5H7^O;:X+8!<_B^!X=EMM,3(7.-?7"0'G8=#P.7.DY)@XQEX0 2R?O
MBMXAL:2S@=D27DQT' "0/3 5J818!,$##[,4:J3T0W&HS;C ._#*/4%LV+RO
M,W-A(B$3]#)3KY;S<3E0.0#W *\SQAY$-F1T8^PH,)IT0V?.Z/P"G#T$W@-.
M;X.+!(PRH#9,*I2[53NR\'VX^;9*0;9R@VSJ4:OTYK.;9D6OJ1\#B"64DE.0
M==C!3^DIRE7F%JE,/66^^)JDHZX& ^UGZN%#]B#/C ERPCD&:RK4PHEG=Y??
MJUPY;FA[02B5:!^BI)CATCQQ>O*Z0O4D3(N2 H8"<\<@++/-6&.*)ZV2S%/+
M6=)YE_'R:YUB//M91;/U8F<5!2<NLH3DR0.7-ROF37F(<24U\1DZ!^%[%<$D
M#HO3X92,Y7,:P*J,ANC;^$$$:@OSB- ;I34^A\"/V7.)><M6CNOV4#Z%@"@N
M[UBT6AMY%NA,]*=/.XY_R<*8>K/(PF !CP8[QJDMVF$T@@V='K\M?FQ)?IR9
MF#2AEB3Z8I=R R;=$4_BH\()N&O?_M??UWE\LV)L66F_NLVRMANY$M9FI754
M__Z>6$STU&50V> &4*[.X5L@P^DL!M^B['K%3W>\J5+UXAI0JV(\[]9O197E
ME_)6U1T.!B]&F%4U_!]HH=&,4QK'.P>0Q+^R),0XG/N5HQ-N#\$W#ZO,@6"]
MZE!!J_+WCJH K6&T:H99UVMZHV981M5A$\NH#,5(UL 6G=T^0^% _N3^J=P*
M.E-S^=M,Q4D:N/\KDF]%>]-Y9\O0M7_)@D $[4_5BZC"P5E.OJ8K?+ $ELZ[
M["]A W8I_>:K*?Z]C#^_C,?P6*86!RW-R;V2V+6RPG-GO;,*C.>I_,G*]O/+
MTDI^>JK^\14%K69*0:L5(+\7M_<I;K4%<?L4'R2MJD3,2L NE'WE>Q8_:R]^
MWXSX64NMW<HSS+V]>TV!J^\%[IL1N/H*>[>\!O[;#Y_JSYT\V?/W+OB[;BSP
M]]7VY2??/MN;M3W??Z-\WPW\,*Z]V+CLZD R_GNG@'H'7U:R?1/X9*O<OH.,
M)AZY[W73^]=-K=8B*U_+JHV;N&IC_N[7BK*-?,G&LB@PK@[)U^Y_^Q)CZ-8;
M$)A=8-X-T))=TSNF;G> .&!EW2D55%WM.D .<9SXUE-\ ^M<UE20/WZ^^4*<
M^!>%#RN+!\?K/@7[SNHZ]N\LO&2%HFF^W&L*WU2%8N_\E\N3VZ\W9[VW7^XU
M?QV0LS\CE\>E:^N]UZ2N1MSDW\)Q(F]*;!KA^S6RQ# ^[198NT]"V&!H"-3/
M)_?9D'J#Q+A)JQMWP&/V"&M_Y70T$L.  W);7+S,\]3K:K2Z43&;YE8*K6(:
MYDN4E-6;S>U+RHZV-:<CUW$\MJ-*JL]?+TXN3\CY9;? ("Y8 J.^PA1LX7 L
M&H9G2[3OE*H__[N]@8?VMC J]KRJ897\&@Q][9I&'O[PY2?F@5W;YE=O7[,D
M;:=<\'KT>D]4B4.[_W9M1C ^=/&PKTRZ0Y<-P("F3[E=R=_(5'?7NC K!P.T
M)R#6HE^GSQLMDNLO_,+%[MRM4XSOVPL!_EN_QE3M!\X4_AN*D=?Y?U!+ P04
M    "  JAVE7EL/%P6T"  !T!P  $    &AU;2TR,#(S,3$P.2YX<V3-55MO
MVC 4?N=7>'F>R0T*B0J5UJK2)+95K-7Z-AGG)+&:V)GM%/KO9YM$-&U9A[2'
M\8)]SO>=^W'.+W9UA1Y!*B;XP@O'@8> 4Y$Q7BR\N]MK//<NEJ/1^0>,[S^M
M5^A*T+8&KM&E!*(A0UNF2Z1+0#^$?&"/!-U41.="UA@O'>U2-$^2%:5&41#%
M/:S7RG0*DSR8QQ.<S*8!GIR%9YA,IAF>1G&<1S"9)6'PL4@#"G.2;Q(\,R<\
MR;,0;Z(\PW$XI4D2SA,ZFSNC.Y4J6D)-D$F-JW2G%EZI=9/Z_G:['6_CL9"%
M'P5!Z-]_67UW4*_#5HP_#-"[C:QZ?.Q;]88HZ.%E6P_0YDXX&5-1^S;7, P2
M#Q&M)=NT&JY-4:X@)VVE%U[+?[6D8CF#S%2\ EO3 >"96A-9@/Y*:E -H?"N
MR^4((5L&5C=":L3?)'9U"),D\7<V,0_MR[82E&@W#4?KX/#8'G$8F0Z,=RKS
M_+]R.S3$N-*$4SC%M[GAGO<O8C@T];08>M[I,3AC"NBX$(]^!LQU[FWWZAC<
M'K ]#'T2SH5V?"OI9$W#>"[V B.R@:=]]&O(^SUY-?QOC(C[2XFD4E3OS)/?
M2-& U S4\\5Q!DH)N6&W->Z']F=%-F,32(]X97_8 :OV#06JU2&1GJN?&L-5
MIOX5[$OS'^?=2#@U;T-1YKEP;3XQ?<N_-7K$LH5W*<S#?T,*$YZ5WZT_'WM:
MG-L#O+?96\T@9YRYJ0O<+T3X\*7 R#&1I9[[+PDO3+4*LF]\Z<XO\^S('>0/
M1$HJVE:G\PYA':5UPKZ.W9;YPS7;WY^MHA/L]WLY^@U02P,$%     @ *H=I
M5W63:A]I"@  2UX  !0   !H=6TM,C R,S$Q,#E?;&%B+GAM;-5<76_;.!9]
M[Z_0>E]V@6$M491$%FT&W4P[*#;3!DV*&>QB8?!+B3"R%,A*D_S[I60[D6+)
M)JE8U;PDCGUU>>Z)SN6]).6W/]\O4^>[+%9)GKV;>:_=F2,SGHLDNWHW^W;Y
M$>#9SR>O7KW]&P!__.OKF?-+SF^7,BN=TT+24@KG+BFOG?):.K_GQ9_)=^J<
MI[2,\V()P$E]V6E^\U D5]>E UWH;\VVGQ9O HEB%_L(D"AP 0J]$% 4"!!
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M0F4IH)5-\N_/2(EW\WDJ6 *BYL*Q)4HS?.<1.1SQW4\WZW+V%>.FJ*OW^_R
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M^]'NBC_:^Q]02P$"% ,4    "  JAVE7HEO>2*4R   0-@$ &
M    @ $     97AH:6)I=#0R+6-L;W-I;F<X>&LN:'1M4$L! A0#%     @
M*H=I5P3M[^=7(@  AKH  !@              ( !VS(  &5X:&EB:70T,RUC
M;&]S:6YG.'AK+FAT;5!+ 0(4 Q0    ( "J':5=MIA&O-#(  & I 0 8
M          "  6A5  !E>&AI8FET-#0M8VQO<VEN9SAX:RYH=&U02P$"% ,4
M    "  JAVE7XM I-4TB  #3N   &               @ '2AP  97AH:6)I
M=#0U+6-L;W-I;F<X>&LN:'1M4$L! A0#%     @ *H=I5WV15OOH$@  G6$
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M+3(P,C,Q,3 Y+GAS9%!+ 0(4 Q0    ( "J':5=UDVH?:0H  $M>   4
M          "  7'J  !H=6TM,C R,S$Q,#E?;&%B+GAM;%!+ 0(4 Q0    (
M "J':5>13YUJKP8  .4P   4              "  0SU  !H=6TM,C R,S$Q
@,#E?<')E+GAM;%!+!08     "@ * *4"  #M^P     !

end
</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
